Interaction between neurons, glia and target field cells in regulating the survival of cranial sensory neurons by Spöri, Bodo Karim Grischa
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JL Aims: During embryonic development, most cutaneous sensory neurons depend for their
survival on a supply ofNGF synthesised in the skin. NGF promotes survival by binding to the
trkA receptor tyrosine kinase whose signalling is modulated by the common neurotrophin
receptor p75. trkA is expressed in trigeminal neurons shortly after axons reach their targets
and NGF expression begins with the arrival of the earliest axons. This thesis was aimed at
investigating interactions between neurons and targets using the trigeminal ganglion and its
maxillary target field. Specifically, it assessed a. whether the induction and subsequent
developmental changes in trkA mRNA seen in the ganglion in vivo are intrinsically regulated
or dependent upon extrinsic signals, and whether N regulation ofNGF expression in the target
field is influenced by the innervating ganglion. Further, it was aimed at c. assessing the
importance of the trkA, trkB (BDNF-receptor) and full-length and truncated p75 neurotrophin
receptors in promoting survival in the developing trigeminal ganglion, and d. determining the
role of non target-related survival-mechanisms by Schwann cell precursors on trigeminal
ganglion neurons and other cranial sensory ganglia, namely the nodose, dorsal root and
superior cervical ganglia.
2. Methodology: a. and b. Ganglion-target interactions and their effect on trkA and NGF
expression were assessed using cultures of trigeminal ganglia and its target fields alone or in
combination. Complementary approaches used knockout mice that increased or decreased the
neuronal population in the trigeminal ganglion in vivo. c. The role of the neurotrophin
receptors trkA, trkB and p75 in trigeminal neuron survival was assessed using knockout mice,
including double knockout mice for trkA and trkB. d. The role of Schwann cell precursors in
the survival of different populations of cranial sensory neurons was assessed using ErbB3
knockouts, which lack these cells.
3. Main Findings: a. Upregulation of trkA mRNA expression in the trigeminal ganglion
appears to follow an intrinsic programme, with in vitro expression levels mimicking levels in
vivo. However, extrinsic signals from the target-fields have a negative effect on trkA
expression in vitro, b. Early target field NGF mRNA expression was positively influenced by
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ganglion innervation in vitro, and was significantly lower in the early target fields of embryos
lacking trigeminal neurons early in development in vivo. c. Double trkA/trkB knockouts
displayed neuronal death in the trigeminal ganglion, in a pattern suggesting that during certain
phases in development there are subsets of neurons, which can survive with either one or the
other receptor, whereas at other developmental stages both receptors are required. Neuronal
losses in different p75 mutant embryos suggest a survival-promoting effect of p75 early in
embryonic development, with truncated p75 having a role earlier in development than full-
length p75. d. Neuronal deficiencies in ErbB3-t- embryos support the idea that populations of
cranial sensory neurons differ in their survival-requirement for Schwann cell precursors early
in development, with early trigeminal and dorsal root neurons being more dependent on this
support than early nodose neurons.
4. Synthesis and conclusions: a. and b. The results suggest that in addition to intrinsic
mechanisms of regulation, trkA and NGF expression are subject to complex reciprocal
interactions between the trigeminal ganglion and its target fields early in development. The
control of survival of neurons during development may thus involve more than the restricted
supply of survival factor from the target field, c, Sequential dependence of sensory neurons on
one or more survival factor probably serves to increase survival to maximize the 'choice' of
the target field during naturally occurring cell death, and to establish heterogeneity in the
ganglion, d. Differences in the sensitivity of cranial sensory neurons to trophic support by
Schwann cell precursors during early development are presumably related to the distance
different populations grow to their target fields. Thus, in addition to survival provided by the
target field, neurons appear to depend on survival signals from surrounding cells between the
ganglion and the target field.
Overall, these data support modifications to the way we should think about the way target
derived signals regulate the survival of peripheral neurons. Rather than being a passive receipt
of a restricted supply of NGF from the target field, it appears that complex target-ganglion
interactions are involved, as well as input from other neurotrophic factors, either separately or





In 1909 Shorey (Shorey, 1909) made an interesting discovery: she found that if the
limb buds in chick embryos were removed, the numbers of spinal motor neurons and
sensory ganglia neurons was subsequently greatly reduced. Transplantation of a
supernumerary limb in contrast was found to lead to hyperplasia of the motor column
and spinal ganglia supplying the limb (May, 1933). Further experiments by
Hamburger (1958) found that removal of the 'target tissue' ofmotor neurons in chick
embryos prior to innervation caused these to die. Hamburger (1975) even observed a
40 percent reduction in motor neurons after connection when the target field was
present. This phenomenon was termed 'naturally occurring cell death'. These
observations led to the hypothesis that these neurons are in competition for limited
amounts of 'trophic factor' provided by the innervated target. According to this
hypothesis, neurons are generated in excess, and due to the limited amount of trophic
factor, neurons that do not get sufficient amounts die.
Since these discoveries, a wealth of evidence has emerged in support of the
neurotrophic theory. The first neurotrophic factor to be identified was Nerve Growth
Factor (NGF) (Cohen et al., 1954), which was found to support the survival of dorsal
root sensory neurons (Levi-Montalcini and Hamburger, 1953). NGF is part of a
family of trophic factors termed neurotrophins, which act through their tropomyosin-
receptor-kinase (trk) and/or p75 receptors to promote survival. Other members of this
family include Brain Derived Neurotrophic Factor (BDNF) (Barde et al., 1982),
Neurotrophin-3 (Hohn et al., 1990), and Neurotrophin-4/5 (Hallbook et al., 1991).
As well as being supported by trophic factors from their target fields there is now also
evidence of neurons being supported by other cells nearby, or indeed in an autocrine
manner by themselves. As addition to their trophic function for neurons, some trophic
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factors, such as the neurotrophins, have been found to fulfil important roles in
supporting neuronal precursors, inducing neurogenesis, and in guiding neuronal
processes to their target fields. The experiments presented in this thesis are aimed at
clarifying the interactions between neurons, glia and target field cells in regulating the
survival of cranial sensory neurons.
This introductory section is aimed at providing background information about the
neuronal populations studied in these experiments, namely the trigeminal, nodose,
dorsal root and superior cervical ganglia, and the actions exerted on them by growth
factors belonging to the neurotrophin family. I will begin with an overview of the
development of the nervous system, particularly the peripheral nervous system, from
neural induction to the point that neurons extend axons to their target fields (1.1). I
will then review evidence for the 'neurotrophic hypothesis', including a description of
the discovery of neurotrophins and how they support neuronal survival when
neuronal processes arrive in the vicinity of their target fields (1.2). The molecular
biology of the neurotrophins, the main trophic factors of interest to this thesis, and
their receptors, will then be discussed in more detail (1.3). The mechanism of
programmed cell death taking place in neurons during development, 'apoptosis', will
then be described, together with the intracellular events underlying this process, and
the pathways through which neurotrophin signalling modulates these death/survival
pathways (1.4). This will be followed by an overview of the role of neurotrophins in
the developing peripheral nervous system and a detailed description of the
experimental systems used, such as the trigeminal ganglion and other peripheral
nervous system ganglia (1.5), before introducing the objectives of the experiments
presented in this thesis (1.6).
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1.1 Development of the vertebrate nervous system
This section will first describe the general origins of the nervous system, before
going into more detail about the embryonic origins of the particular cell types of
interest in this study, namely the neurons of the crania! ganglia. This will be followed
by an overview of the cues that guide neuron progenitor cells to the sites of
developing ganglia and stop them migrating, factors important for the differentiation
of these cells, and the cues governing growth of axons to their target fields.
1.1.1 Origins of the nervous system
Christian Pander was the first to describe three germ layers created during early
embryogenesis in the chick: the ectoderm, mesoderm and endoderm, which give rise
to specific organ systems (Pander, 1817). Karl Ernst von Baer, having examined the
fetal anatomy of numerous species, proposed that all animals have three germ layers,
and that the organs derived from them are constant across species (von Baer, 1928)
This has been found to be true for most species, although some invertebrate animals,
like the jellyfish, lack a true mesoderm (Gilbert, 2003). The endoderm gives rise to
epithelial lining of the digestive, respiratory, biliary and urogenital systems. The
mesoderm gives rise to cells of the muscular, circulatory, lymphatic, reproductive
and excretory systems, dermis of the skin and cells lining the body cavities. The
ectoderm gives rise to the epidermis of the skin and its derivatives, the adrenal
medulla, cornea and lens of the eye, epithelium of the pineal and pituitary glands and
the neurons and glia (with the exception of microglia) of the nervous system (from
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Gilbert et al., 2003). It is the fate of the cells in this last layer that the rest of this
subchapter will describe.
The nervous system originates from ectodermal cells (neuroectodermal cells) located
along the dorsal midline of the embryo at the gastrula stage, which form a thickened
region of ectoderm termed the neural plate (figure 1.1A). During a process known as
neurulation the neural plate invaginates ventrally and forms a neural groove. The
walls of this neural groove are relerred to as the neural folds (Figure LIB). These
folds move together and join dorsally, forming the neural tube (Figure 1.1C). The
central nervous system develops from the walls of the neural tube, with the caudal
region giving rise to the spinal cord and the rostral region becoming the brain. While
joining, some of the cells of the neural fold separate laterally from the others to form
the neural crest between the neural plate and the surface non-neural ectoderm
(Weston, 1963) (Figure 1.1D). The neural crest was first described in 1868 by
Wilhelm His as Zwischenstrang. His also described this group of cells as the source
of spinal and cranial ganglia (cited in Hall, 1999). This was confirmed by Harrison in
1904 (Harrison, 1904), in one of the first experiments to use microsurgery. Harrison
destroyed segments of neural crest together with the dorsal half of the neural tube
from frog embryos and obtained larvae lacking spinal ganglia. It has been shown that
the induction of this neural crest is dependent on interactions between the neuronal
and non-neuronal ectoderm (reviewed in LeDouarin and Kalcheim, 1999).
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Schematic representation of the origin of the nervous system. (A) shows ectodermal cells, along the
dorsal midline of the embryo, forming the neural plate. (B) shows the process of neurulation - the
neural plate invaginates ventrally and forms the neural grove. (C) shows the dorsal walls of the neural
grove, the neural folds, subsequently joining together, forming the neural tube. (D) shows the
formation of the neural crest from cells that separate from the neural fold as it joins (adapted from
Bearet al„ 1996).
1.1.2 Organisation and origin of the peripheral nervous system
The peripheral nervous system (PNS) can be subdivided into two divisions: the
somatic PNS, and the visceral or autonomic PNS. The somatic PNS includes sensory
and motor systems involved with voluntary control, whereas the autonomic PNS is
involved with involuntary control of internal organs. The sensory neurons of the PNS
are segregated into cranial and dorsal root ganglia, whereas the cell bodies of the
motor neurons are located in the brainstem and spinal cord. The autonomic nervous
system has three subdivisions: the sympathetic and parasympathetic, which consist of
pre-ganglionic neurons located in the brainstem and spinal cord and post-ganglionic
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neurons located in autonomic ganglia, and the enteric nervous system located in the
gastrointestinal tract.
The ganglia in the peripheral nervous system have two distinct origins: the neural
crest and the neurogenic placodes. Neural crest cells are a pluripotent, migratory
population of cells that give rise to the facial skeleton, melanocytes, and most of the
neurons and glial cells of the PNS (Weston, 1963). Placodes are paired ectodermal
'unthinnings' that form at the late gastrula stages. At early stages of development the
embryonic ectoderm is generally thick, but it subsequently thins out, apart from
regions giving rise to the placodes, hence 'unthinning' (Graham and Begbie, 2000).
There are two distinct types of placodes: sensory placodes, which contribute to
several sensory organs, and the neurogenic placodes, which supply neurons for the
formation of certain cranial sensory ganglia (LeDouarin, 1982). The neurogenic
placodes can be subdivided into groups that differ in the way they develop and in the
structures they contribute to, namely, the dorsolateral and epibranchial placodes
(Shimeld and Holland, 2000).
The dorsolateral placodes form in proximity of the CNS regions and include the
olfactory placode, the opthalmic and maxillomandibular trigeminal placodes and the
otic placode. The epibranchial placodes, forming at the clefts between the branchial
arches, generate the neurons of the geniculate, petrosal and nodose ganglia (reviewed
by Graham and Begbie, 2000). Like neural crest cells, placode cells are able to form
cutaneous and visceral sensory neurons, neuroendocrine cells and glia (Baker and
Bronner-Fraser, 2001). However, they are confined to the head region and cannot
form autonomic or enteric neurons, melanocytes, smooth muscle and bone like
neural crest cells can.
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It was initially suggested that neurogenic placodes develop in response to migrating
neural crest cells. Removal of the neural crest prior to migration and placode-specific
markers has shown this not to be the case (Stone, 1922; Ma et al., 1998; Fode et al.,
1998). Rather it seems that the pharyngeal endoderm has a role in inducing
neurogenesis in the epibranchial ectoderm, an event mediated by bone
morphogenetic protein-7 (BMP-7) (Begbie et ah, 1999). The above-mentioned bone
morphogenetic protein (BMP) family of growth and differentiation factors and its
inhibitors, such as the secretory proteins Noggin and Chordin, perform important
functions during the formation of the nervous system. Although these proteins,
related to the transforming growth factor-(3 (TGF-(3) superfamily, were first named
for their ability to induce ectopic bone formation (Urist, 1965; Wozney et ah, 1988),
they have since been found to be important in developmental processes, such as the
induction of the central nervous system (Sasai and De Robertis, 1997) and the
formation of the neural crest as an example (Liem et ah, 1997; Selleck et ah, 1998;
Streit and Stern, 1999; Garcia-Castro et ah, 2002). The following sections will
illustrate that the BMP family and its inhibitors are also important for other
developmental processes, such as epithelial-mesenchymal transition and
neurogenesis.
1.1.3 Epithelial-Mesenchvmal Transition (EMT)
Both the neural crest and neurogenic placode populations of neurons migrate to their
spatial position in the embryo head. The mechanisms governing the migration of
neuronal precursors have mainly been studied in the migrating neural crest cells,
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therefore I will concentrate on describing migratory mechanisms believed to act in
this population, although much is still largely unknown.
Neural crest cells migrate along stereotypical pathways to their final destinations,
with ventromedially migrating cells contributing to Schwann cells, chromaffin cells,
and sensory and sympathetic ganglia (LeDouarin and Teillet, 1974). It seems that
many factors necessary for neural crest induction are also necessary for migration of
these cells. The first step ofmigration, the epithelial-mesenchymal transition (EMT),
by which neural crest cells 'convert' to mesenchymal cells able to delaminate and
migrate through the extracellular matrix (Duband et al., 1995) seems to be controlled
by some of the crest inducing factors or homologues of them. Blocking of BMP in
the chick spinal cord through Noggin, for example, has been shown to prevent neural
crest delamination (Sela-Donenfeld and Kalcheim, 1999). Transgenic Noggin
expression in the posterior hindbrain of mouse embryos greatly reduces the amount
of crest cells in that region (Kanzler et al., 2000). BMP induced Slug has also been
implicated in the initiation of EMT, with antisense oligonucleotides preventing
migration of the crest in both chick (Nieto et al., 1994) and Xenopus embryos (Carl et
al., 1999). Inducible Xenopus Slug mutants neural crest cells fail to migrate, and if
the mutation is induced earlier fail to form a neural crest (LaBonne and Bronner-
Fraser, 2000). Slug is believed to interact with the cadherin family of cell adhesion
molecules, which has been implicated in the migration process of neural crest cells.
The upregulation (Nakagawa and Takeichi, 1995; Takeichi et al., 2000), and
downregulation (Akitaya and Bronner-Fraser, 1992; Nakagawa and Takeichi, 1995)
of different members of the cadherins in neural crest cells suggests an important role
in delamination and migration (Nieto, 2001). Indeed, it has been shown that a
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relative of Slug, Snail, which is thought to mediate similar actions to Slug in
mammals (Sefton et al., 1998), can trigger EMT by repressing E-cadherin (Cano et
ah, 2000).
The placode-derived neurons undergo a similar process of epithelial-mesenchymal
transition as the neural crest cells before they migrate. Neurogenins 1 and 2 have
been shown to play a role in this, as mutations in these neurogenin genes results in
failure of the neuroblasts to delaminate, with mutations in neurogenin 1 influencing
migration in trigeminal placodes (Ma et al., 1998), and neurogenin 2 mutations
preventing migration in epibranchial placodes (Fode et al., 1998).
1.1.4 Migration
After delamination, neurons start migrating away from the dorsal neural tube towards
their target areas, a migration regulated by attractive and repulsive signals obtained
from the environment. Neurons migrate by the same mechanisms as other cells
(reviewed by Lambert de Rouvroit and Goffinet, 2001): They extend their leading
edges, preceded by filopodia and lamelipodia, followed by 'nucleokinesis', i.e. the
nucleus moving into the leading processes, and retraction of the trailing process.
Early migration from the neural crest includes cells giving rise to Schwann cells and
the neurons and satellite cells of dorsal root ganglia, autonomic ganglia, certain
cranial sensory ganglia and the enteric nervous system. Neural crest cells specified as
melanoblasts travel dorsolaterally in a later migration. This spatial and temporal
pattern of migration is mediated by attractive and repulsive substances in the
hindbrain, somites and surrounding structures (reviewed by Krull, 2001). Ephrins
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and peanut agglutin (PNA) binding proteins are involved in the inhibitory forces
preventing early migrating neural crest cells, giving rise to sensory and sympathetic
neurons, from migrating dorsolaterally at the early stages of migration (Santiago and
Erickson, 2002; Oakley et al., 1994). Interestingly, migration of late migrating
melanoblasts is promoted by ephrins in the dorsolateral path, giving ephrins a dual
repulsive/attractive role in sorting these two populations of neural crest cells
(Santiago and Erickson, 2002).
Early migrating trunk neural crest cells that give rise to the sensory and sympathetic
ganglia travel through the somatic mesoderm (see arrows figure 1.2D), shortly after
this compartmentalises into an epithelial dermomyotome and a mesenchymal
sclerotome (Guillory and Bronner-Fraser, 1986). Early migrating trunk crest cells
enter the rostral half of the somatic sclerotome while avoiding the caudal half of the
sclerotome, with the migration pattern becoming discontinuous and segmental
(Keynes et ah, 1990). The main repulsive cues identified for neural crest migration
include repulsive cues in the caudal sclerotome, such as the Eph family of receptor
tyrosine kinases (RTKs) and their ligands (Krull et ah, 1997; Wang and Anderson,
1997), and PNA binding proteins, thought to play a role in generating the segmental
pattern of migration of crest cells (Krull et ah, 1995). Other proteins, such as F-
spondin (Debby-Brafman et ah, 1999), collagen IX (Ring et ah, 1996), and Notch
have also been proposed to play a role, with mutations of Notch and its receptor
Delta-1 causing severe disruption in the segmental pattern of migration by neural
crest cells, possibly due to modulation of the distribution pattern of the ephrins (De
Bellard et ah, 2002). A possible attractive cue for trunk neural crest cells has been
identified in the form of thrombospondin (Tucker et ah, 1999), which is found in the
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rostral half-sclerotome that crest cells travel through in vivo and promotes neural
crest migration and adhesion in vitro. The crest cells destined to form the dorsal root
ganglion stop migrating and aggregate within the sclerotome, just outside the spinal
cord, while some cells continue ventrally forming the sympathetic ganglia.
In the caudal region of vertebrates, neural crest cells migrate from the hindbrain in
three main streams from rhombomeres 2, 4 and 6 into the branchial arches 1, 2 and 3
respectively, where they form cranial ganglia and some of the facial skeleton
(Lumsden et al., 1991; Kontges and Lumsden, 1996). This migration in streams is
thought to be crucial to patterning, committing neural crest cells to a specific
anterior-posterior identity (Krumlauf, 1994), and has been suggested to be due to cell
death, by apoptosis, ofmany of the neural crest cells in rhombomeres 3 and 5. This is
induced by signals emanating from rhombomere 4, while cells not dying join the
main streams ofmigrating cells in the rhombomeres next to them (Ellies et al., 2000;
Birgbauer et al., 1995). There is some evidence that migrating crest cells are kept
separate by ephrins, since blocking ephrins can lead to intermixing between the
streams (Smith et al., 1997; Ilelbling et al., 1998). Some neural crest cells stop
ventral migration in proximity of the neural tube and aggregate, forming cranial
ganglia. Some of these aggregates are joined by placodal-derived cells to form
ganglia of mixed origin, such as the trigeminal ganglion (D'Amico-Martel and
Noden, 1983). The maxillary and mandibular processes in the embryo are derived
from ectoderm and neural crest-derived mesenchyme that migrates into the first
branchial arch (Cobourne and Sharpe, 2002). The satellite cells and most of the
neurons of the trigeminal ganglion form from crest cells in the first branchial arch,
the satellite cells of the vestibular and geniculate ganglia from crest cells in the
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second branchial arch, and the satellite cells and neurons of the superior
glossopharyngeal ganglion and the satellite cells of the inferior glossopharyngeal
(petrosal) ganglion from cells in the third branchial arch (Lumsden et al., 1991).
The neural crest has been shown to be essential for the migration of epibranchial
placode cells to their final positions (Begbie and Graham, 2001). Epibranchial
placode-derived neurons are associated temporally and spatially with late streams of
dorsal neural crest cells (Baker et al., 1999). When the migration of the crest cells is
prevented by prior removal of the hindbrain using microsurgery, placode-derived
neurons still form, but do not migrate from the placodal ectoderm any more and do
not project axons in the way they do normally (Begbie and Graham, 2001). The same
study found disruptions in the development of ganglia developing from dorsolateral
placode-derived cells, such as the trigeminal ganglion, suggesting that there is a
regulatory effect of the neural crest on migration and axon pathfinding of many
placode-derived ganglia, although the molecular basis for this is not known thus far.
It has been suggested that neurotrophins such as Brain Derived Neurotrophic Factor
(BDNF) and Neurotrophin-3 (N 1-3) released from the neural tube can act to promote
the survival of some migrating cells (Kalcheim, 1996), since some neural-crest
progenitors die when the action of survival factors from the neural tube is prevented
(Kalcheim and LeDouarin, 1986). BDNF, NT-3 and Fibroblast Growth Factor (FGF)
were identified as factors able to support migrating neural crest cells in culture
(Kalcheim et al., 1987, Kalcheim, 1989).
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1.1.5 Arrest of migration, neurogenesis and gliogenesis of neural
crest and neurogenic placode-derived cells
The signals involved in localising neural crest and placode-derived cells to their final
destination are unclear. Physical barriers, changes in migratory ability and signals
from surrounding tissues have been proposed (McKeown et ah, 2003). A recent
study has suggested that signals from the notochord and floor plate have a regulatory
function in arresting migration of cells destined for the sensory ganglia (Fedtsova et
al., 2003). A component of these signals was found to be Sonic hedgehog (Shh), a
member of the Hedgehog family of secreted signalling proteins, which could arrest
the migration of trigeminal precursors. This was confirmed by the phenotype of Shh
null mutant mouse embryos, in which the cells destined for the trigeminal ganglion
continued to grow towards the midline, eventually forming one single fused
ganglion, instead of two symmetrical ganglia. Some effects on the arrest ofmigration
of precursors of the DRG were also observed in these mice. Shh upregulates the
expression of the hyaluronan-binding proteoglycan PG-M/versican which is naturally
tound in the extracellular matrix and belongs to a family known to have effects on
the migratory properties of neural crest cells (Perris and Perrisinotto, 2000). Shh may
act by restricting the migratory ability of sensory ganglia precursor cells through the
extracellular matrix, setting an 'exclusion zone' for migration and determining the
final morphology of the sensory ganglia at both cranial and trunk levels (Fedtsova et
al., 2003).
BMP-4 and BMP-7 have been shown to induce neurogenesis of some sympathetic
neurons (Varley and Maxwell, 1996; Reissmann et ah, 1996; Schneider et al., 1999).
This has been demonstrated in vivo by using ectopic expression of the BMP inhibitor
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Noggin, which prevents formation of sympathetic neurons (Schneider et al., 1999).
Mashl (Shah et al., 1996; Schneider at al., 1999) and Phox2a (Hirsch et al., 1998;
Stanke et al., 1999) have been shown to be downstream effectors of these BMPs.
The transcription factors neurogenin 1 and 2 have a role in neurogenesis of sensory-
neurons since their absence results in a reduction in sensory neuron subsets. In DRG,
neurogenin 2 seems to be required for the formation of large-diameter sensory
neurons, whereas neurogenin 1 is required for small-diameter neurons, as well as
specifying large-diameter neuron precursors (Ma et al., 1999). Neurogeninl has also
been found to have a role in inhibiting gliogenesis, by binding the CBP/Smadl or
p300/Smadl transcriptional co-activator and sequestering it away from the promoters
of glial genes, preventing transcription (Sun et al., 2001). The same report suggests
that BMPs can induce neurogenesis in the presence of neurogenin 1, whereas they
induce gliogenesis in its absence. Another factor known to have an effect in the
generation of sensory neuron subtypes, NeuroD, has been shown to act downstream
of neurogenin (Anderson, 1999). Inhibition ofNotch results in an increase of cells in
the pcriphcial sensory ganglia expressing neuronal markers, suggesting an important
role of Notch signalling in generating both neural cells and glial cells in the same
aggregation of neural crest cells, since Notch expression has also been shown to lead
to an increase of glial cells in peripheral ganglia (Morrison et al., 2000). Figure 1.2
summarises some of the factors involved in neuronal differentiation and prevention
ofglial differentiation.
There also seems to be a role for neurotrophins in neurogenesis (Kalcheim, 1996). In
the chick embryo dorsal root ganglion, the maturation of some neurons is accelerated
by BDNF and NT-3 (without effect on their survival). Antisense-BDNF
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oligonucleotides greatly reduce the number of neurons undergoing this maturation in
culture (Wright et ah, 1992). BDNF and NT-3 also seem to promote maturation of
early trigeminal ganglion cells (Buchman and Davies, 1993).
In more general terms, the differentiation of sensory neurons also appears to be
linked to interactions between the neural crest and the neurogenic placodes, at least
as far as the trigeminal ganglion is concerned. Neural crest cells, which make up the
majority of cells in the ganglion, reach the position of the trigeminal ganglion first
but don't differentiate. Placodal cells, which arrive later, actually differentiate first,
before the neural crest derived cells do so (Covell and Noden, 1989).
Apart from Notch, gliogenesis from neural crest cells seems to be mediated by
neuregulin. Neuronal derived neuregulins play a major role in controlling the
development and survival of satellite and Schwann cell precursors. (Riethmacher et
al., 1997; Hagedorn et al. 2000; Mirsky et al., 2002). Neuregulins signal through
members of the ErbB family of receptor tyrosine kinases, namely ErbB 1, 2, 3 and 4
(Gassinan and Lemke, 1997; Garratt et al., 2000). To induce gliogenesis, neuregulin
acts via its ErbB3 receptor, which heterodimerises with the co-receptor ErbB2 to
differentiate glia at the expense of neurons (Shah et al., 1994). Consequently ErbB3
knockout mice lack Schwann cells and their precursors (Reithmacher et al., 1997).
(refer to chapters 2 and 6 for more detail on the ErbB3 knockout).
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Figure showing some Factors known to be involved in the control of neuronal and glial differentiation,
and their interaction. The gliogenesis pathway is indicated with red arrows and the neurogenesis
pathway with green arrows. Neurogenin 1 inhibits gliogenesis by binding and sequestering the
transcriptional co-activator CBP/p300/Smadl. In the absence of Neurogenin 1, this transcriptional co-
activator is recruited to the promoters of glial genes by binding to activated STAT1/3 (signal
transducer and activator of transcription 1/3). This results in the expression of genes such as GFAP
(glial fibrillary acidic protein) and glial differentiation. When present, Ncurogeninl binds the
CBP/p300/Smadl complex, recruiting it to the promoters of neuronal genes, and sequestering it from
the promoters of glial genes. Neurogeninl also inhibits the activation of STAT1/3. By these two
mechanisms, Neurogeninl not only promotes the expression of neuronal genes but inhibits the
expression of glial genes. Consistent with this model, bone morphogenetic proteins promote
neurogenesis in the presence of Neurogeninl and gliogenesis in the absence of Neurogeninl
(Morrisson. 200. Notch activation may promote glial lineage determination by inhibiting the
expression of proneural genes such as Neurogenin. LIF-R, leukemia inhibitory factor receptor; BMP-
R, bone morphogenetic protein receptor; NeuroD, a neurogenic transcription factor downstream of
Neurogeninl (adapted from Morrisson, 2001).
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1.1.6 Axonal guidance by diffusible substances in the peripheral
nervous system
As a final step in their initial development, neurons extend processes to their target
fields. Two types of guidance cues have been proposed to guide neuronal processes:
local and target-derived factors. These factors can be either attractive or repulsive.
Some embryonic structures known as 'choice points' serve as intermediate targets on
the trajectory where the actions of guidance cues play a decisive role in directing
nerve growth (Tessier-Lavigne and Goodman, 1996).
A key structure in the guidance of neuronal processes is the growth cone, an
irregular, spiky enlargement at the tip of the growing fibre. It was first described in
1890 by Ramon y Cajal from sections of embryonic spinal cord stained with silver
chromate (Ramon y Cajal, 1890). Described by Ramon y Cajal (from fixed samples)
as being "endowed with amoeboid movements", the growth cone was indeed found
to be a motile structure by Harrison (1910). In his classic experiments, Harrison
isolated pieces of the neural tube of a frog embryo prior to outgrowth, and reared
them in frog's lymph. He was then able to study individual nerve fibres and their
growth cones under the microscope. Thus was invented tissue culture. This new
technique also enabled Harrison to demonstrate that axons extend from a single cell
body (Harrison, 1907, 1910), rather than being composed of individual sheath cells
in segments, as had been previously claimed by Schwann, Hensen, Held and others
(reviewed in Hamburger, 1980).
Following his discovery of the growth cone, Ramon y Cajal proposed that it was
responsible for axonal pathfinding. He suggested 'chemotropism', a chemical
attraction of the growth cone by substances produced by target structures, as a
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mechanism by which neuronal processes may be guided (reviewed by Hamburger,
1980).
One of the early experiments studying the growth of neuronal processes and its
dependence on guidance cues during development was done using co-cultures of the
trigeminal ganglion and its targets, the maxillary and mandibular processes
(Lumsden and Davies, 1983). Trigeminal ganglia were grown on a collagen matrix
together with either one of their target fields, or with cutaneous targets innervated by
other sensory neurons, such the hyoid process or the forelimb bud. The outgrowth of
neurites from the ganglion was observed (Figure 1.3), and it was found that both the
maxillary and the mandibular process elicited and attracted neurite outgrowth
towards them at the stage when it is normally initiated in the trigeminal ganglion.
The hyoid process or the forelimb bud in contrast did not elicit or attract axons
growing from the trigeminal ganglion. It was thus hypothesised, that a diffusible
factor emanated from the maxillary process, attracting outgrowth towards it. This
trigeminal attractant was coined 'Maxillary Factor', thought to be emanating from
the target field epithelium (Lumsden and Davies, 1986).
Some of the components of Maxillary Factor have recently been identified in the
form of NT-3 and BDNF (O'Connor and Tessier-Lavigne, 1999). Anti-NT-3 and
anti-BNDF were shown to reduce neurite outgrowth from the trigeminal ganglion,
completely abolishing it when both were applied simultaneously. Studying ganglia of
knockout mice for NT-3 and BDNF confirmed this inhibition in outgrowth, with NT-
3 mutation having more effect than BDNF mutation. In vivo studies showed no
defect in the growth of the trigeminal nerve in these two mutants however, raising
the possibility that other factors may be involved in the initial growth of axons
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(O'Connor and Tessier-Lavigne, 1999). Indeed it may be that these molecules have
an effect on the outgrowth of secondary fibres, but not on pioneer axons, which
would be guided by different mechanisms.
Neurotrophins have since been found to be involved in the guidance projections from
other ganglia. As an example, using GFP-tagging to visualise outgrowth, it was
found that neurotrophin-containing ectopically placed beads attracted sensory
neurons growing in the mouse limb bud, whereas antibodies to the neurotrophins
inhibited elongation of sensory and motor axons in the limb bud (Tucker et al.,
2001).
In addition to neurotrophins, members of the GDNF family (glial cell-derived
neurotrophic factor) may also play a role in guiding axons in the PNS (reviewed by
Markus et al., 2002). It has recently been found that soluble GFRal, a co-receptor for
GDNF, is able to potentiate neurite outgrowth from nodose neurons in response to
GDNF. Also, GFRal is downregulated in the target fields of the nodose ganglion
(heart and carotid body) once these have been innervated. Together with other data,
this raises the possibility that membrane-bound and soluble GFRal could act with
GNDF as a long-range guidance cue for these axons (Ledda et al., 2002). Flepatocyte
Growth Factor (FIGF) acting through its receptor Met, and FGF signalling have also
been implicated in axonal growth (Ebens et al., 1996; Maina et al., 1997; McFarlane,
1996).
Other candidates for chemoattraction and chemorepulsion include the netrins. These
proteins were originally shown in co-culture experiments to attract commissural
neurons of the developing vertebrate spinal cord to their intermediate target, the floor
plate (Tessier-Lavigne et al., 1988). Extracts of chicken brain were found to have
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similar effects to that of the floorplate, and this led to the identification of netrin 1
and 2 as the active factors in the extracts. Netrin-1 mRNA is restricted to the floor
plate during the period in development when commissural neurons grow toward it in
vivo. Netrin-2 mRNA is expressed in the ventral 2/3 of the spinal cord, suggesting
that it may function as an intermediate guidance factor. The netrins are homologous
to UNC-6 in C.elegans, which can act as an attractant or a repellent for axons
depending on the receptors they express. UNC-40 is the receptor mediating repellent
action and UNC-5 is the receptor for attractive action (Hedgecock et al., 1990). The
vertebrate homologue of UNC-5, DCC, is expressed on commissural neurons at the
appropriate stage of development (Keino-Masu et al., 1996). Also, it was found that
substances secreted in the floor plate could act as repulsive cues for some types of
motor neurons (Guthrie and Pini, 1995). In vitro evidence suggests that Netrin-1,
which acts as a chemoattractant for commissural axons (Tessier-Lavigne et al.,
1988), is released from floorplate cells and repels trochlear motor axons (Calamarino
and Tessier-Lavigne, 1995).
Another family of recently identified guidance cues are the semaphorins and their
receptors, acting as chemorepellants for a variety of neurons in the CNS and PNS
(reviewed by Raper, 2000), although it has recently been found that some
semaphorins can act as chemoattractive guidance molecules too (Polleux et al.,
2000). Knockouts of the chemorepellant semaphorin III/D for example have shown
semaphorins are involved in pathfinding of projections from the trigeminal ganglia in
the developing branchial arches (Kitsukawa et al., 1997; Taniguchi et al., 1997).
Whisker follicle innervation appears normal however, suggesting that other factors
are involved in trigeminal sensory fibre guidance (Ulupinar et al., 1999). Neuropilin-
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2 (receptor for semaphorin III/F) is also required for the organisation and
fasciculation of several PNS and CNS nerves, as has been demonstrated using
knockouts (Chen et ah, 2000; Giger et ah, 2000). Other components associated with
semaphoring signalling are the plexins, with PlexA3 knockouts showing that it is an
essential component of the Semaphorin III/F receptor complex for guidance of SCG
axons (Cheng et ah, 2001).
Figure 1.3: Mouse embryo at the stage of trigeminal neurite outgrowth to its
target fields and setup of co-cultures
targets in vitro, whereas growth is not elicited by the presence of cutaneous targets of other ganglia.
TG: Trigeminal ganglion. Mx: Maxillary process, Md: Mandibular process, H: Hyoid process. LB:
Forelimb bud (Adapted from Davies and Lumsden, 1999).
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The other well-studied family of guidance molecules in both the CNS and PNS are
the ephrins and their receptors located on axonal growth cones (reviewed by Holder
and Klein, 1999), which have been found to be able to influence neurite outgrowth
from DRG for example (Lai et al., 1999). Slit-2, a factor so far mainly been found to
mediate CNS axon guidance, has also been shown to induce axon branching in some
sensory neurons. It stimulates the formation of axon collateral branches by NGF-
responsive neurons of the DRG (Wang et al., 1999).
As well as acting as guidance cues themselves, it has been proposed that
neurotrophins can modulate the action of some guidance cues. NGF, BDNF and NT-
3 have all been shown to modulate the growth cone collapse induced by semaphorin
(Dontchev and Letourneau, 2002; Ming et al., 1999).
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1.2 The neurotrophic hypothesis, neurotrophic factors
and modes of trophic support
Some of the experimental observations leading to the formulation of the neurotrophic
hypothesis have been mentioned in the introduction to this chapter. This section is
aimed at providing more detail about the neurotrophic hypothesis, the main evidence
in support of it, and the factors mediating trophic effects. Instances of target-derived
trophic support and its initiation, and alternatives to target-derived trophic support
will also be mentioned, showing how trophic factors can be provided by cells other
than those of the target field (Davies, 2003). Finally, the interesting finding that
trophic factors are able to mediate death in certain circumstances will be described.
1.2.1 The neurotrophic hypothesis
Neurons are initially generated in excess during neuronal development. Shortly after
neurons begin to innervate their target tissue, large numbers die by apoptosis
(reviewed by Oppenheim, 1991). The neurotrophic hypothesis states that the target
fields regulate the final number of neurons innervating them by synthesising limited
amounts of trophic factor(s) required by the neurons for their survival. Neurons that
do not get sufficient amounts of this factor subsequently die, resulting in innervation
appropriate to the requirements of the target field. This concept was confirmed by
experiments in which the grafting of an additional limb bud near the original one
reduced naturally occurring cell death of neurons, implying that two limb buds would
release additional amounts of a putative survival factor that would result in the
survival of more neurons (Hollyday and Hamburger, 1976). Also, the proportion of
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neurons undergoing cell death was proportional to the amount of limb tissue
removed (Hamburger, 1939a; b). Together with Rita Levi-Montalcini, Victor
Hamburger demonstrated that DRG neurons are normally generated in great excess,
with a subsequent reduction in number following the generation of these cells
(Hamburger and Levi-Montalcini, 1949).
To examine the hypothesis that a trophic factor promotes neuronal survival sarcomas
180 and 37 were implanted in the hind-limb fields of embryonic chicks to increase
the bulk of potential target tissue for innervation. These sarcomas were invaded by
peripheral ganglia processes and certain ganglia grew in size up to six-fold their
normal size (Bueker, 1948; Levi-Montalcini and Hamburger, 1951). This suggested
that the sarcomas produced a factor that was conveyed along the nerve fibres to
promote survival of the neurons. The factor in question was found to be diffusible,
supporting neurons even when their processes did not invade the sarcomas (Levi-
Montalcini and Hamburger, 1953). Levi-Montalcini decided to devise a tissue culture
bioassay to help isolate this substance, by culturing small sympathetic and sensory
ganglia in proximity of small fragments of the tumours. The result of these
experiments was rather astonishing: after twelve hours in culture, nerve fibres had
grown out from the entire periphery of sensory and sympathetic ganglia and had
spread out radially around the explants (Levi-Montalcini et al., 1954). This "NGF
(Nerve Growth Factor) halo" could then be used to assess the presence of this factor
in any tissue or fluid. The term Nerve Growth Factor was coined when Stanley
Cohen, Rita Levi-Montalcini and Viktor Hamburger identified the active part of the
sarcomas in the microsomal fraction (Cohen et ah, 1954). In an interesting
coincidence, Cohen then attempted to use snake venom to further purify the tumoral
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factor. As a source of phosphodiesterase, snake venom was meant to degrade the
nucleic acids present in the active fraction. This was done to establish whether
nucleic acids were an essential component ofNGF or if it was the protein that was
responsible for the observed effects. Surprisingly, addition of the snake venom
potentiated the effect of the active fraction, an effect attributed to the presence of
NGF in the snake venom, but at a much higher concentration than in the sarcomas
(Cohen and Levi-Montalcini, 1956). Testing of the homologue of the venom gland in
the mouse, the salivary glands, resulted in the identification of an even richer source
of NGF, allowing Stanley Cohen to purify and characterize NGF further (Cohen,
1959; 1960) (see section 1.3.1 for a detailed description of the NGF protein).
Anti-NGF antibodies administrated during the phase of target field innervation
reduced numbers of neurons in neural crest derived sensory and sympathetic ganglia
(Levi-Montalcini & Angeletti, 1966, 1968) whereas administration of NGF reduced
cell death in these ganglia (Hamburger et al., 1981). In mice with targeted null
mutations of the NGF gene (Crowley et al., 1994) and its receptor trkA (Smeyne et
al., 1994) the same populations ot neurons were lost as a result of increased cell
death.
Since the initial findings by Levi-Montalcini and her colleagues, a wealth of
evidence has emerged in support of the neurotrophic hypothesis. NGF is retrogradely
transported from the synaptic terminals to the cell bodies of sympathetic neurons
(Hendry et al., 1974; Johnson et al., 1978). Smooth and cardiac muscle, the targets of
sympathetic neurons, were found to be the source of this NGF (Korsching and
Thoenen, 1983).
NGF does not affect the survival and proliferation of sympathetic neuroblasts
52
(Ernsberger et al., 1989), and sympathetic neurons become dependent on NGF close
to the time they start innervating their targets (Korsching and Thoenen, 1988).
Likewise, sensory neurons survive independently of neurotrophins when their axons
are growing to their targets (Davies and Lumsden, 1984; Ernsberger and Rohrer,
1988; Davies, 1989), and upon reaching their targets, these neurons become
dependent on neurotrophins for their survival (Buchman and Davies, 1993). It has
been suggested that neurotrophins can promote the survival of some migrating cells
destined to become sensory neurons, but this occurs before they differentiate
(Kalcheim, 1996). Furthermore, the distance peripheral sensory axons need to grow
to their targets is correlated with the duration of neurotrophic factor independence
(Vogel and Davies, 1991). More details about this period of neurotrophin
independence are described in chapter 6. Also, synthesis of NGF in target fields
coincides with the time point of innervation by NGF-dependent neurons (Davies et
al., 1987), and the final innervation density of target fields by neurons is proportional
to the amount ofNGF synthesised in them. Cutaneous regions with high innervation
density have higher levels of NGF mKNA than regions with lower innervation
density (Harper and Davies, 1990).
1.2.2 The neurotrophins
In 1982, Yves-Alain Barde purified Brain-Derived Growth Factor (BDNF) from pig
brain, which bore a highly homologous primary structure to NGF. It promoted the
survival of dorsal root ganglion embryonic sensory neurons in vitro, and
administration in vivo prevented their death during the phase of naturally occurring
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cell death (Hofer and Barde, 1988). Several additional related neurotrophins were
subsequently identified: Neurotrophin-3 (NT-3) (Ernfors et al., 1990; Hohn et al.,
1990; Jones and Reichardt, 1990; Rosenthal et al., 1990), Neurotrophin-4/5 (NT-4/5)
(Berkemeier et al., 1991; Hallbrook et al., 1991; Ip et al., 1992), NT-6 (Gotz et al.,
1994) and NT-7 (Nilsson et al., 1998).
Several receptors have been identified for the neurotrophins: members of the trk
(tropomyosin-receptor-kinase) family of receptor tyrosine kinases and the common
neurotrophin receptor p75. TrkA predominantly binds NGF, trkB mainly binds
BDNF and NT-4 and trkC binds NT-3, although NT-3 can also signal less efficiently
via trkA and trkB (Barbacid et al., 1994). All neurotrophins bind to p75 with similar
affinity (Rodriguez-Tebar et al., 1990, 1992). p75 has several functions depending
upon the cells in which it is expressed. For example, it can enhance neurotrophin
signalling in the presence of trkA (see sections 1.2.7, 1.4.9, 1.5.5), or promote cell
death in the absence of trkA (see sections 1.2.7, 1.4.9).
The inleiactions between these neurotrophins and their receptors can be seen in
figure 1.4. In addition to biochemical evidence for the above receptor/ligand
interactions, histological studies of knockout mice have revealed corresponding
neuronal deficiencies in trkA, trkB, and trkC knockout mice (Smeyne et al., 1994;
Klein et al., 1993) and in NGF, BDNF, and NT-3 knockout mice (Crowley et al.,
1994; Frnfors et al., 1994; Fiu et al., 1995; Farinas et al., 1994). These studies also
provided evidence that NT-3 signalling via TrkA and TrkB is physiologically
relevant, since neuronal deficits in NT-3 knockouts are more severe than in trkC
knockout mice for certain neuronal populations. Further evidence for selective
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receptor/1 igand interactions was provided by the demonstration that transfection of
BDNF-dependent neurons with a trkA expression plasmid conferred an NGF
survival response (Allsopp et al. 1993) and vice versa (Ninkina et al., 1996).
Figure 1.4; Ligand-receptor specificities of the neurotrophin family and its
trk receptors
Schematic diagram summarising the interaction of neurotrophins with members of the trk family of
tyrosine kinase receptors. Large arrows indicate stronger interactions and weak arrows weaker
interactions. NGF binds to trkA (Klein et al.. 1991). BDNF and NT-4/5 bind to trkB (, and NT-3 binds
predominantly to trkC (Lamballe et al., 1991), but also to a lesser extent to trkA and trkB (Berkemeier
et al., 1991; Klein et al„ 1991; Huang et al., 1999).
In addition to promoting neuronal survival, neurotrophins have been found to
regulate neuroblast proliferation and differentiation, recovery after injury and
synaptic plasticity in particular locations in the developing and mature nervous
system. Dale Purves (1988) formulated the trophic theory of neural connections,
55
which extends the trophic actions of survival factors to neuronal connectivity, the
regulation of axonal and dendritic branches. The pattern of neural connections would
thus be regulated by factors in the target, allowing for adjustments during
development and maturation of the animal. I shall not go into detail about other
functions of neurotrophins, as this thesis is mainly concerned with the period in
development relating to survival of neurons.
1.2.3 Other trophic factors
Although the neurotrophins and their receptors, described in detail in section 1.3, are
the main factors of interest in the studies presented in this thesis, several other
proteins have been identified that are able to support the survival of a range of
neuronal populations during development. In this subsection I shall briefly mention
the best characterised families of neurotrophic factors.
A The Neurotrophic Cytokines
The neurotrophic cytokines include ciliary neurotrophic factor (CNTF), leukaemia
inhibitory factor (LIF), oncostatin-M (OSM), cardiotrophin-1 (CT-1) and interleukin-
6 (IL-6). They signal through a multicomponent receptor signalling system
consisting of dimers of signal transducing p components, consisting of either gpl30
homodimers (11-6) or gpl30/LIFR.p heterodimers (CNTF, LIF, CT-1). Receptor
complexes for CNTF and IL-6 include an additional a component. Specific receptor
subunits determine the specificity for each cytokine (Stahl and Yancopoulos, 1994).
CNTF was initially identified as a trophic factor for parasympathetic neurons of the
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embryonic chicken ciliary ganglion (Adler et al., 1979; Barbin et al., 1984), and has
since been demonstrated to be able to support various neuronal populations of both
the CNS and PNS including motor, sympathetic and certain sensory neurons (Barbin
et al., 1984; Manthorpe & Varon, 1985; Arakawa et al 1990; Oppenheim et al., 1991;
Martinou et al., 1992; Burnham et al., 1994; Vejsada et al., 1995; Horton et al.,
1998).
LIF promotes the survival of motor neurons, sympathetic neurons and certain
sensory neurons (Li et al., 1995; Sendtner et al., 1996; Martinou et al., 1992; Murphy
et al., 1993; Kotzbauer et al., 1994; Thaler et al., 1994; Horton et al., 1998).
QSM promotes the survival of a subset of late fetal DRG neurons in culture, as well
as embryonic sensory neurons of the trigeminal and nodose ganglia (Ware et al.,
1995, Horton et al., 1998).
CT-1 promotes the survival of cultured ciliary ganglion neurons (Pennica et al.,
1995), midbrain dopaminergic neurons and motor neurons (Pennica et al., 1995,
1996) and embryonic and postnatal sensory neurons (Horton et al., 1998).
TL-6 has been shown to have a trophic action on a proportion of forebrain cholinergic
and midbrain catecholaminergic neurons and embryonic sensory neurons (Hama et
al., 1989; Kushima et al., 1992; Horton et al., 1998).
B The TGF-B superfamily
The Transforming Growth Factor- P (TGF-P) superfamily of neurotrophic factors
includes a variety of subfamilies, such as TGF-P itself, Bone Morphogenetic Proteins
(BMPs), Growth/Differentiation Factors (GDFs), and the glial cell line-derived
neurotrophic factor (GDNF) family.
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The GDNF family includes GDNF (Linet al., 1993), neurturin (NTN) (Kotzbauer et
al., 1996), persephin (PSP) (Milbrandt et al., 1998), and artemin (ART) (Baloh et al.,
1998b). Members of the GDNF family act through a multicomponent receptor
signalling system comprising the transmembrane tyrosine kinase Ret plus one of four
glycosyl-phosphatidyl inositol- (GPI-) linked proteins, the GDNF Family Receptors
al-4 (GFRal-4) (Saarma and Sariola, 1999). Different members of the GDNF family
preferentially activate Ret with one of these subunits, although some are able to use
alternative heterodimer receptors in some circumstances (e.g. Buj-Bello et al., 1997;
Baloh et al., 1997; Cacalano et al., 1998). The preferred receptors are GFRal for
GDNF, GFRa2 for NTN, GFRa3 for Artemin, and GFRa4 for PSP. (Jing et al.,
1996; Treanor et al., 1996; Baloh et al., 1997; Buj-Bello et al., 1997; Creedon et al.,
1997; Klein et al., 1997; Sanicola et al., 1997; Baloh et al., 1998; Enokido et al.,
1998; Thompson et al., 1998; Trupp et al., 1998; Forgie et al., 1999).
GDNF family members exert neurotrophic effects on both CNS and PNS neurons. In
the CNS, GDNF, NTN and ART support the survival of midbrain dopaminergic
neurons (Cacalano et al., 1998; Baloh et al., 1998) and GDNF, NTN and PSP
promote the survival of some motor neurons (Henderson et al., 1994; Oppenheim et
al., 1995; Moore et al., 1996; Sanchez et al., 1996; Heuckeroth et al., 1998;
Milbrandt et al., 1998, Cacalano et al., 1998; Enomoto et al., 1998). In the PNS,
GDNF, NTN and ART support sympathetic neurons and certain sensory neurons
(Henderson et al., 1994; Kotzbauer et al., 1996; Buj-Bello et al., 1995; Moore et al.,
1996; Sanchez et al., 1996; Pichel et al., 1996; Matheson et al., 1997; Molliver et al.,
1997; Baloh et al., 1998; Millbrandt et al., 1998; Cacalano et al., 1998; Enomoto et
al., 1998; Nishino et al., 1999; Enomoto et al., 2000; Baudet et al., 2000; Andres et
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al., 2001).
TGFP proteins appear to regulate the survival of some neurons by modulating their
response to other neurotrophic factors (Krieglstein et al., 2002). For example, they
increase the trophic potency of neurotrophins on DRG neurons (Krieglstein and
Unsicker, 1996) and of CNTF and FGF on chick ciliary ganglion neurons
(Krieglstein et al., 1998). TGFPs also synergise with GDNF in promoting the
survival of certain PNS neurons and CNS dopaminergic neurons (Krieglstein et al.,
1998).
C Hepatocyte Growth Factor (HGF) and Macrophage Stimulating protein
(MSP)
Hepatocyte Growth Factor (HGF). which acts via the c-met receptor tyrosine kinase,
is a pleiotropic factor with recently identified neurotrophic actions (reviewed by
Maina and Klein, 1999). As well as being a chemoattractant and neurite growth
promoter (Ebens ct al., 1996; Maina et al., 1997; 1998; Yang et al., 1998; Davey et
al., 2000), FTGF promotes the in vitro survival of spinal motor neurons and
sympathetic neuroblasts (Ebens et al., 1996; Wong et al., 1997; Yamamoto et al.,
1997; Maina et al., 1998). It also enhances the neurotrophic actions of other trophic
factors, such as CNTF, on spinal motor neurons, sensory neurons and
parasympathetic neurons (Ebens et al., 1996, Wong et al., 1997; Davey et al., 2000).
It is also needed for the survival of the full complement of DRG neurons in vivo,
probably by synergising with NGF (Maina et al., 1997).
Macrophage Stimulating Protein (MSP) is a secreted protein that has a 45% sequence
identity to HGF (Leonard and Skeel, 1978; Yoshimura et al., 1993) and signals
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through the Ron receptor tyrosine kinase (Wang et ah, 1994). It has recently been
identified to act as a neurotrophic factor in the later embryonic and postnatal
development of the trigeminal and dorsal root ganglia (Forgie et al., 2003), being
able to support almost as many neurons as NGF in the postnatal period. MSP also
promotes the survival early SCG neurons (Forgie et ah, 2003).
1.2.4 Trophic support between ganglion and target field
As already stated, the first identified mode of action by neurotrophins was as factors
released from the target field - an action that can be mediated by retrograde
neurotrophin transport, with neurotrophins binding to their trk receptors and being
transported to the cell body in a neurotrophin-receptor complex (Watson et ah,
1999). Other modes of support have since been identified (Davies, 2003), including
retrograde transport from non-target tissue, anterograde action from afferents and
autocrine action.
It has been shown that some tissues lying on the pathway the axons grow towards
their targets can provide intermediate trophic support to neurons (Davies, 1997).
BDNF and NT-3 for example, which support the survival of early trigeminal
ganglion neurons, are initially expressed in tissue that lies on the path trigeminal
axons grow towards their peripheral targets (Buchman and Davies, 1993), and are
likely to act as survival factors at this stage because substantial numbers die at this
time in trkB and NT-3 knockout mice (Pinon et al., 1996; Wilkinson et al., 1996).
NT-3 is also expressed in tissues along the course DRG axons grow to their targets
(Farinas et al., 1996; White et al., 1996; Liebl et al., 1997). In the central nervous
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system there is some evidence that spinal commissural neurons also depend on
substances released by an intermediate target, the floorplate (Wang et al., 1999).
Glial cells have also been implicated in the maintenance of neurons, since these have
been found to synthesize trophic factors (Lindsay et al., 1982; Saarma and Sariola,
1999; Mirsky, 2002; Chapter 6). In embryos lacking Schwann cells and Schwann cell
precursors due to mutations in neuregulin (the main trophic factor for early Schwann
cells) or one of its ErbB receptors there is widespread loss of sensory and motor
neurons during development (Meyer and Birchmeier, 1995; Gasmann et al., 1995;
Lee et al., 1995; Riethmacher et al., 1997). It is possible that some of the trophic
function of Schwann cells is mediated after the period of target field innervation,
since the enhanced neuronal death observed in ErbB3 knockout embryos occurs later
in development than the one observed in trkB and NT-3 knockouts (Davies, 2003).
More evidence for intermediate trophic support by Schwann cells can be seen in
chapter 6.
1.2.5 Anterograde trophic support
Another source of trophic factor for some neurons comes from their afferent inputs.
The first evidence for this came from the observation that some populations of
neurons undergo increased naturally occurring cell death upon deafferenation, and
less upon hyperinnervation (Linden and Serfaty, 1985; Wright, 1987; Furber et al.,
1987; Linden, 1994). Indeed, a number of instances have been identified, in which
trophic factors are anterogradely transported. In some situations this may be due to a
survival-unrelated function of the trophic factor at the synapse, but there is evidence
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that some anterogradely transported factors do induce survival (Altar et al., 1997).
For example, BDNF is anterogradely transported and released from some sensory
neurons (Zhou and Rush, 1996; Michael et al., 1997) and is expressed during the
period of naturally occurring cell death. When these NGF-dependent neurons are
cultured in vitro they release BDNF, which is able to maintain co-cultured BDNF-
dependent neurons (Robinson et al., 1996). Cortical axons have been shown to
anterogradely transport BDNF to the striatum, and a subset of striatal neurons is
missing in BDNF null mutant mice, suggesting that these neurons are reliant on
anterogradely transported BDNF in vivo (Altar et al., 1997). Noradrenergic neurons
overexpressing BDNF are neuroprotective to innervated motor neurons following
axotomy, suggesting an anterograde support function (Fawcett et al., 1998). There is
some evidence that anterogradely transported BDNF from retinal ganglion cells is
involved in the survival of the superior colliculus (Caleo et al., 2000). NT-3 has also
been shown to be anterogradely transported, by retinal ganglion cell axons (von
Bartheld and Butowt, 2000).
Another mode of afferent support has been found to be dependent on electrical
activity. Blocking electrical activity results in enhanced loss of neurons in the
developing chick superior cervical ganglion (Madedrut et al., 1988). This trophic
effect has been attributed to the afferents maintaining their target cells in a
depolarised state (Bennet and White, 1979), leading to influx of calcium through
voltage-dependent calcium channels and sustaining survival by intracellular
mechanisms which are not fully understood (Franklin and Johnson, 1992).
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1.2.6 Autocrine trophic support
Evidence that trophic factors can act by an autocrine mechanism comes from several
sources. Many cortical neurons co-express BDNF and TrkB in vivo (Miranda et al.,
1993; Kokaia et al., 1993; Ferrer et al., 1997; Schwartz et al., 1997; Pitts and Miller,
2000; Dieni and Rees, 2002), and the survival of these neurons in culture is reduced
by BDNF antiserum (Ghosh et al., 1994). An early maturational change in embryonic
chicken DRG neurons is accelerated by exogenous BDNF and reduced by antisense-
BDNF oligonucleotides (Wright et al., 1992). No effects of BDNF on survival were
found in this study or another recent study of early embryonic sensory neurons
(Huber et al., 2000), but a subsequent study using antisense-BDNF in the adult DRG
reported that a subset of neurons are supported by a BDNF autocrine loop (Acheson
et al., 1995). However, since trkB appears to be expressed predominantly in NGF-
dependent trkA-expressing neurons in the adult (Kashiba et al., 1997), an autocrine
mechanism would appear to be ruled out in vivo (Lewin and Barde, 1996).
NGF has also recently been implicated in an autocrine loop in developing retinal
horizontal cells (Karlsson et al., 2001). These neurons express both NGF and trkA,
and can be killed with NGF antisense oligonucleotides. HGF appears to act by an
autocrine loop mechanism in sympathetic neuroblasts, which express both HGF and
Met, and many of these cells are killed by anti-HGF in culture (Maina et al., 1998).
Further, neurotrophic factors promote the expression of second survival factors that
act in an autocrine manner. There is evidence that the neurotrophic protein Reg-2,
whose expression in motor neurons is activated by CNTF, mediates the CNTF
survival effect on these neurons in an autocrine/paracrine manner. Blocking of Reg-2
expression abrogates the survival response of CNTF on cultured motor neurons
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(Nishimune et al., 2000). TGF-P, which promotes the survival of some DRG neurons
in combination with NT-3 and NT-4, does so in an autocrine loop manner. It is
released by DRG neurons and promotes their survival (Krieglstein and Unsicker,
1996).
1.2.7 Trophic factors as pro-apoptotic factors
Although p75 has been shown to enhance the trkA-mediated survival effects of NGF
(Davies et al., 1993; Horton et al., 1997; Ryden et al., 1997 and chapter 5), in
oligodendrocytes p75 was shown to mediate a cytotoxic response to high levels of
NGF (Casaccia-Bonnefil, 1996). The first indication for the involvement of p75 in
promoting cell death came from the observation that a reduction in p75 expression by
antisense oligonucleotides enhanced the in vitro survival of NGF-deprived postnatal
DRG neurons (Barrett and Bartlett, 1994). Further evidence indicating that
endogenous NGF acting via p75 promotes neuronal death came from studies of the
chicken embryo retina (Frade et al., 1996). Anti-NGF antibodies or antibodies that
block binding of NGF to p75 cause a marked reduction in the number of cells that
undergo apoptosis in the E4 retina before retinal axons begin innervating the tectum.
At this early stage of development NGF is expressed in the retina and the great
majority of cells that normally undergo apoptosis express p75 but not TrkA. Further
in vivo evidence includes the finding that basal forebrain cholinergic neurons, which
express p75 under normal circumstances, are present in elevated numbers in p75-
deficient mice (Van der Zee et al., 1996; Naumann et al., 2002).
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BDNF may also have a detrimental effect by binding to p75, with BDNF increasing
death in some sympathetic neurons (Bamji et al., 1998). Also, NT-4 appears to act
through p75 to induce apoptosis in trigeminal neurons (Agerman et ah, 2000).
Ontogenetic neuron death of ciliary, dorsal root and spinal motor neurons is largely
prevented, and neuronal losses following limb bud ablation are greatly reduced
following immuno-neutralisation of endogenous TGF[3 in the chick embryo
(Krieglstcin et ah, 2000). Further, TGFp neutralisation has the same effect as NGF
neutralisation in preventing neuronal death in the early developing retina (Diinker et
ah, 2001), suggesting that this trophic factor can signal to induce cell death as well.
The significance of the pro-apoptotic pathways activated by 'trophic' factors is not
well understood as yet, with relatively few observations reported in vivo. In these
instances, the observations have been made either during development or following
ischaemic stress. Pro-apoptotic mechanisms may thus serve to ensure the efficient
elimination of cells during developmental processes or in stress-related conditions.
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1.3 Molecular biology of neurotrophins and neurotrophin
receptors
This section describes the best-characterised neurotrophins. Emphasis will be on
NGF, BDNF and NT-3 and their receptors, since these are relevant to the research
presented in this thesis. In particular, this section focuses on the discovery, genetics
and structure of these neurotrophins and their isoforms.
1.3.1 Nerve Growth Factor (NGF)
Analysis of the sarcomas 180 and 37 (see above) led to the initial isolation ofNerve
Growth Factor (NGF) (Cohen et al., 1954). NGF was subsequently isolated and
characterised from other sources, such as snake venom (Cohen et al., 1959) and the
adult male mouse submandibular gland (Cohen, 1960).
The human NGF gene is composed of a single 3' exon that encodes the entire
prepropeptide, and three upstream exons that give rise to 5' untranslated sequences
(D'Mello and Fleinrich, 1991). Promoter activity is associated with the first and third
exon. The majority of transcripts contain exon I, with the other exons undergoing
alternative splicing to give rise to various mRNAs with different 5'untranslated
regions (5'UTR's), which may be responsible for stabilising the mRNA and
facilitating translation (Metsis, 2001). Transcripts initiated from the promoter linked
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to the exon III encode this exon and the 4 coding exon. The mechanisms regulating
the transcription of the NGF gene are not well understood, although it is known that
transcription factors such as c-fos play a role (Hengerer et al., 1990).
Biologically active NGF (the P-subunit of NGF) extracted from the mouse
submandibular gland (Angletti and Bradshaw, 1971) is expressed in a complex
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(termed 7S complex) with two other molecules termed a- and y-NGF (Figure 1.5)
(Bax et ah, 1997). NGF is expressed as a prepropeptide comprising a signalling
peptide and a propeptide. The y subunit of the complex is a highly specific protease,
and appears to be needed to process pre-NGF into its active mature form (Jongstra-
Bile et ah, 1989). The precise function of the a subunit of the complex is not known,
although it has been suggested that it protects NGF from enzymatic degradation (Bax
et ah, 1997). Active NGF is a non-covalently held dimer of two subunits comprising
118 amino acids per monomer (Angletti and Bradshaw, 1971). Each monomer
(figure 1.6) has at one end six cysteine residues forming three disulfide bridges. Two
of these bridges and their residues form a ring structure. The third disulfide bridge
passes through this ring, forming a 'cysteine knot' (McDonald and Hendrickson,
1993; Murray-Rust et ah, 1993). Binding specificity is conferred by four hairpin loop
regions, whose amino acids vary between neurotrophins (Ebendal et ah, 1992).
Braced by these two regions are two anti-parallel p strands, which form a flat surface
where the two subunits associate, giving the molecule an elongated shape
(McDonald et ah, 1991; Holland et ah, 1994). Hydrophobic forces stabilise the two
protomers of the NGF dimer in a head-to-head conformation. This structural pattern
is conserved in the other neurotrophins (Robinson et ah, 1995), apart from the above
mentioned hairpin loop regions.
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Figure 1.5; Complex of B-, a- and y-NGF
Ribbon diagram showing the structure of the 7S NGF complex (PDB access code I SGF). The P-NGF
dimer is in red in the center, two copies of a-NGF are shown in green, and two copies of y-NGF in
blue (from Wiesmann and de Vos, 2000).
Figure 1.6: Structure of the NGF monomer
C-Terminus
Ribbon diagram depicting the structure of the NGF monomer. Shown are the six cysteine-rich
domains forming a cysteine knot (gray and yellow near top), the four hairpin loop regions (L1-L4),
and the two pairs of twisted, anti-parallel P-strands (A-D) (from Wiesmann and de Vos, 2000). The
structural pattern is conserved in other neurotrophins, with variations in the hairpin loop regions
(Robinson et al., 1995).
68
1.3.2 Brain Derived Neurotrophic Factor (BDND
Like NGF, biologically active BDNF exists as a homodimer with each monomer
being a 12.3 kDa 119 amino acid glycosylated protein. BDNF was first isolated from
porcine brain (Barde et al., 1982) and has approximately 55% homology with the
sequence ofNGF. Like NGF, it conserves the six cysteine residues forming the three
disulphide bridges (Leibroch et al., 1989), and exists as a homodimer (Radziejewski
et al., 1992), giving it a very similar structure.
The rat BDNF gene contains four upstream noncoding exons in addition to the 3'
coding exon. Each of the exons in the BDNF gene has its own promoter (Timmusk et
al., 1994). Different promoters of the BDNF gene are used during development in
different cell types, giving rise to mRNAs containing only one of the upstream
noncoding exons spliced to the coding exon. BDNF mRNA containing exons I, II
and III is mainly expressed in the brain, while transcripts containing exon IV
predominate in the lung and heart (Timmusk et al., 1993; Metsis et al., 1993).
Transcriptional up-regulation of the rat BDNF gene has been observed upon
activation of glutamate receptors (Metsis et al., 1993). A neuron-restrictive silencing
element-type sequence in the first intron of the gene is thought to modulate the levels
of mRNA containing exons I and II in the glutamatergic system of the brain
(Timmusk et al., 1999). It has been found that a 5kb region of promoter III is
involved in gene induction after sciatic nerve transection (Timmusk et al., 1995),
while regions flanking promoters I-III have been implicated as calcium-responsive
regions (Bishop et al., 1997). Indeed, it was found that there were two regulatory
sequences in the proximal promoter region involved in regulation of transcription in
response to calcium influx. One, a calcium-response element, could regulate BNDF-
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expression in both embryonic and postnatal cortical neurons (Shieh et al., 1998), the
other, a cAMP response element (activated by CaM Kinase IV via CREB) appears to
only regulate BDNF expression in postnatal neurons (Tao et a., 1998). Promoter IV
is activated by CaM Kinase II (Takeuchi et al., 2000). c-fos also appears to regulate
BDNF expression (Zhang et al., 2002).
1.3.3 Neurotrophin-3 (NT-3)
NT-3 was isolated by using degenerate primers with sequences based on the
conserved domains ofNGF and BDNF in the polymerase chain reaction (Hohn et al.,
1990). It exists as a homodimer (Radziejewski et al., 1992) with each monomer
being a 12.6 kDa 119 amino acid basic protein, and has a 50-60% amino acid identity
with NGF and BDNF. Like these two proteins it possesses six cysteine residues.
The mouse NT-3 gene has two upstream non-coding exons that are flanked by
promoters (Leingartner and Lindholm, 1994). Transcription gives rise to mRNA
containing only one of the upstream noncoding exons spliced to the 3' coding exon.
There seem to be several transaction start sites in each of the upstream exons.
Multiple NT-3 mRNA variants which differ slightly in length can be generated due




A phylogenetic analysis of the DNA sequences of members of the neurotrophin
family in Xenopus ovary led to the discovery ofNT-4/5 (Hallbook et al., 1991). NT-
4 is a 13900 Dalton protein with a 50-60% amino acid homology with the previously
discovered members of the neurotrophin family, and has a similar structure
(Hallbook et ah, 1991). Homologues of NT-4 were identified in mammals and
termed NT-4 (Ip et ah, 1992) or NT-5 (Berkemeier et ah, 1991). It appears as if both
proteins are identical and the mammalian equivalent of Xenopus NT-4 is often
referred to as NT-4/5.
The rat NT-4 gene has two upstream non-coding exons (Salin et ah, 1997).
Transcription can be from exons 1 or II, giving rise to mRNA containing either both
exons and the coding exon III, or just exons II and III.
1.3.5 NT-6 and NT-7
Attempts to clone the fish NGF gene in the platyfish Xiphophorus maculatus resulted
in the discovery of NT-6 (Gotz et ah, 1994). NT-6 is a 16000 Dalton protein. It
contains a hydrophobic domain at the N-terminus with the characteristics of a signal
peptide, a pro-region containing basic motifs necessary for the proteolytic cleavage
of the precursor protein, and the disulphide cysteine residues common to other
neurotrophins. NT-6 is unique in that it has 22 amino acid residues inserted between
the second and third conserved cysteine domains. NT-7 was identified from the carp
Cyprinus carpio and zebrafish Danio rerio using a PCR-based approach (Nilsson et
ah, 1998; Ko et ah, 1998). Amino acid sequence analysis of NT-7 has revealed a
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high degree of homology with fish NGF and NT-6 (65% and 63% respectively)
(Nilsson et al., 1998; Ko et ah, 1998). NT-6 and NT-7 have only been found in fish.
1.3.6 Pro-neurotrophins
The importance of pro-neurotrophins was recently identified by Lee et ah (2001).
Neurotrophins are initially produced as precursors, before being cleaved
intracellulary by proteases, such as furin or the NGF subunit y. Lee and colleagues
discovered proNGF and proBDNF in a variety of tissues in vivo. Using a mutant
NGF molecule with the 'pro' domain but resistance to furin cleavage, they performed
a series of binding studies, and surprisingly found that the equilibrium-binding
constant of proNGF to p75 was five fold higher than the one of mature NGF,
whereas binding affinity to trkA was greatly reduced. Further, they found that
proNGF could act as a potent cell-death inducer in sympathetic neurons. The balance
between the availability of proNGF and mature NGF in cells expressing both trkA
and p75 could thus represent the balance between death and survival in these cells.
There may thus be a novel principle by which neurotrophins exert their actions
through their two different receptors: in mature form, they would act as survival
factors; and in proneurotrophin form, as a death signal. However, even using a
mutant form of proNGF, isolation and further analysis proved difficult, since this
was still sensitive to cleavage (Chao and Bothwell, 2002). So there would have to be
mechanisms in vivo that protect the proNGF protein from cleavage.
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1.3.7 The trk receptors
The trk proto-oncogene encodes a 140 kDa glycoprotein, and was initially identified
in a human colon carcinoma (Martin-Zanca et al., 1986, 1989). The proto-oncogene
encodes two tyrosine kinases of 790 and 796 amino acid residues known as trkA
(Martin-Zanca et al., 1989). The two isoforms have a 32-amino acid long putative
signal peptide, an NH2-terminal ligand binding extracellular domain (see below), a
single transmembrane domain, and a cytoplasmic domain containing a catalytic
tyrosine kinase domain. The 796 amino acid isoform is primarily expressed in
neurons (Barker et al., 1993). Screening with the trk probe allowed the identification
of two additional members of the trk family: trkB (Klein et al. 1989) and trkC
(Lamballe et al. 1991). The tyrosine kinase domains of these two receptors share an
85% homology to trkA. The extracellular domain of all trk receptors includes two
cysteine-rich domains (domains 1 and 3), 3 leucine-rich repeats (domain 2) and two
immunoglobin (Ig)-like domains (domains 4+5) (Schneider and Schweiger, 1991).
The extracellular domain shows 50-55% homology between the different trks
(Lamballe et al., 1991).
Figure 1.7 shows the trk structures and some isoforms. Trk receptors bind their
respective neurotrophins with high affinity (Kj ~10(-11) M; Godfrey and Shooter,
1986; Rodriguez-Tebar and Barde, 1988) and are capable of internalising them.
Neurotrophin binding dimerises its receptor, inducing a series of
autophosphorylations of the tyrosine kinases, which are connected to a second
messenger system (Kaplan et al., 1991; Kaplan and Stephens, 1994). Domain 5 of the
extracellular domain is the one most commonly associated with ligand binding, as it
is sufficient for neurotrophin binding (Perez et al., 1995; Ultsch et al., 1999).
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Another component of the extracellular domain however, the leucine-rich domain 2,
also appears to have a binding affinity for neurotrophins (Windisch et al., 1995;
Haniu et al., 1997; Ninkina et al., 1997).
The extracellular domain of the trk receptors is encoded by nine exons in the case of
trkA and C (Indo et al., 1997; Ichaso et al., 1998), and by 10 exons in the case of
trkB (Strohmaier et al., 1996). Alternative splicing can give rise to isoforms of trk
with different interaction specificities to its ligands (Strohmaier et al., 1996).
TrkA is highly expressed in NGF-dependent neurons of the mouse embryo (Martin-
Zanca et al., 1990). Evidence for interaction between NGF and this receptor comes
from ectopic expression in cells non-responsive to NGF (Allsopp et al. 1993). TrkB
is the high affinity receptor for BDNF and NT-4 (Klein et al., 1991), and trkC binds
NT-3 but not the other neurotrophins (Lamballe et al., 1993). Some signalling
through trkA and trkB can occur via NT-3 (Klein et al., 1991), especially in the
absence of p75 (Brennan et al., 1999).
Trk isoforms that lack the kinase domain and hence cannot activate the kinase
domain associated signalling pathways are abundantly expressed in the mouse. Two
truncated trkB receptor isoforms have been identified in the mouse, both containing a
short cytoplasmic domain in place of the tyrosine kinase catalytic region (Klein et al.,
1990; Middlemas et al., 1991). Other trkB variants containing deletions in domain 2
(leucine-rich) of the extracellular domain as a result of alternative splicing, have also
been identified and shown to display impaired ligand binding. Both isoforms of trkB
with normal and deleted domain 2, and normal or truncated kinase domain are found
in neurons (Ninkina et al., 1997; Ninkina et al., 1996). TrkC has three isoforms with
insertions in the kinase domain, and four lacking the kinase domain (Klein et al.,
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1990; Middelmas et al., 1991; Lamballe et al., 1993; Tsoulfas et al., 1993;
Valenzuela et al., 1993; Garner & Large, 1994). The exact function of these trk
variants is unknown, but in the case of trkB it has been suggested that BDNF
responsiveness in developing sensory neurons is modulated by the relative level of
catalytic and non-catalytic trkB isoforms, as indicated by their relative expression
levels in the trigeminal ganglion. Over-expressing truncated trkB isoforms decreases
the sensitivity of these neurons to BDNF (Ninkina et al., 1996). Another proposed
function of truncated forms of trkB is to present BDNF to full-length receptors,
thereby positively regulating the BDNF response (Beck et al., 1993).
Although the mechanisms controlling trk receptor expression are still largely
unknown, it has recently emerged that the transcription factor Brn3a plays an
important role in regulating the expression of trks during development (Huang et al.,
1999).
1.3.8 The low-affinity p75 receptor
The mature low affinity p75 receptor (Kd ~10(-9) M; Godfrey and Shooter, 1986;
Rodriguez-Tebar and Barde, 1988) is a 75kD glycosylated 399 amino acid protein
derived from a 427 amino acid polypeptide precursor (Radeke et al., 1987). It has a
short cytoplasmic domain, a single transmembrane segment and four extracellular
cysteine-rich domains, which are required for neurotrophin binding (see figure 1.7)
(Welcher et al., 1991). The cytoplasmic domain incorporates a death domain similar
to that of TNF receptors, although proteins such as TRADD or FADD cannot attach
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(Wang et al., 2001). The domain consists of six a helices arranged in a compact
globular domain typical for death receptors (Liepinsh et al., 1997).
Figure 1.7: Neurotrophin receptors and their isoforms
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General strueture of trk receptors, some of their isoforms. and p75. The trkA isoform on the left hand
side with a 6 amino acid insertion is the one commonly expressed in neurons (Barker et al., 1993).
Also shown is the trkB receptor, with its isoforms either lacking a kinase domain (Klein et al.. 1990;
Middlemas et al., 1991) or having deletions in the extracellular domain 2 (leucine-rich) (Ninkina et
al.. 1997), and the trkC receptor, which can exist with insertions in the kinase domain, or lacking the
kinase domain (Tsoulfas et al.. 1993; Valenzucla et al., 1993). The p75 receptor with its 4 cysteine-
rich domains and short intracellular domain is also represented (Radeke et al.. 1987).
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A truncated form of p75 exists, which is composed of the extracellular domain
(DiStefano and Johnson, 1988). This truncated form binds the neurotrophins with the
same affinity as the full-length receptor and has been suggested to compete with the
full-length receptor and thereby limit the activity of the neurotrophins. p75 has been
shown to bind all neurotrophins with similar affinity, although the rate constants for
the ligands are different: NGF was found to dissociate from the p75 receptor more
rapidly than NT-3, which itself dissociates quicker than BDNF (Rodriguez-Tebar et
al„ 1992).
Weskamp and Reichhardt (1991) observed two distinct classes of high-affinity NGF
receptors, one of which seemed to be dependent on p75 since it disappeared in the
presence of p75 antibodies. This observation suggests that the high affinity NGF
receptor can be composed of either two p75-trkA heterodimers or a trkA homodimer.
By forming heterodimers with trkA, p75 could increase the number of available
binding sites for NGF. Another possibility supported by experimental evidence (see
below) is that p75 associated to trkA induces conformational changes in the latter,
which leads to an increased binding affinity for NGF (Esposito et ah, 2001). In p75
knockout mice there is a partial loss of sensory and sympathetic neurons, which
would be explained by p75 enhancing trk activation (Lee et ah, 1992).
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1.4 Cellular mechanisms controlling death and survival
and their interaction with neurotrophins
This section is aimed at examining the 'apoptotic' mode of cell death that neurons
undergo during development. Once the components of the cells death/survival
machinery have been described, I will give an overview of the major intracellular
pathways, which connect the neurotrophins to these processes. This will include the
second messenger pathways associated with trk autophosphorylation and p75
activation either in the presence or absence of trk signalling. The life/death
mechanisms described below are not present in all neurons. Some of the mechanisms
only exist in subpopulations of neurons. This explains why some populations can be
insensitive to overexpression of a particular 'pro-apoptotic' molecule as an example,
whereas others will undergo apoptosis at different rates in response to it. A summary
of the mechanisms described in this section can be seen in figures 1.8 and 1.9.
1.4.1 Apoptosis versus necrosis
Cells undergoing cell death during development undergo a unique and distinct set of
structural changes called 'Programmed cell death' or 'Apoptosis', that is a mode of
gene-directed cellular self-destruction requiring RNA and protein synthesis (Cohen
& Duke, 1984; Scolt & Davies, 1990). Apoptosis was first identified in development
and could be clearly distinguished from 'necrosis', the mode of cell death previously
known. The term 'apoptosis' was not coined until 1972 however, when it was
described in detail by Kerr, Wyllie and Currie as a means of distinguishing a
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morphologically distinctive form of cell death that was associated with normal
physiology (Kerr et al., 1972). Apoptosis during development is an active and
widespread mechanism responsible for removing superfluous cells, or cells that have
fulfilled their function and are not needed (Oppenheim et al., 1991; Williams, 1991).
The 'naturally occurring cell death' described in section 1.2 occurs by apoptosis.
Extrinsic or intrinsic 'induction signals' are followed by a cascade of physiological
modifications in the cell, which lead to cell death. Typical signs of apoptosis involve
separation of the cell from neighbouring cells and loss of membrane structures, such
as microvilli and desmosomes. This is followed by plasma membrane blebbing and
contortion. Apoptosis then enters its irreversible stage characterised by cytoplasmic
condensation and increased cell density. The nuclear chromatin condenses to form
dense granular caps, which is followed by DNA and cellular fragmentation, and
phagocytosis by macrophages or surrounding cells (Wyllie et al., 1980).
Whereas early apoptosis tends to be associated with a shrinking of cells (apoptotic
volume decrease - AVD), necrosis is characterised by cellular swelling (necrotic
volume increase - NVI) and culminates in the rupture of plasma and internal
membranes and leakage of cellular contents. Necrotic cell death is a response to
major stresses to the cell and involves rapid lysis of cellular membranes without any
requirement for protein synthesis. Necrosis is a far more dangerous route to follow
for groups of cells, since the necrotic death of one cell and the intracellular spillage
that ensues may cause stress to other cells, necessitating the activation of resident
phagocytes and attraction of leukocytes (inflammation). In systems where the
interaction between cells needs to be tightly regulated, such as in neuronal
development, a more specific and controlled type of death is advantageous.
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During neuronal development there are two modes by which apoptosis can be
induced: firstly, there is a lack of neurotrophic factor support, suppressing the
constant survival signal required by some neurons. Secondly, there is ligand-induced
activation of'death receptors', inducing intracellular apoptosis pathways.
1.4.2 Intracellular pathways associated with apoptosis
The first indications about the intracellular events required for apoptosis where
gained from studying mutants of the nematode Caenorhabditis elegans (C.elegans)
that were defective in the apoptotic pathway. C.elegans is particularly useful for
studying apoptosis due to its low cell number, with a well-determined number of
cells being born (1090 cells) and undergoing programmed cell death (131 cells)
during development. Genetic analysis of mutants led to the identification of three
genes needed for the life/death decision in somatic cells of C.elegans: ced-3 and ced-
4 (Ellis & Horvitz, 1986), and ced-9 (Hengartner et al., 1992). ced-3 and ced-4
activation is sufficient and ncccssaiy to induce cell death, ced-9, in contrast, is
required for the survival of the cell.
Study of these genes revealed that ced-3 encodes an aspartate-specific protease with
a cysteine-containing active site, whose expression is required for all of the cell death
in C.elegans (Xu et al. 1996). Related genes have been discovered in the mammalian
genome, forming the caspase family (cysteine-containing asp-ase). ced-4 possesses
an ATP-dependent hydrolytic activity thought to promote processing and activation
of ced-3 by interacting with ced-3 in a 'casposome' (Hengartner, 1997). ced-9
represses activation of ced-4 and therefore ced-3 by sequestering ced-4 to the
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mitochondrial membrane, preventing it from interacting with ced-3 (Chinnaiyan et
al., 1997; Wu et ah, 1997). A mammalian homologue of ced-4 exists in the form of
Apaf-1 (Zou et ah, 1997). Ced-9 has mammalian homologues in the form of bcl-2
and bcl-XL, collectively called bcl-2-like proteins (Hengartner and Horvitz, 1994).
The apoptotic machinery is extremely well conserved phylogenically. bcl-2 can act
as a substitute in ced-9 nematode mutants for example (Hengartner and Horvitz,
1994). More recently another molecule known as EGL-1 was discovered in
C.elegans (Conradt and Horvitz, 1998). EGL-1 binds to ced-9 via an amphipatic
structure known as the BH3 domain (see below), inducing the release of ced-4. ced-4
can then translocate to the cytosolic side of the nuclear envelope where it forms the
casposome with ced-3 and induces programmed cell death (Chen et ah, 2000). EGL-
1 has homologues in mammalian cells in the form of BH3-only proteins, such as Bik
and Bad, which are thought to 'sense' apoptotic signals, and then 'mediate' these by
releasing pro-apoptotic bcl-2 family members from intracellular structures they are
sequestered to or from the anti-apoptotic bcl-2 family members they are bound to.
The main 'executors' of apoptosis are the caspases, cleaving selected intracellular
proteins, essential for cell viability. So far ced-3 is the only caspase identified in
C.elegans, whereas in mammalian cells there are 'initiator' and 'effector' caspases.
'Initiator' caspases, such as caspases-2, 8-10 and -12, may not have any direct role in
cleaving intracellular proteins. Rather, they cleave and therefore activate 'effector'
caspases, such as caspase-3, -0, and -7, which in turn execute apoptosis, creating a
cascade of events (Chinnaiyan and Dixit, 1996). The constituent presence of caspases
in cells necessitates the presence of powerful suppressors, to avoid inappropriate
activation. The machinery for apoptosis is probably regulated by the levels/activity
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of suppressor and executor present. Pro-apoptotic proteins, such as bax, are able to
accelerate apoptosis, either directly (Xiang et al., 1996), or by blocking anti-
apoptotic proteins such as bcl-2 (Oltvai et al., 1993).
Bax and bcl-2 are both members of the bcl-2-family of mammalian cell death
regulators including pro-apoptotic proteins, such as Bax (Oltvai et al., 1993), Bad
(Yang et al., 1995), and Bik (Boyd et al., 1995), and anti-apoptotic proteins, such as
bcl-2 (Hockenbery et al., 1990) and bcl-XL (Boise et al., 1993). The bcl-2 family can
be defined by the presence of either some or all of four structural motifs in the
protein sequence: BH1, BH2, BH3 and BH4. These motifs enable the proteins to
hetero- or homodimerise, thereby interacting with each other to regulate apoptosis.
Mutations in BH1 and BH2 of bcl-2 prevent it from binding to bax and lead to
amplified apoptosis (Yin et al., 1994). The BH3-domain present in many pro-
apoptotic proteins is essential for interaction with anti-apoptotic members of the
family, such as bcl-2 and bcl-xL (Wang et al., 1996; Zha et al., 1997). BH4 is needed
for the protective effect of bcl-2 and bcl-XL (Reed, 1997).
It has been proposed that the ratio of pro-apoplotic to anti-apoptotic proteins
determines whether a cell survives or undergoes apoptosis by varying the amount of
homodimers of the pro- or anti-apoptotic proteins present (rheostat model)
(Korsmeyer et al., 1993). However, although interaction of bcl-2 family proteins is
important in regulating apoptosis, they can each act independently of other family
members (Knudson and Korsmeycr, 1997).
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1.4.3 The role ofMitochondria in apoptosis
It is thought that a large proportion of caspase activation during apoptosis is due to
the action of bcl-2 family members on mitochondria. Cytochrome c released from the
inside of mitochondria strongly activates caspases. This, in conjunction with the
finding that bcl-2 is primarily localized in mitochondrial plasma membranes
(Hockenbery, 1990) led to the idea that the action of bcl-2 may be connected with the
mitochondria. A collapse in the mitochondria's inner transmembrane potential occurs
before DNA fragmentation (Vayssiere et al., 1994), a phenomenon observed
irrespective of the mode of apoptosis activation. This permeability transition (PT) is
thought to be executed by mitochondrial megachannels (PT pores) (Petit et al.,
1996), rendering the membrane permeable to ions and paving the way for an
equilibration of ions across the membrane. This dissipates the H+ gradient across the
inner membrane, uncoupling the respiratory chain and ATP synthesis. Swelling of
the matrix induced by this ion equilibration can lead to outer membrane disruption
and release of cytochrome c and other important proteins, such as apoptosis-inducing
factor (AIT) (Lorenzo et al., 1999). Products released from the mitochondria were
found to activate nuclear endonucleases, as well as stimulating caspase-3 activation
(Liu et al., 1996; Susin et al., 1997). Other pro-apoptotic molecules released from the
mitochondria, such as Smac/DIABLO (Du et al., 2000) and the serine protease
Htr2A/Omi (Hegde et al., 2002), can sequester or degrade anti-apoptotic substances
and therefore potentiate the action of pro-apoptotic proteins. Cell-free studies have
shown that mitochondrial products are necessary for many events associated with the
induction of apoptosis in mammalian cells (Zamzami et al., 1996).
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Bcl-2 and bcl-XL inhibit or retard the mitochondrial changes observed in apoptotic
cells (Susin et al., 1996; Kharbanda et ah, 1997), an anti-apoptotic effect dependent
on localization to mitochondrial membranes (Decaudin et ah, 1997). Pro-apoptotic
members of the bcl-2 family like bax increase mitochondrial membrane permeability.
The structures of both pro- (bax) and anti-apoptotic (bcl-2, bcl-XL) members of the
bcl-2 family have similarities to some ion channel forming bacterial toxins
(Muchmore et ah, 1996). They are able to form ion-conducting channels in artificial
lipid membranes, suggesting they may do so in vivo (Minn et ah, 1997; Schendel et
ah, 1997; Schlesinger et ah, 1997). It is thus possible, that some bcl-2 family proteins
act by regulating an electrochemical gradient or by interacting with other
components in the plasma membrane of mitochondria, such as the PT pore. This is
especially significant since it was recently shown that the release ofmany apoptosis-
inducing molecules, such as cytochrome c, from the mitochondria precedes the
disruption of the mitochondrial membrane due to swelling (von Ahsen et ah 2000).
This indicates that swelling and membrane disruption are by-products of the channels
made by the pro-apoptotic molecules in the mitochondrial membrane, and that
membrane disruption serves to potentiate the apoptotic processes further
downstream. Bcl-2 and bcl-xL can only form channels at a non-physiologically low
pH of 4 however, and there are no measurements of these channels in vivo (Minn et
ah, 1997; Schendel et ah, 1997). It is thus unlikely that channels formed by these two
anti-apoptotic molecules are significant in vivo. Pro-apoptotic members of the bcl-2
family such as Bax, in contrast, form pores at physiological pH (Schlesinger et ah,
1997). These pores are large enough to allow passage of fluorescent-labeled
cytochrome c (Saito et ah, 2001), and bax and bak are able to elicit cytochrome c
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release from isolated mitochondria (Degenhardt et al., 2002). It is thought that anti-
apoptotic bcl-2-family proteins prevent bax from undergoing the conformational
change needed for these pores to form. Further to forming pores alone, bax can
interact directly with components of the PT pore (reviewed in Zamzami and
Kroemer, 2001). Blocking of the PT pore only slows the progression of apoptosis
without being able to rescue the cell however (Desagher and Martinou, 2000). Also,
the PT pore spans both inner and outer membranes of mitochondria. Most substances
known to induce apoptosis lie between these membranes, making the PT pore an
unlikely source for the release of substances from the intermembrane space (Borner,
2003).
Other organelles may also be involved in the actions of the bcl-2 family on
mitochondrial permeability, such as the endoplasmatic reticulum (ER) and the
perinuclear membrane, whose membranes bcl-2 is also localized to (Chen-Levy et
al., 1989; Hockenbery et al., 1990; Jacobson et al., 1993). Bcl-2 bound to other
membranes may be able to act as a scavenger molecule for pro-apoptotic molecules
such as Bax, inhibiting their actions on mitochondria/caspases. ER-bound bcl-2,
prevents Bax's translocation to mitochondria (Ferri and Krocmer, 2001). Anti-
apoptotic members of the Bcl-2 family can prevent cytochrome c mediated apoptosis
when overexpressed (Li et al., 1997; Rosse et al., 1998), suggesting actions
downstream of their effects on mitochondria. Bcl-2 has been shown to regulate the
activity of membrane associated pro-caspase-3 independently of cytochrome c
(Krebs et al., 1999) and Bc1-xl can bind directly to Apaf-1 preventing it from
activating pro-caspase-9 (Hu et al., 1998; Pan et al., 1998). It remains to be
determined whether this effect can occur at physiological concentrations of anti-
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apoptotic bcl-2 proteins in vivo. Bcl-2 and Bc1-xl have been found to bind to a
variety of proteins non-specifically when overexpressed (Borner, 2003). Some of the
above effects could thus be explained by non-specific binding of these proteins.
1.4.4 Receptor-mediated and other modes of apoptosis
There are other mechanisms of cell death that do not require mitochondria. The main
identified mode is the mechanism of receptor-mediated apoptosis, by which
extracellular ligands can induce direct activation of pro-apoptotic proteins such as
caspases by interacting with so-called 'death-receptors', allowing them to bypass the
mitochondrial apoptotic machinery. This pathway may at times use the mitochondrial
pathway to amplify the death signals it induces. This is done after the point of no
return is reached and is not essential to this pathway. This pathway is mainly induced
by extracellular death-inducing ligands of the tumor necrosis factor (TNF)
superfamily (reviewed by Locksley et al., 2001). These bind to specific receptors on
the plasma membrane leading to their dimerisation. The 'death domain' of these
receptors attracts adaptor proteins, such as TNF receptor associated death domain
(TRADD) and Fas-associated death domain (FADD). These have a similar function
as ced-4/Apaf-l, forming a casposome with the initiator caspase-8. The formation of
this complex stimulates activation of caspase-8, which then in turn activates a variety
of effector caspases leading to the execution of the 'death-signal'. Since FADD and
TRADD have no homology to ced-4/Apaf-l despite having a similar function, the
bcl-2 family of proteins has no actions on this pathway (Huang et al., 1999). One of
the actions by which caspase-8 can potentiate its apoptotic signal is by cleaving Bid,
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allowing it to form pores in the mitochondrial membrane, a path likely to be used in
vivo to enhance and accelerate the cells response to the death receptor.
There is evidence that other apoptosis pathways exist in addition to the mitochondrial
and the receptor-mediated pathway. Apoptosis can be prevented in cells lacking
functional mitochondria by overexpressing bcl-2 (Jacobson et al., 1993), suggesting
some mitochondria-independent modes of action for the bcl-2 family. The ion pore
forming capabilities of the bcl-2 family are not restricted to the mitochondrial plasma
membrane, enabling it to make such pores or modulate existing ones in other
organelles, such as the Endoplasmatic Reticulum (ER). Release of calcium from ER
stores accompanies apoptosis in certain cells, with bcl-2 blocking this calcium
release and apoptosis (Lam et al., 1994). Studies overexpressing bcl-2 found that it
can have important effects on calcium handling by the ER, such as decreasing the
calcium pool in the ER (Pinton et al., 2000). However, calcium release does not seem
to be a prerequisite for apoptosis to occur, and bcl-2 can still prevent apoptosis
associated with high cytosolic calcium levels (Zhong et al., 1993). Intracellular
calcium may thus act as a potentiator rather than an initiator of apoptosis.
There appear to be apoptotic pathways involving the ER that are independent of the
bcl-2 family and calcium release, such as over-activation of the ER processes
involved in handling misfolded and aggregated proteins (Rao et al., 2002). Further, a
casposome complex including caspase-8 was recently described recruited to the ER
membrane (Breckenridge et al., 2002).
Another possible pathway for apoptosis is thought to occur via free radicals (Buttke
and Sandstrom, 1994). Bcl-2 is found at sites of free radical generation in the cell,
acting as an anti-oxidant, preventing lipid peroxidation as an example (Hockenbery
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et al., 1993; Kane et al., 1993). Induction of cell death by free radicals is associated
with necrotic cell death, illustrating the ability of bcl-2 family proteins to protect the
cell from different components of the apoptotic machinery, and from different modes
of cell death such as necrosis. It is likely that apoptosis in vivo uses more than one of
the above mitochondria-dependent and independent mechanisms, with some triggers
of apoptosis, such as ER stress, involving mitochondria in their apoptotic cascade
(Elyaman et al., 2002).
1.4.5 Apoptosis in the nervous system
The first indication that neuronal cells undergo a programmed mode of cell death
following neurotrophic factor withdrawal came from the discovery that the death of
growth factor deprived cultured sensory and sympathetic neurons could be prevented
using inhibitors of RNA and protein synthesis (Scott and Davies, 1990; Martin et al.,
1988).
Subsequently, it was found that high levels of bcl-2 expression are found in neurons
and supporting cells of developing peripheral sympathetic and sensory ganglia, and
these levels were retained postnatally and into adulthood. In the CNS, levels of bcl-2
are initially high, but are downregulated after birth (Merry and Korsmeyer, 1996),
whereas bcl-XL levels continue increasing into adulthood (Gonzales-Garcia, 1995).
Both the pro- and anti-apoptotic members of bcl-2-family protein are involved in the
programmed cell death of neurons. Overexpression of bcl-2, for example, reduces the
death of cultured sympathetic and sensory neurons deprived of survival factors
(Garcia et al., 1992; Allsopp et al., 1993; Farlie et al., 1995). Overexpression of bcl-2
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in vivo protects neurons from naturally occurring neuronal death and ischemia
(Martinou et al., 1994). A reduction in the endogenous levels of bcl-2 reduces
neuronal survival (Veis et al., 1993; Allsopp et al., 1995; Michaelidis et al., 1996;
Pinon et al., 1997), and bcl-xi deficiency produces massive neuronal loss (Motoyama
et al., 1995). Cell death in bcl-xi-l- mice occurs before target innervation and thus
before the period of naturally occurring cell death and the main period of trophic
requirement. Immature neurons are thus supported by bcl-xL. Cell death in bcl-2-l-
mice is increased during the period of naturally occurring cell death of neurotrophin-
dependent sensory neuron populations, such as the trigeminal and nodose ganglia
(Middleton et al., 2000).
Bax is widely expressed in the nervous system (Deckwerth et al., 1996).
Overexpression results in an acceleration of neuronal death upon neurotrophin
withdrawal (Vekrellis et al., 1997; Martinou et al., 1998), whereas a reduction of
endogenous bax promotes the survival of some neurons, even without neurotrophic
factors (Deckwerth et al., 1996; Gillardon et al., 1996; Miller et al., 1997; White et
al., 1998; Middleton et al., 2000). Bim also plays an important role in the survival of
neurons. Cultures of neurons from knockout embryos of the BH3 protein Bim are
resistant to cytokine withdrawal (Putcha et al., 2001).
Apaf-1 (a homologue of ced-4) knockout embryos show a decreased apoptosis in
many neuronal populations, with little effect on other cell types, suggesting that the
Apaf-l/caspase-9 pathway is of particular importance to neuronal survival
(Honarpour et al., 2000). Inhibition of caspases blocks neuronal cell death induced
by neurotrophic factor withdrawal (Cryns and Yuan, 1998). Null mutations in
caspase-3 and -9 (which activates caspase-3) produce similar effects on neural
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progenitor cell populations in the brain to those observed in apaf-1 mutants, with
ectopic cell masses appearing in the cortex, hippocampus and striatum of the mice
(Kuida et ah, 1996, 1998).
In addition to its role in apoptosis, bcl-2 is involved in axonal growth from trigeminal
sensory neurons. Cultured bcl-2-I- neurons extend axons more slowly (44-60%
shorter after 48h incubation of Ell trigeminal neurons), independently of bcl-2's
influence on survival (Hilton et al., 1997). bcl-2 also appears to be involved in the
early maturation of this neuronal population (Middleton et ah, 1998).
Receptor-mediated death has recently been identified as important in mediating the
death of sensory and sympathetic neurons upon NGF withdrawal (Barker et ah,
2001). Antibodies against tumor necrosis factor a (TNFa) and TNF-receptor 1 rescue
neurons deprived of NGF, and fewer neurons die during the phase of naturally
occurring cell death in 77VF-deficient embryos.
NF-kB, a protein that can suppress receptor-mediated apoptosis (Van Antwerp et ah,
1996), is induced by NGF in Schwann cells (Carter et ah, 1996). Activation ofNF-
kB following NGF binding to p75 also promotes the survival of developing
trigeminal neurons (Hamanoue et ah, 1999). Furthermore, NF-kB is able to mediate
the survival response of developing nodose neurons to cytokines (Middleton et ah,
2000).
1.4.6 Second messenger pathways activated by trks
More and more evidence has emerged dissecting the intracellular pathways that
neurotrophins and their receptors utilise to influence the above described
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death/survival mechanisms. The first step is the activation of second messenger
pathways through receptor binding. Ligand-induced dimerisation and trans-
phosphorylation of the trk receptor leads to the recruitment and phosphorylation of
proteins, such as phospholipase C-yl (PLC- yl) (Ohmichi et al., 1991; Belia et ah,
1991), the Sue 1-associated neurotrophic factor target (SHP-1), the SH2-containing
adaptor protein (She) (Stephens et ah, 1994; Nakamura et ah, 1996), and the SH2-
containing tyrosine phosphatase-1 (SHP-1) (Vambutas et ah, 1995).
Phosphorylated PLC-yl mediates the phosphorylation and activation of protein
kinase C and induces mechanisms that play a part in calcium homeostasis (Guiton et
ah, 1994).
To instigate the Ras/mitogen-activated protein kinase (MAPK) pathway that is
implicated in neuronal survival, phosphorylated She recruits the adaptor protein
Grb2, which in turn leads to activation of the guanine nucleotide exchange factor son
of sevenless (SOS) that subsequently activates Ras. Downstream of Ras lie Raf,
ERK-1, 2 and 5, as well as p38MAPK (Grewal et ah, 1999; Ballif and Blenis, 2001;
Stephens et ah, 1994; Xing et ah, 1996; Meakin et ah, 1999; Atwal et ah, 2000). The
ERKs lead to the activation of p90 ribosomal S6 kinase (RSK), which in turn
phosphorylates the cAMP response element-binding protein (CREB) (Xing et ah,
1996; Watson et al, 2001), whereas p38MAPK can directly activate CREB
transcription factor (Riccio et ah, 1999).
The Shc/Grb2 complex is also involved in the activation of the PI3K pathway. The
complex activates insulin receptor substrates (IRS)-l and -2 and Grb-associated
binder-1 (Gab-l), which induces PI3K causing recruitment of 3-phosphoinositide-
dependent kinase 1 (PDK) and its substrate protein kinase B (AKT/PKB) (Holgado-
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Madruga et al., 1997; Yamada et al., 1997; Vanhaesebroeck and Alessi, 2000). In
addition to the above pathway, PI3K can also be activated directly through Ras, a
pathway essential for the maintenance of some sensory neurons (Klesse and Parada,
1998). It has recently been demonstrated that inhibition of the PI3-Kinase pathway
induces cell death in adult SCG neurons and nodose neurons (Orike et al., 2001;
Alonzi et al., 2001).
1.4.7 Transcriptional induction of survival/death
Ligand-induced dimerisation and autophosphorylation of trks leads to the activation
of CREB by the Ras/MAPK pathway. CREB absence in some sympathetic and
sensory neurons triggers Bax-dependent apoptosis (Lonze et al., 2002). One of the
actions of CREB is to up-regulate bcl-2 upon growth factor stimulation (Pugazhenthi
et al., 1999, 2000). AKT, activated by the PI3K pathway can inhibit the forkhead
transcription factor 1 (FKHLR1), which controls the expression of apoptosis-
inducing gene products, such as FasL (Brunet et al., 1999), which promotes
apoptosis by binding to the Fas receptor (Le-Nicolescu et al., 1999). ERK5 has been
shown to activate the MAF-2 transcription factor thought to be involved in neuronal
survival (Kato et al., 1997; Mao et al., 1999).
De novo synthesis of proteins is required for most modes of apoptosis, and it is
essential for apoptosis upon NGF-withdrawal (Martin et al., 1988). An inducible
transcription factor, which coordinates the expression of other genes, is thus likely to
be activated by neurotrophin withdrawal. A possible candidate for this is the c-Jun
proto-oncogene that is activated by Jun N-terminal kinase (JNK). In sympathetic
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neurons, anti-c-Jun antibodies and dominant-negative c-Jun have been found to block
cell death (Deshmuk and Johnson, 1998; Ham et al., 1995). Also, specific antibodies
blocking JNK signal transduction inhibit neurotrophin-withdrawal mediated cell
death. Downstream signalling in response to neurotrophic factor withdrawal/p75
activation leads to an increase in the levels of the tumor suppressor p53. Apoptosis in
these cells can be partially blocked by inhibiting the increase in p53. p53 activation is
downstream of JNK and upstream of Bax activation (Aloyz et al., 1998). Other
signalling molecules have been identified, which are induced upon neurotrophic
factor withdrawal and are upstream of JNK activation, such as the small GTP-
binding proteins cdc42/Racl (Bazenet et al., 1998), Apoptosis signal-regulating
kinase 1 (Ask-1) (Kanamoto et al., 2000), and MAPKKKs (Aloyz et al., 1998; Xu et
al., 2001). MAPKKKs can phosphorylate and activate MKK 4/7 (Xu et al., 2001),
which can activate JNK isoforms (Bruckner et al., 2001). p53 induces the BH3-only
proteins PUMA/Bbc3 and Noxa (Han et al., 2001; Nakano and Vousden, 2001).
Although the precise role of these proteins in apoptosis is not known yet, they may
act like other BH3-only proteins by releasing pro-apoptotic members of the bcl-2
family. The JNK-p53-Bax apoptotic pathway that is initiated upon neurotrophin
withdrawal can be induced by p75 activation alone, suggesting that p75 takes a major
role in mediating this effect (Aloyz et al., 1998). Interestingly, trkA activation in
sympathetic neurons can prevent death by silencing JNK and the connected
activation of p53. This occurs through activation of Ras (Mazzoni et al., 1999).
Another pathway, not requiring the activation of JNK, can operate upon neurotrophic
factor withdrawal. It involves the activation of the cell cycle regulatory molecules
CDK4/6 (Park et al., 1997), which phosphorylate and activate the retinoblastoma
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tumor suppressor protein (pRb) (Park et al., 2000). pRb in turn is a potential activator
of p53.
A further example of transcriptional control by neurotrophins involves the BH3-only
proteins Hrk/DP5 and Bim. Hrk/DP5 is upregulated upon NGF withdrawal from
neurons via c-jun, as is Bim (Harris and Johnson, 2001, Whitfield et al., 2001).
Hrk/DP5 protein is particularly interesting since its levels reach their peak
simultaneously with the peak of programmed cell death in neurons (Imaizumi et al.,
1997), and activation of Hrk/DP5 induces cell death in cerebellar granule neurons in
a Bax-dependent manner (Harris and Johnson, 2001). The potent pro-apoptotic
action of Bim is described below.
1.4.8 Modulation of BH3-only proteins by trk signalling
One of the major ways through which neurotrophin receptors signalling activates
survival mechanisms is by inactivating BH3-only proteins. The BH3-only protein
Bad for example is sequestered by phosphorylations to 14-3-3 scaffold proteins in
the cytoplasm, preventing its activation of Bax and other pro-apoptotic bcl-2 family
proteins. AKT/PKB, a transducer of growth factor survival signals via the PI3K
pathway, is one of the kinases known to phosphorylate Bad (Datta et al., 1997; del
Peso et al., 1997). Raf, which links growth factor receptors to the Ras/mitogen-
activated protein kinases (MAPK) cascade can also phosphorylate Bad (Wang et al.,
1996). In the absence of growth factors, the Bad 'BH3-only sensor' is
dephosphorylated and released from the 14-3-3 scaffold proteins where it is free to
interact with members of the bcl-2 family and activate the apoptotic machinery.
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Other BH3-only proteins, such as Bim and Bif, are also involved in apoptotic
pathways during development, with knockouts leading to embryonic lethality by
E9.5 (Buillet et ah, 1999). Like Bad, they are normally sequestered in an inactive
state. Bim is sequestered to the dynein light chain LC8, a component of the
microtubules (Puthalakath et ah, 1999). Withdrawal of NGF can induce expression
of Bim in cultured sympathetic neurons, and neurons from Bim-/- mice are
transiently protected against apoptosis in response to NGF withdrawal. This suggests
that Bim is involved in the induction of death upon trophic factor withdrawal (Putcha
et ah, 2001). Indeed, NGF-induced activation of the MEK/MAPK pathway, leads to
down-regulation and phosphorylation of Bim, thereby inactivating it (Biswas and
Greene, 2002). JNK-mediated Bim phosphorylation in contrast has been shown to
lead to Bax activation and apoptosis upon trophic factor deprivation (Putcha et ah,
2003). One of the downstream targets of Bim appears to be bcl-2, since the
phenotype of bcl-2 knockouts can be prevented by knocking out Bim (Buillet et ah,
2001). Bim may thus act by binding to bcl-2/bcl-xl and releasing Bax or Bak to carry
out their apoptosis-inducing functions. This is reinforced by the discovery that Bim,
Bad and Bid are unable to induce apoptosis in Bax/Bak double knockout cells
(Cheng et ah, 2001). NGF can thus function both by inhibiting the transcription of
pro-apoptotic molecules, and inactivating the proteins already present in the cell.
1.4.9 Survival/death pathways associated with the p75 receptor
p75 has been found to suppress receptor-mediated apoptosis by activating NF-kB
(Van Antwerp et ah, 1996; Hamanoue et ah, 1999). p75 is believed to activate NF-
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kB through its adaptor protein TNF-associated factor 6 (TRAF6) (Khursigara et al.,
1999), which has been shown to activate 'NF-kB activating kinase' (NIK), which
phosphorylates 'inhibitor of IkB kinase' (IKK). Phosphorylation of IkB by IKK
results in the release and nuclear translocation ofNF-kB (Arch et al., 1998). NF-kB
activates genes involved in neuronal survival (reviewed by Wang et al., 2002). p75
has been suggested to act as a 'switch' in neurons, activating the JNK/p53 pathway
in the absence of trk signalling, leading to the death of the neuron, whereas in the
presence of trk signalling it would activate the NF-kB pathway, collaborating with
trk survival signals to maintain the neuron. However, p75 may also signal for
survival in the absence of trkA or ligand-binding to p75, by activating the
PI3K/AKT-pathway (reviewed by Roux et al., 2002).
Ceramide is generated upon p75 ligand binding (Dobrowsky et al., 1995) and it has
been suggested that it inactivates Ras-dependent pathways (Midler et al., 1998) and
PI3K-dependent pathways (Zundel et al., 2000), thereby promoting cell death.
Another pathway via which p75 could induce apoptosis in the absence of NGF/trk
signalling, is through proteins which have recently been described to interact with it:
neurotrophin receptor interacting factor (NRIF) (Casademut et al., 1999),
ueurolrophin-receptor interacting melanoma-associated antigen (NRAGE) (Salehi et
al., 2000) and p75NTR-associated cell death executor (NADE) (Mukai et al., 2000).
TRAF family members also interact with p75 and induce apoptosis (Ye et al., 1999).
It is not known however, whether these proteins are regulated by neurotrophins.
In addition to neurotrophins, p75 can bind several other proteins with nanomolar
affinities, such as the neurotoxic prion protein fragment PrP and the AP amyloid
peptide. p75 is also a co-receptor for myelin-derived axon growth inhibitory proteins
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(Dechant and Barde, 2002; Hempstead et al., 2002). Signalling pathways activated
by binding of these alternative ligands have yet to be determined.










Interaction of the bcl-2 family with mitochondria. Bax, Bid. Bint and Bad promote apoptosis by
interacting with mitochondria and making the mitochondrial outer membrane permeable to
cytochrome c (Cyto C) and other pro-apoptotic proteins. These in turn activate the apoptosome. which
initiates a cascade of caspases that execute cell death. Anti-apoptotic proteins, such as bcl-2 and bcl-
XL prevent the actions of the pro-apoptotic members of the family.
Figure 1.9 legend: Figure showing the intracellular signalling mechanisms leading to death or survival
upon neurotrophins binding or not binding. The left side shows the intracellular apoptosis pathways
thought to occur when neurotrophins bind to p75 alone, or when p75 and/or trk have no ligand. The
right side shows the intracellular pathways thought to mediate survival upon neurotrophin binding to
its trk receptor or to a high affinity receptor created through an association of trk and p75. NT:
Neurotrophin; pro NT: Proneurotrophin.
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1.5 The PNS - model of neurotrophin action
The experimental systems that form the basis of this thesis are the ganglia of the
mouse peripheral nervous system. In this section I shall briefly describe the
importance of neurotrophins and their receptors in the developing PNS as determined
by expression studies, tissue culture and knockout studies. I shall then describe the
ganglia studied in the experiments presented in this thesis in more detail and
illustrate their suitability for the types of study conducted and their dependence on
neurotrophins. Peripheral sensory ganglia are ideal for studies of neuronal numbers
through development, as their numbers tend to be rather constant at determined
stages of development, and unlike neuronal populations in the CNS, sensory
ganglion neurons reside in discrete ganglia throughout development. This enables
quantitative determination of the effects of trophic/death factors and cell-cell
interactions during development (Kirstein and Farinas, 2002).
1.5.1 Function of NGF in PNS development
NGF-I- mice have an impaired nociceptive system and thus do not respond to
noxious mechanical stimuli such as pinching of their tail (Crowley et al., 1994).
Histological analysis of these knockouts showed reduced numbers of neurons in the
trigeminal, dorsal root (restricted to neurons conveying nociceptive and
thermoceptive information) and sympathetic ganglia (Crowley et al., 1994). The
sympathetic chain of knockout mice is non-existent 2 weeks after birth, due to the
excessive death of differentiated sympathetic neurons at the period when they
undergo naturally occurring cell death (Crowley et al., 1994). Further, small
99
nociceptive neurons in the DRG continually express trkA, whereas thermoceptive
neurons do so only prenatally. Both are lost in trkA knockouts (Smeyne et al., 1994),
revealing the importance of NGF during the phase of naturally occurring cell death
(Silos-Santiago et ah, 1995). trkA deficient mice exhibit similar deficits to NGF
knockouts, such as insensitivity to pain, temperature and noxious olfactory stimuli.
Also, extensive neuronal cell loss occurs in trigeminal, sympathetic and dorsal root
ganglia of trkA deficient mice (Crowley et ah, 1994).
NGF overexpression in the mouse results in increased neuronal survival in certain
sensory and sympathetic ganglia, indicating a reduction of programmed or naturally
occurring cell death during development (Albers et ah, 1994). These mice also
display hyperalgesia to noxious stimuli.
In vitro experiments have demonstrated that most sensory neurons that respond to
NGF are of neural crest origin (Davies and Lindsay, 1995), whereas neurogenic
placode-derived neurons seem unresponsive to NGF (Davies, 1989). Recently
however, it was demonstrated that a subset of the placode-derived nodose neurons
depends on trophic support by NGF during development (Forgie et ah, 2000).
1.5.2 Function of BDNF in PNS development
The central nervous system is the predominant site of BDNF mRNA expression,
especially the cerebellum, cerebral cortex and the hippocampus, where it is confined
to a subset of pyramidal and granular neurons (Liebrock et ah, 1989; Hofer et ah,
1990; Maisonpierre et ah, 1990a, Yan et ah, 1997). It is expressed at much lower
levels in the peripheral nervous system in specific neuronal populations and central
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and peripheral target fields (see below). trkB is widely expressed in both the CNS
and PNS (Klein et al., 1990a,b).
BDNF promotes the survival of DRG, trigeminal, geniculate, vestibular and nodose
neurons in culture (Lindsey et ah, 1985; Davies et ah, 1986; Davies et ah, 1987;
Hofer & Barde 1988, Ernfors et ah, 1994; Jones et ah, 1994). Central target fields
(i.e. spinal cord and hindbrain) of BDNF-dependent neurons express BDNF mRNA
(Ernfors et ah, 1990a; Ernfors et ah, 1990b; Hofer et ah, 1990; Philips et ah, 1990).
BDNF mRNA is also detected in DRG, trigeminal, jugular ganglia and sympathetic
ganglia themselves (Ernfors et ah, 1988; Schecterson and Bothwell, 1992; Wright et
ah, 1992; Robinson et al; 1996a), which suggests paracrine or autocrine survival
mechanisms for some BDNF-dependent neurons as described above (see 1.2.6).
BDNF-/- mice develop symptoms of nervous system dysfunction and display
substantially reduced numbers of cranial and dorsal root sensory ganglion neurons
(Ernfors et ah, 1994, Jones et ah, 1994). The majority of BDNF-/- mice die within 2
days of birth. Major neuronal deficiencies in sensory ganglia, including the vestibular
ganglia, result in deficiencies in coordination, balance and respiration. Some CNS
populations of neurons, such as cortical neurons that respond to BDNF in culture
(Ghosh et ah, 1994), appear unaffected by the mutation, raising the possibility of
some compensatory effect by other neurotrophins. For example, motor neurons are
supported by BDNF, NT-3 and NT-4 in vitro (Henderson et ah, 1993). It may thus be
that some of the other factors compensate for the gap left by BDNF in vivo,
especially since NT-4 binds to trkB with high affinity. trkB-/- mice are viable at birth
but are unable to feed and die within the first 48hrs of birth (Klein et ah, 1993).
These knockouts display neuronal loss in the trigeminal, nodose and dorsal root
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ganglia (Klein et al., 1993). trkB knockouts also display some neuronal loss in the
facial motor nucleus and in spinal cord motor neuron populations at lumbar levels
L2-L5 (Klein et al., 1993).
1.5.3 Function of NT-3 in PNS development
NT-3 mRNA is found in a variety of tissues during development and adulthood. In
the peripheral nervous system NT-3 is widely expressed, including in target tissues
of sensory and sympathetic ganglia (Ernfors et al., 1992; Pirvola et al., 1992;
Hallbook et al., 1993; Henderson et al., 1993), with the spatio-temporal pattern of
expression indicating an action as a trophic factor for neurons. Consequently, trkC
has been detected within cranial and DRG sensory and sympathetic ganglia
(Tessarollo et al., 1993; Lamballe et al., 1994). Early neurons of the trigeminal
ganglion depend on NT-3 for survival as well as BDNF (Buchman and Davies, 1993;
Wilkerson et al., 1996), and NT-3 expression in the whisker pad dermis and
epidermis increases towards the time point that trigeminal ganglion neurons reach
this target field. It reaches its maximum during the early stages of innervation before
rapidly declining following the loss of responsiveness of trigeminal neurons to
BDNF and NT-3 (Buchman and Davies, 1993).
Further, NT-3 promotes the survival of other sensory and sympathetic neurons such
as neurons of the lumbar and cervical DRG (Hory-Lee et al., 1993), nodose neurons
(Gaese et al., 1994; Ockel et al., 1996), neurons of the spiral ganglia (Gao et al.,
1995; Ernfors et al., 1995), and a subset of sympathetic neurons that also require
NGF (Wyatt et al., 1997; Francis et al., 1999). Localised expression studies show
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that NT-3 is able to rescue proprioceptive neurons in NT-3 knockout mice,
suggesting a trophic role for NT-3 on this population (Wright et al., 1997).
Cutaneous overexpression ofNT-3 increases the number of sensory and sympathetic
neurons in peripheral ganglia, enlarges touch dome mechanoreceptor units and
increases hair follicle innervation (Albers et al., 1996).
NT-3-/- mice lack the main components of the proprioceptive system, such as the
large diameter myelinated DRG sensory neurons, explaining the severe defect in
limb movement observed after birth (Ernfors et al., 1994b; Farinas et al., 1994;
Tessarollo et al., 1994). These mutants die shortly after birth due to absent food
intake, and display neuronal loss in other neuronal populations, such as the nodose,
trigeminal, superior cervical and spiral ganglia (Ernfors et al., 1994b; Tessarollo et
al., 1994; Bovolenta et al., 1996; Farinas et al., 1996; Fritzsch et al., 1997; Wyatt et
al., 1997). Tike NT-3-/- mice, trkC-/- mice have deficiencies within the peripheral
nervous system, such as reductions of neuronal numbers in vestibular neurons and
some cochlear neurons innervating inner hair cells (Schimmang et al., 1995).
Interestingly, lumbar DRGs of trkC-T embryos loose 18% of their neurons (Klein et
al., 1994; Minichiello et al., 1995), whereas NT-3-/- mice loose 66% at birth (Ernfors
et al., 1994a; Farinas et al 1994). Neurons in spiral ganglia, display 51% (trkC-/-)
and 86% (.NT-3-/-) reductions (Schimmang et al., 1995). This indicates that NT-3 can
signal via other receptors to promote survival. This is most likely to occur through
trkA and trkB, as trigeminal and nodose neurons from trkC-/- embryos can be
supported by NT-3 in vitro, whereas neurons from trkA and trkB knockouts cannot
(Davies et al., 1995).
103
Further to its role as a neurotrophic factor, NT-3 promotes the differentiation and
maturation of PNS sensory neurons before dependence on other neurotrophins
(Wright et al., 1992; Buchmann & Davies, 1993; Elshamy and Ernfors, 1996). It also
promotes neurite outgrowth from embryonic sensory neurons and supports the
development of distinct axon morphologies (Dijkhuizen et al., 1997; Lentz et al.,
1999).
1.5.4 Function of NT-4/5 in PNS development
Peak expression of NT-4/5 within peripheral targets coincides with the peak of
naturally occurring neuronal cell death in peripheral ganglia, suggesting a role for
NT-4/5 as a target-derived trophic factor. NT-4/5 can support mouse NGF-dependent
trigeminal and jugular neurons at early stages of target field innervation, and mouse
BDNF-dependent nodose neurons during the phase of naturally occurring cell death
(Davies et al., 1993; Ibanez et al., 1993). It also supports the in vitro survival of
developing DRG and paravertebral sympathetic neurons (Hallbook et al., 1991), and
postnatal spiral ganglion and vestibular neurons (Zheng et al., 1995a; Zheng et al.,
1995b).
NT-4/5-/- mice display a marked loss of sensory neurons in the nodose-petrosal and
geniculate ganglia.
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1.5.5 Function of p75 in PNS development
p75 is expressed in the PNS and CNS ofmice (Ernfors et al., 1988; Yan & Johnson,
1989). During development it is expressed in NGF-dependent spinal and cranial
sensory neurons, as well as sympathetic neurons (Heuer et al., 1990; Hallbook et al.,
1990). The dose-response curve to NGF in trigeminal, DRG and SCG ganglia of
p75-/- mice is shifted to higher NGF concentrations (Davies et al., 1993; Fee et al.,
1993; 1994). This indicates that p75 enhances the sensitivity of NGF-dependent
neurons to NGF. In accordance with this, mutant NGF which can solely bind to trkA
but not to p75 is less efficient at promoting the survival of embryonic trigeminal
sensory and postnatal SCG neurons (Horton et al., 1997). It has been shown that
overexpressing trkA or trkB with p75 alters the binding affinity of trkA for NGF and
trkB for BDNF, NT-3 and NT4/5 (Makadeo et al., 1994; Bibel et al., 1999). The
sensitising effect appears to be restricted to NGF though, since p75 deficient neurons
do not show a decreased sensitivity to other members of the neurotrophin family
(Davies et al., 1993b; Fee et al., 1994).
Recent evidence shows that in some neuronal populations, such as in the early retina,
p75 expressed without trkA may induce cell death upon NGF-binding (Frade et al.,
1996; see 1.2.7). BDNF activation of p75 in the absence of trkB may also contribute
to developmental cell death of sympathetic neurons (Bamji et al., 1998).
p75-/- mice are viable and fertile (Fee et al., 1992). However, they display ulceration
of the extremities, and a decrease in response to thermal stimuli (Fee et al., 1992).
Neural loss is apparent in embryonic and postnatal trigeminal, dorsal root, and
postnatal SCG (Fee et al., 1994). This observation supports the in vitro observation
105
that p75 enhances the sensitivity of NGF-responsive neurons to NGF (Davies et al.,
1993; Lee et al., 1993; 1994).
Apart from its survival-associated effects, p75 has recently been found to promote
peripheral nerve development by regulating axonal growth and arborisation, with
peripheral nerves being severely stunted in p75-/- mice (Bentley and Lee, 2000).
Further, it plays an important role in Schwann cell migration in the PNS, with
reduced migration observed in vitro (Anton et al., 19994; Bentley and Lee, 2000).
1.5.6 The Trigeminal ganglion
Cutaneous sensory neurons in the trigeminal ganglion, derived mainly from the
neural crest, but also from the dorsolateral placodes (D'Amico-Martel and Noden,
1983), transmit information on touch, pain and temperature from the face and jaws
(Dubner et al., 1978; Davies, 1988). The main peripheral sensory projections from
the ganglia are to the maxillary and mandibular processes, and an opthalmic
projection. In vertebrates, the maxillary nerve innervates amongst other things the
upper lip, lateral portions of the nose, part of the oral cavity, maxillary sinus and the
upper dental arch. The mandibular nerve mainly provides innervation to the lower
lip, the chin, the lower teeth gingival and the anterior two thirds of the tongue. The
opthalmic nerve principally innervates the forehead, upper eyelid and cornea (refer to
Lazarov, 2002 for exhaustive listing). Central projecting axons of trigeminal neurons
terminate on several groups of second order sensory neurons in the brainstem, which
convey the information to the somatosensory cortex via the thalamus (Kruger and
Young, 1981; Pfaller and Arvidsson, 1988). The mouse trigeminal ganglion is highly
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advantageous to study sensory neurons at various stages of development (Davies,
1997), as has become clear by the wealth of studies reviewed in this Introduction
thus far. Substantial knowledge has been gained about the neurotrophins and their
actions by studying this neuronal population. It is the largest of the sensory ganglia in
the embryo and one of the first neuronal elements to differentiate in utero (Stainier
and Gilbert, 1991). It is thus easily identifiable for dissection, being visible from E9
(Stainier and Gilbert, 1991), and enough neurons can be isolated from it at very early
stages of development for assessment of survival and gene expression in culture. Its
size makes the ganglion readily identifiable very early in development using
histological techniques. Further, the peripheral (maxillary and mandibular) and
central (hindbrain) target fields of the trigeminal ganglion are clearly defined
structures, which enables their dissection during early stages of development. This
enables the study of the way the trigeminal ganglion and its target fields interact in
vitro and allows quantitative studies of both receptor expression in the trigeminal
ganglion and trophic factor expression in the targets (reviewed by Lindsay, 1996;
Davies, 1998).
Trigeminal ganglion neurons in the rodent belong to three distinct groups: small-
sized cells, related to cutaneous branches, medium-sized cells related to corneal
afferents, and large-sized cells related to oral and perioral branches, including the
tooth pulp (reviewed in Lazarov, 2002). The neurons in the ganglion are
pseudounipolar with a single axon, which divides into a peripheral and a central
branch. Although glutamate appears to be the principal neurotransmitter in the
trigeminal sensory system, GABA and a variety of peptides also play an important
role (reviewed by Lazarov, 2002).
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During development of the mouse embryo, neurons in the ganglion are first
distinguishable at about E9 (Stainier and Gilbert, 1991). The trigeminal ganglion
sends fibres to its peripheral targets from E9.5 to E13.5 (Davies, 1988). The number
of postmitotic neurons in the trigeminal ganglion increases between E9 and El3,
before decreasing due to apoptosis and reaching a stable number by birth (Davies and
Lumsden, 1984; Pinon et al., 1996). The peak in apoptosis occurs between El3 and
El5 with hardly any apoptotic cells visible prior to birth (Pinon et al., 1996).
Initially, before the phase of axonal outgrowth and target field innervation,
trigeminal neurons survive independently of survival factors. Cultured mouse
neurons at E10 are independent. This is the stage at which the first neurons start
growing towards their peripheral targets in vivo. 24 to 48hrs into the culture, at the
time they begin contacting the target field in vivo (~E11-E12), these neurons become
dependent on BDNF and NT-3, but not NGF, for their survival (Buchman and
Davies, 1993; Paul and Davies, 1995). This is supported by in vivo studies of trkB-/-
mice, which are missing this early population of neurons, an effect not seen in trkA-
/- mice (Pinon et al., 1996). When cultures are established later in development, NGF
promotes the survival of an increasing proportion of neurons (Buchman and Davies,
1993), an observation confirmed by a later loss of trigeminal neurons in trkA-l- mice
(Pinon et al., 1996; Wilkinson et al., 1996). This switch in neurotrophin dependence
from BDNF/NT-3 to NGF during development will be described in more detail in
chapter 5. Later in development, there is a further change in the survival
requirements of the trigeminal ganglion neurons, maintaining their dependence on
NGF, but also becoming dependent on MSP (Forgie et al., 2003). The sequential
nature of this response by trigeminal neurons to trophic factors is matched by the
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sequential nature of the expression of their receptors (Buchman and Davies, 1993;
Ninkina et al., 1996; Forgie et al., 2003). During the late fetal period, CNTF, LIF,
OSM and CT-1 promote the survival of a subset of NGF-responsive neurons (Horton
et al., 1998). The discoveries of neurotrophin-independent survival, neurotrophin
switching and neurotrophin co-operativity were mainly made from work on the
trigeminal ganglion, illustrating the importance of this ganglion for studying
developmental neurobiology. In the adult, trigeminal primary sensory neurons
mature and become less dependent on classic neurotrophic factors for their survival,
as it seems that they become more dependent on neurotransmitters and neuropeptides
(Lazarov, 2002).
1.5.7 The nodose ganglion
Nodose neurons, derived from the epibranchial placodes, act as baroreceptors and
chemoreceptors, transmitting information about heart rate, blood pressure, bronchial
irritation and visceral distension for example (reviewed by Lindsay, 1996; Davies,
1998). Nodose neurons are first discernible at —El 1 and increase in number up to
~E13, before decreasing due to programmed cell death. Cell death, observed as
pyknotic nuclei, reaches its peak at El3 (see chapter 6). Multiple neurotrophins
control the survival of neurons from the nodose-petrosal sensory ganglion complex
(NPC), so-called because it is difficult to distinguish between these two neuronal
populations in the mouse. Approximately half of all neurons in this complex are lost
in null mutants for BDNF, NT-3 or NT4/5 and GDNF (Ernfors et al., 1994; Liu et al.,
1995; Conover et al., 1995; Erickson et al., 2001), indicating that many NPC neurons
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must require more than one factor to promote their survival during development.
Further knockout studies indicate that BDNF and NT-4/5 promote the survival of
predominantly different subpopulations of these neurons by signalling through the
trkB receptor (Conover et ah, 1995; Erickson et ah, 1996). BDNF is required for the
survival of functionally distinct populations of dopaminergic vascular afferents
innervating the carotid body. This suggests that trophic requirements ofNPC neurons
are not modality-specific but may instead be associated with innervation of particular
organ systems (Brady et al, 1999). BDNF/GDNF double knockouts have shown that
petrosal ganglion innervation, but not nodose ganglion innervation of the carotid
body by dopaminergic neurons of the NPC complex require both BDNF and GDNF
(Erickson et ah, 2001). GDNF and BDNF are transiently expressed in the targets of
these afferents from the onset of sensory innervation up to the time at which fetal
NPC neurons become BDNF-dependent in vitro (Brady et ah, 1999; Erickson et ah,
2001). GDNF along with BDNF may play a role in regulating neurite growth,
branching and terminal arborisation from neonatal and adult nodose neurons (Niwa
et ah, 2002).
Throughout their development, nodose neurons are supported by CNTF, LIF, OSM
and CT-1, and display an additional survival response to IL-6 in the late fetal period
(Harper et ah, 1998).
1.5.8 The dorsal root ganglion (DRG)
Neural crest derived dorsal root ganglia (DRG) perform a similar sensory function to
the trigeminal ganglion in the trunk, acting as nociceptors, mechanoceptors and
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proprioceptors to the skin, muscle and viscera. The neuronal population of the DRG
displays variations in cell soma size and axon diameter, reflecting differences in
function, although there is some overlap (Scott, 1992). DRG neurons are first
discernible at ~E10. Neuronal numbers in the DRG increase up to ~E13, before
decreasing (Lawson and Biscoe, 1973; Farinas et al., 1996). The main phase of cell
death occurs between El 1 and El2, before the axons have reached their target fields
(Farinas et ah, 1996; ElShamy and Ernfors, 1996).
Survival of early embryonic DRG neurons in culture is promoted by NGF, BDNF
and NT-3, whereas neonatal neurons mainly respond to NGF alone (Memberg and
Hall, 1996; Lefcort et ah, 1996). This suggests a dependence on multiple factors
early in development before dependence on predominantly NGF at later stages, a
hypothesis supported by DRG phenotypes in single and double mutant mice for trkA
and trkB, and for NT-3 and trkC (Minichiello et ah, 1995; White et ah, 1996; Farinas
et ah, 1997). This indicates neurotrophin switching, as observed in the trigeminal
ganglion. Just after birth, some of the trkA/NGF-dependent neurons switch to GDNF
and FGF responsiveness for survival (Molliver et ah, 1997; Acosta et ah, 2001). As
DRG neurons mature, they become less dependent on neurotrophins for survival,
with adult DRG neurons surviving for long periods in vitro in the absence of NGF
(Dodge et ah, 2002).
NT-3 is also involved in the formation of neurons from precursor cells in the DRG.
Premature differentiation of precursor cells occurs in the absence ofNT-3, reducing
the generation of post-mitotic neurons between El2 and El3 (Farinas et ah, 1997).
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1.5.9 The superior cervical sympathetic ganglion (SCG)
The SCG consists of postganglionic cells, which receive preganglionic innervation
from the spinal cord and project to structures in the head. Their axons travel along
branches of the carotid arteries to their targets in the head, such as the eyes and the
lacrimal and salivary glands (Kandel et al., 2000). The SCG is first distinguishable at
approximately El3 in the mouse, with most neurogenesis completed by El5.5 and
apoptotic bodies observed between El5.5 and P0 (Fagan et al., 1996).
During development, sympathetic neurons express both trkA and trkC, but no trkB.
trkC expression precedes trkA expression, but decreases to very low levels by birth
(Birren et al., 1993; DiCicco-Bloom et al., 1993; Wyatt and Davies, 1995; Fagan et
al., 1995; Wyatt et al., 1996). Postnatally, the SCG is virtually absent in NGF-I- and
trkA-l- mice (Crowley et al., 1994; Smeyne et al., 1994; Fagan et al., 1996). In NT-3-
/-mice the SCG is reduced by half postnatally (Ernfors et al., 1994; Farinas et al.,
1994; Tessarolo et al., 1996). The absence of such a strong effect in trkC-l- mice
(Fagan et al., 1996; Tessarolo et al., 1997) suggests that NT-3 mediates its trophic
action through trkA.
Contrary to evidence that the survival of early sympathetic neuroblasts is enhanced
by NT-3 and that this may be the cause for the reduced neuronal numbers seen
postnatally in NT-3 deficient mice (Dechant et al., 1993; Birren and Anderson, 1993;
ElShamy et al., 1996), it was found that the main phase of increased cell death in
NT-3-deficient embryos in the SCG occurs between E16 and El8, thus post-
neurogenesis (Wyatt et al., 1997). Postnatally, a large proportion of neurons still
respond to NT-3 withdrawal by apoptosis (Zhou and Rush, 1995). In NGF-/-, NT-3-I-
double knockout mice cell death is not significantly increased compared to NGF-/-
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mice, suggesting that these neurotrophins control the survival of the same neurons
(Francis et al., 1999). Knockout studies have revealed that GDNF, artemin and the c-
ret receptor are also important to SCG neuron survival (Moore et ah, 1996; Durbec et
ah, 1996; Nishino et ah, 1999).
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1.6 Research objectives
The general aim of the experiments presented in this thesis was to examine factors
involved in the neuronal survival of sensory neurons during embryonic development.
This included assessing the regulation of survival factors, such as NGF, BDNF and
NT-3 in the target fields, and the factors influencing neurotrophin receptor
expression by neurons. In addition, the effect of mutations in receptors/survival
factors on the survival/apoptosis rates in the developing ganglia was assessed using
mice with null mutations in specific genes. The specific aims were:
I To examine the regulation of trkA receptor expression in the trigeminal
ganglion during the time period that axons from the ganglion reach their
target fields, an event associated with an increase in trkA expression. This
included investigations on whether expression requires extrinsic or intrinsic
signals, and whether growth factors affect trkA expression in vitro. The
influence of the peripheral and central target fields of the trigeminal ganglion
was also assessed (Chapter 3).
II To assess the role of the trigeminal ganglion in regulating NGF, BDNF and
NT-3 expression in the maxillary process, its main peripheral target field,
during the period of target field innervation (Chapter 4).
III To assess the role trkA and trkB play in the development of the trigeminal
ganglion using double mutants of these two receptors, with the aim of
identifying whether there are periods during development where neurons
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critically require neurotrophin signalling through either alone or both. The
importance of p75 during the development of the trigeminal ganglion was
also studied using p75-deficient mice, to assess when in development p75
begins to play a role in regulating neuron survival. The role of a recently
discovered truncated p75 isoform in regulating neuronal survival was also
assessed. This was done by comparing a newly generated null mutant lacking
this isoform with a partial p75 mutant in which it is still functional (Chapter
5).
To assess the role of neuroglial cells in the survival of different populations
of cranial sensory neurons. This was done by assessing cell survival and
death in the trigeminal, dorsal root, nodose and superior cervical ganglia of






2.1 Retrieval and dissection of embryos
This section aims describe the methods employed to make the tungsten needles used
in dissections, the way embryos were retrieved from the pregnant mothers and how
embryos were subsequently dissected for use in either histology, RT-PCR or in tissue
culture.
2.1.1 Preparation of tungsten needles
Tungsten needles were made from 0.5mm tungsten wire cut to 3 to 5 cm lengths
using a grind wheel. The end 1 cm was bend by an angle of approximately 60° and
immersed horizontally in 1M KOH solution. A current of 3 to 12V AC was passed
through the wire and another electrode immersed in the solution. The tungsten was
etched away, until it formed a taper from the bend to the tip of the needle. The bent
portion was then briefly placed vertically in the solution until a sharp point was
formed at the tip, and was then washed in water to remove the solution.
2.1.2 Preparation of dissection and culture media
All dissections and preparations of neuronal cultures were carried out in a laminar
flow hood using standard aseptic techniques. Dissections involved using straight and
curved fine watchmaker's forceps, fine scissors and tungsten needles. For dissection
of ganglia a Nikon stereomicroscope with zoom lens was used, which was
illuminated by a fibre optic light source. All dissections were carried out in sterile
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Petri dishes containing LI5 medium without sodium bicarbonate that had previously
been heated to 37°C.
Dissection Media:
PBS was produced by adding 10 tablets of PBS (OXOID) to 11 of distilled water.
Once the tablets had dissolved the solution was autoclaved at 115°C for 10 minutes.
To make L-15 a 11 unit of L-15 powder (GibcoBRL) was dissolved in 11 of double
distilled water. 100 mg streptomycin (Sigma) and 60 mg penicillin (Sigma) were
added and the pH set to 7.3. The solution was then filter sterilised through a 0.22pm
filter (Gelman Sc.).
Culture media:
Powdered F14 (a special formulation from Imperial labs) was made up with highly
purified water that was sequentially passed through a charcoal filter, reverse osmosis
system and a Milli-Q system before being double distilled. F14 medium was made
from frozen lOx concentrate. To prepare the lOx concentrate a 5L unit of F14
powder (Imperial Labs) was added to 1L of double distilled water containing 500 mg
streptomycin (Sigma) and 300 mg penicillin (Sigma) and the solution frozen in 50ml
aliquots. A 50ml aliquot of 10xF14 was diluted in 450ml of distilled water followed
by the addition of lg of sodium bicarbonate (BDH). CCL was passed through the
medium until the pH reached between pH6.5 and pH7 changing the colour of the
mixture to brownish-yellow. Following addition of supplements (see below), the
medium was then filter sterilised through a 0.22 pm filter, and stored at 4°C.
Two supplements were use in these studies: Sato and Albumax® I.
Sato is made up from 2 mM L-glutamine, 0.35% bovine serum albumin (Pathocyte-
4, ICN), 60 ng/ml progesterone, 16 pg/ml putrescine, 400 ng/ml L-thyroxine, 38
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ng/ml sodium selenite and 340 ng/ml tri-iodo-thyronine. The use of the Sato
supplement was employed, as it is conducive for the growth of neuronal but not non-
neuronal cells.
Albumax® I is a lipid-rich bovine serum for cell culture provided by Gibco. It is
chromatographically purified, isolating naturally occurring lipids with purified
albumin, leading to excellent growth promoting characteristics. Albumax® I
promotes the survival of neurons but can also support the survival of some non-
neuronal cells. Albumax® I was used at approximately 2mg/ml.
These media were used with and without neurotrophins in the medium. When
neurotrophins were added they were used at 10 ng/ml (concentration recommended
by Prof. Alun Davies, EC50 varies with age and neurotrophin used between 2 and
60pg/ml (Buchman and Davies, 1993)). The neurotrophins employed in these
experiments were NGF (Genentech), BDNF (Regeron Pharm.), and NT-3 (Regeron
Pharm.). For storage neurotrophins were kept at -80°C in F-14 with 10% HIHS at
pH5.5.
Fxplant studies were conducted in BD Matrigel™ (BD Biosciences). This is a
solubilised basement membrane preparation extracted from the Engelbreth Holm
Swarm mouse sarcoma rich in extracellular proteins, mainly laminin and collagen
IV, as well as some growth factors occurring naturally in the tumour. At room
temperature the Matrigel Matrix polymerises, producing biologically active matrix
material resembling the mammalian cellular basement membrane.
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2.1.3 Retrieval of embryos
The pregnant female was killed by cervical dislocation at the required stage of
gestation. After washing the female's abdomen with 70% alcohol, an incision was
made in the skin on the front of the abdomen. The skin was pulled away from the
incision by grasping the skin above and below between the index finger and the
thumb of each hand. A small incision was made in the anterior abdominal muscle
using a pair of fine scissors, while holding the muscle with a pair of toothed forceps.
This allowed air to enter the peritoneal cavity and hence enabled the incision to be
extended without risk of cutting the intestines (which could contaminate the
dissection with bacteria). The uterine horns were removed by holding them with
toothed forceps and cutting them free with fine scissors. The uterine horns were then
transferred to a Petri dish with PBS for histology or LI5 for further dissection and
tissue culture.
For young embryos (El0.5 to El2.5) a small hole was made in the musculature on
the anti-mesometrial border of the uterine horn, causing the embryo to be extruded
within its mcmbianes by contraction of the remaining uterine muscles. The
membranes could be removed using watchmaker forceps after detaching the embryo
from the uterine horn. Older embryos (> El3) could be removed from the uterine
horn by making a continuous incision along the antimesometrial border of the uterine
horn, exposing them with their membranes. Embryos were staged according to the
criteria set by Theiler (1970). Figure 2.1 shows an Ell mouse head indicating the
main structures of interest in these experiments, giving a foundation for the
description of the dissections.
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Figure 2.1; Medial aspect of the head of an Ell mouse embryo
Drawing showing the medial aspect of the head of an Ell mouse embryo. The location of the
trigeminal (red - TG) and nodose (blue - N) ganglia is marked, as well as the Maxillary process (Mx),
Mandibular process (Mn) and hindbrain (Hb) (adapted from Davies and Lumsden, 1987).
2.1.4 Dissection and processing of embryos for histology
After removal of the membranes the embryos were transferred to a new Petri dish
with PBS and washed a minimum of 3 times in fresh changes of PBS. In knockout
studies, the embryos were washed separately in at least 2 fresh changes of PBS
before dissection to minimize contamination by the mothers or siblings blood. For
the dissection, the tools were sterilized with alcohol between each embryo. The
embryos heads were separated from their bodies using a tungsten needle for embryos
of E13 and under or scissors for older embryos. The cut was made just above the
arms to be able to incorporate the nodose, cranial DRG and the SCG ganglia in block
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for the histological analysis. The embryo's bodies were retained for genotyping as
described before. The heads were transferred to the chosen fixative for the required
amount of time.
2.1.5 Dissection of the maxillary process, hindbrain and trigeminal
ganglion
After removal of the chorion and amnion using watchmaker's forceps, the embryos
were transferred to a new Petri dish with L-15 and washed a minimum of 3 times in
fresh changes of L-15. In knockout studies, the embryos were then washed as
described above to avoid contamination with DNA from other embryos.
To dissect the trigeminal ganglion and its target-fields different techniques were
employed depending on the age of the embryo to be dissected. For embryos younger
than El3 two coronal incisions were made through the head using tungsten needles,
one above each eye, the other between the maxillary and mandibular processes of the
first branchial arch (see figure 2.2A).
In the slice obtained (figure 2.2B) the trigeminal ganglion, the maxillary process and
the hindbrain were easily recognisable due to slightly opaque colorations (trigeminal
and hindbrain) or the physical position of the maxillary, slightly sticking out from the
slice. The observed structures can be removed from the tissue slice and freed of any
adherent tissue using tungsten needles. When the structures were needed with their
neural connections intact, these could also be distinguished due to their opaque
colour, and the dissection performed so as to not damage them. To free the
trigeminal ganglion of mesenchymal tissue, one needle was used to steady the
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ganglion and the other to pinch off the adherent tissue against the bottom of the Petri
dish. The hindbrain and maxillary process were freed in a similar fashion. The
dissected trigeminal ganglion, maxillary process and hindbrain were then transferred
to a Petri dish containing pre-heated L15 medium using a siliconised Pasteur pipette.
Figure 2.2; Dissection of the trigeminal ganglion, maxillary process and
fn si rn m < ■ ■ ■
hindbrain from mouse embryos younger than E13
A: Lateral aspect of an El 1 head indicating the location of the transverse incisions used to obtain the
slice of tissue containing the trigeminal ganglion (TG), maxillary process (Mx) and Hindbrain (Hb).
B: Rostral aspect of the slice showing the position of these structures. Also shown are the mandibular
process (Mn) and fourth ventricle (IV) (Adapted from Davies and Lumsden, 1984).
For the dissection of trigeminal ganglia of embryos El3 or older, a fine pair of
scissors was used to cut through the cartilage and bone of the developing head. Using
a pair of forceps to steady the embryo, the top of the skull was removed in a plane
just above the eyes and whisker pads. This was followed by a second cut parallel to
the first, passing through the mouth. The tissue slices were transferred to a fresh Petri
dish containing LI5 medium and two further cuts were made with tungsten needles
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in front and behind the trigeminal ganglia. The tissue in front of the ganglia
contained the maxillary process (easily recognised by its five rows of vibrissae), and
the tissue behind the ganglia contained the hindbrain. Tungsten needles were used to
free the ganglia, maxillary processes and hindbrains from the surrounding tissues and
remove adherent connective tissues.
2.1.6 Dissection of the nodose ganglion
These dissections were carried out at El2.5. Using the same plane of section
described for the first incision of the trigeminal dissection above, the top of the skull
and underlying forebrain were removed from the embryo. The embryos were
decapitated and the head was cut in half along the saggital plane. The nodose
ganglion (also known as the inferior vagal ganglion) is situated close to the base of
the skull. Tungsten needles were used to remove the hindbrain from each bisected
head. The slit-like jugular foramen was then opened to the midline by inserting one
tungsten needle into the jugular foramen so that it lay beneath the base of the skull,
medial to the foramen, and bringing a second needle into apposition with the first, so
as to cut through the intervening tissues (Figure 2.3). The 'mouths' of the jugular
foramen were opened using a pair of tungsten needles to reveal the SCG and the
nodose ganglia lying at the base of this foramen. The nodose ganglion was identified
due to its spherical structure and the prominent vagus nerve attached to its distal
aspect, differentiating it from the SCG, which is an elongated structure that is
attached caudally to the sympathetic chain, a nerve that is much thinner than the
vagus nerve and is situated anterior to the internal carotid artery.
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Figure 2.3: Successive stages in the dissection of the nodose ganglion
This figure illustrates successive stages in the dissection of the nodose ganglia (El4 in this example).
The stippled areas show the bisected midline structures lying along and in front of the cranial base.
Part A shows the incision from the jugular foramen (J) to the midline (interrupted line), and the arrow
indicates the direction in which the large ossified part of the occipital bone (O) should be reflected to
subsequently open up the jugular foramen. T, Tongue; ACF: anterior cranial fossa; R: root of the
trigeminal nerve; IE: inner ear. Part B shows the position and shape of the nodose (N) and SCG (S)
ganglia following these steps (from Davies, 1988).
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2.2 Culture of trigeminal ganglion, maxillary process and
hindbrain
2.1.1 Cultures of trigeminal ganglia with/without the maxillary
process or hindbrain
All incubations took place in a humidified CO2 incubator at 37°C with 4% C02-
Trigeminal ganglia were dissected with or without their central and peripheral target-
fields as described and incubated in 500jal L14 + Sato (preheated to 37°C) in
Nunclon™ four well dishes for 24hrs. For Ell ganglia this was performed in
Matrigel with NGF, BNDF and NT-3 (lOng/ml). For experiments where the target
was kept separately to the ganglion, MatrigelIM was employed. A test showed this to
have no significant effect on the observations. Ganglia were cultured either by
themselves, attached to their target-fields, separated and put back together, or left at a
slight distance. The way this was done is represented in Figure 2.4. Matrigel was
kept on ice during use, as this is the temperature required for it to remain in its liquid
form. Ganglia and targets were placed into the culture dish using siliconised pipettes
before ~40pl of matrigel was added, and the ganglia and target-fields were arranged
in the desired configuration using tungsten needles. The matrigel was then left to set
for about 5 minutes, before F14 and Sato were added.
After 24hrs the attached ganglia were removed from the medium into a petri dish
with L-15. They were then detached from any target field they had been in contact
with and freed from matrigel, before being processed for assessment of mRNA
expression.
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Experiments using E10, El2, El3, El4, and El5 ganglia and target-fields were also
carried out in matrigel in medium enriched with NGF, BDNF and NT-3.
Figure 2.4: Variations in culture of the trigeminal ganglion with its central and
peripheral target-fields
Figure showing the subdissection of the ganglion and its target fields (A) and the final position of
these structures when put back together after severing the axons connecting the structures (B). (C)
shows the setup when the structures were left separated by the matrigel matrix. To ascertain that the
matrigel has no effect on the results, the trigeminal by itself or left attached to its target fields were
also cultured in matrix, and the results compared to the ones in absence of matrigel. The comparison
suggested that matrigel had no significant effect on expression. MX: Maxillary; TG: Trigeminal
ganglion; HB: Flindbrain.
2.2.2 Culture of the trigeminal ganglion in maxillary process or
hindbrain homogenate
Ell maxillary processes and hindbrains were collected and 26 of each placed into
500pl of F14 + Sato with proteinase inhibitor. The tissues were then homogenised
and the solution transferred to a fresh 1.5ml Eppendorf tube, before being
centrifuged at 2°C for 2 hours. The liquid phase was then transferred to a fresh
Eppendorf tube and 50% and 10% dilutions from this stock were made in fresh F14
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+ Sato. 50jnl of either the 100%, 50% or 10% stock were then used to incubate Ell
trigeminal ganglia as before.
2.2.3 Culture of the maxillary process with/without the trigeminal
ganglion attached
El0.5 and Ell maxillary ganglia were cultured with or without the trigeminal
ganglion left attached to them for 48 or 60hrs in 500gl F14 + Albumax in 4-well
Nunclon dishes in Matrigel. Matrigel was used since it has some effect in
suppressing the dissociation of the El0.5 ganglion that may take place when the
ganglion is grown in F14 + Albumax alone.
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2.3 RNA extraction and RT-PCR
2.3.1 Background
Of the techniques currently available for mRNA detection and quantification, reverse
transcription-polymerase chain reaction (RT-PCR) is the most sensitive. RT-PCR
involves the reverse transcription of RNA to cDNA, followed by amplification of a
specific cDNA using the PCR technique. The particular variety of RT-PCR used in
these experiments is known as competitive RT-PCR. This enables measurement of
the absolute amount of the mRNA of interest by using known amounts of synthetic
RNA (competitors). These have slightly longer or shorter sequences and are co-
transcribed and co-amplified with the target mRNA. Competitors are designed to
amplify by the same primers in the same reaction, nullifying variables affecting
amplification efficiency. This has been confirmed by carrying out reactions with
known quantities of target and competitor RNA transcripts. The ratio between the
reaction products during the log-phase of the PCR reaction was identical to the initial
ratio between target and competitor RNAs irrespective of the starting levels of these
RNAs (Wyatt and Davies, 1993). Being slightly lighter or heavier enables the
separation of the competitor from the amplified cDNA of interest by gel
electrophoresis. Comparison of the amplified cDNA of the gene of interest with the
closely resembling, known amount, of cDNA from the synthetic RNA enables
quantification of the amount of mRNA of interest present. The sensitivity and
specificity of this RT-PCR technique, as demonstrated by Wyatt and Davies (1993)
using trkA and p75 competitors, can be seen in Figure 2.5, while Figure 2.6 shows
the reliability of this method, demonstrated using GAPDH and NGF competitors.
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Figure 2.5: Sensitivity and specificity of the competitive RT-PCR technique
mm m 98 bp
HP 94 bp
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trk A p75
Autoradiograph showing the products of RT-PCR reactions amplified with either trkA-specific
primers or p75-specific primers. (1) Reactions containing 1 fg of either the trkA or p75 competitor
RNA templates, showing the 78bp and 98bp amplification products, respectively. (2) Reactions
containing total RNA from ten E12 trigeminal neurons, showing the 75bp trkA mRNA and the 94bp
p75 mRNA amplification products, respectively. (3) Reactions containing lfg of the respective
competitor RNA template plus total RNA from ten El 2 trigeminal neurons, showing both sets of the
respective amplification products. (C) No product resulted from control reactions that contained the
respective competitor RNA template plus total RNA from ten El2 trigeminal neurons, but from which
the reverse transcription step was omitted (from Wyatt and Davies, 1993).
Figure 2.6: Reliability of the competitive RT-PCR technique
A-GAPDH
I 2
Sample 1 Sample 2
Mean 11.51 11.68
SE 0.36 0.67
SYBR®Gold (Molecular Probes) stained gels showing the products (in triplicate) of two RT-PCR
reactions amplified with either GAPDH-specific primers (A) or NGF-specific primers (B). (A)
Reactions containing 25pg of the GAPDH competitor RNA (132bp) plus total RNA from two E16
maxillary processes ((1) and (2)) (128bp), showing both sets of the respective amplification products.
(B) Reactions containing 250fg of the NGF competitor RNA (103bp) plus total RNA from the same
El6 maxillary processes ((1) and (2)) as used for the GAPDH reaction (99bp). The table below shows
the mean expression of NGF in fg per pg of GAPDH for the two triplicate samples and the standard
error, at 3.2% and 5.7% of the mean.
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Detailed comparison of competitive RT-PCR with quantitative Northern blotting has
also demonstrated its accuracy and reproducibility over a wide range of
concentrations of target mRNA (Wyatt and Davies, 1993), and a recent study
comparing RT-PCR techniques found mRNA profile trends of competitive RT-PCR
to produce comparable results to real-time RT-PCR (Wall and Edwards, 2001).
Competitor RNA is usually produced from a cDNA template with a deletion or
insertion for distinguishing from endogenous RNA. RNA polymerase is used to in
vitro transcribe the cDNA template into RNA.
Competitors in these experiments were designed by insertion of a small amount of
extra base pairs into cDNA clones, and thus could be identified by being heavier
using gel electrophoresis. All competitors employed in these experiments were
designed and generated by Sean Wyatt and colleagues (references below): Using
primers the specific sequence of cDNA of the gene of interest was amplified using
RT-PCR. RNA for the reverse transcription was extracted from the species that gene
expression was to be studied in (mouse in this case). The size of amplified cDNA of
interest was identified by running the cDNA with a DNA ladder on an agarose gel,
and then removed and purified. The cDNA fragment generated from the PCR
reaction was then cloned into a transcription plasmid vector used to transform
competent cells, which were then plated and grown on agarose. Once colonies were
visible DNA was extracted from several of them using a mini-prep system, and it
was identified which of them had been transformed successfully. This was done by
digestion of plasmid DNA using restriction enzymes. Electrophoresis was used to
identify which constructs contained the correct insert. Once the correct plasmid DNA
had been identified, it was purified using a miniprep plasmid purification kit.
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This was followed by modification of the cDNA insert to distinguish it from the
native template: Plasmid DNA was digested with a restriction enzyme producing X
bp 5' overhangs. These were filled in with Klenow polymerase and the blunt ends re-
ligated, producing an X bp larger cDNA than the native template (creating a
recombinant plasmid).
The recombinant plasmid was then digested using the same restriction enzyme,
which had been used to produce the 5' overhang previously. This was done because
it would cut any plasmids not containing the filled-in sites, making them linear and
thus greatly reducing the transfection efficiency of these now unwanted fragments.
The plasmids were then transformed into competent bacteria, which were grown on
agar plates. As before, once the colonies were visible, the presence of the correct
insert in colonies was asserted using plasmid DNA restriction enzymes and
electrophoresis. PCR and acrylamide gel electrophoresis against an unfilled plasmid
was used to assert that the correct amount of base pairs had been filled in.
The plasmid DNA was then linearised and cut to the required size using a restriction
enzyme. The plasmid was then run on an agarose gel with a DNA ladder and the
band containing the correct linearised DNA excised and purified. The RNA
competitor was then created using in vitro transcription, and any plasmid DNA
eliminated using DNAse. An aliquot of this RNA stock was then used to determine
the RNA concentration spectrophotometrically. The remaining RNA was then
ethanol precipitated and diluted to a concentration of 1 ng/jul, before being stored at -
20°C until required.
Competitors used in these experiments were for the endogenous RNA of
glyceraldehyde phosphate dehydrogenase (GAPDH), trkA, full-length trkB, full-
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length trkC, p75, NGF, BDNF, and NT-3. Details of the competitors used and their
deviation from endogenous RNA are given in Table 2.1, as well as the reference
describing competitor generation.
Table 2.1; Details of size differences between used competitors and endogenous






GAPDH 4 base pairs Wyatt, S. etal. 1997.
trkA 3 base pairs Wyatt, S. and Davies, A. 1993.
trkB 4 base pairs Huber, K. et al. 2000.
trkC 4 base pairs Wyatt, S. et al. 1997.
p75 4 base pairs Wyatt, S. and Davies, A. 1993.
NGF 4 base pairs Produced by S. Wyatt
BDNF 4 base pairs Produced by S. Wyatt
NT-3 4 base pairs Produced by S. Wyatt
GAPDH is a ubiquitous, constitutively expressed housekeeping gene, whose
expression was assessed together with each of the other RNAs of interest. This
allowed the expression to be quantified as express ion/amount of GAPDH mRNA.
This gives a control for differences occurring due to differences in size of the
assessed pieces of tissue, and for differences in concentration due to slight variations
in the extraction procedure. It is important to include the competitor for GAPDH in
the same transcription reaction as the RNA competitor of interest, thus ensuring that
they both get compared to the same amount of sample added to the tube.
Another factor of importance was to ensure that the PCR reaction remained in the log
phase. If the samples were allowed to reach the plateau phase, this induces the
formation of heteroduplex DNA products, seen as a third band becoming visible in
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electrophoresis. Heteroduplex DNA produced in the plateau phase interferes with the
ratio of the homoduplex products of interest, thus leading to inaccuracies. Figure 2.7
shows the example ofNGF and GAPDH target and competitor mRNA amplified for
different cycle numbers, illustrating the consistency of competitive RT-PCR over
different cycle numbers. No significant differences were found between the ratios of
sample over competitor at any of the assessed cycle numbers (GAPDH: ANOVA,
p>0.05; NGF: ANOVA, p>0.05). Graph D shows the amplification ofNGF reaching
the plateau phase at cycle 26. However, the ratio of sample over competitor does not
seem to be significantly affected, illustrating that competitive RT-PCR can remain
accurate even after the exponential phase of the PCR, as claimed previously (Siebert
and Larrick, 1992). Nevertheless we ensured that measurements taken in this study
were in the log phase. Experiments in which heteroduplex DNA was evident,
indicating that sample amplification had reached the plateau phase, were repeated
with lower cycle numbers until no heteroduplex DNA was observed.
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Picture: SYBR®Gold (Molecular Probes) stained gels showing the products (in triplicate) of RT-PCR
reactions amplified with either GAPDH-specific primers (A) or NGF-specific primers (B). (A)
Reactions containing 20pg of the GAPDH competitor RNA (132bp) plus total RNA from an El3
maxillary process (128hp), showing both sets of the respective amplification products over 18 to 22
cycles. (B) Reactions containing 600fg of the NGF competitor RNA (103bp) plus total RNA from the
same El3 maxillary process as used for the GAPDH reaction (99bp), showing both sets of the
respective amplification products over 24 to 28 cycles. The graphs below (C and D) show the product
intensity as measured by Phoretix Analyzer, over the number of amplification cycles. The product
intensity for the competitor (red) and the target (blue) are shown. (C) The GAPDH competitor and
sample cDNA amplify at approximately the same rate during the log-phase of amplification, as shown
by the similar increase in product intensity of the two bands (Pearson correlation r2=0.9985; p<0.001).
Measurements for this sample were done after cycle 19, thus in the log phase. (D) The NGF
competitor and sample cDNA amplify at approximately the same rate, as shown by the similar
increase in product intensity of the two bands (Pearson correlation r2=0.9998; p<0.001). The plateau
phase is clearly reached at cycle 26, as there is no further increase in product intensity in Phoretix
Analyzer. Measurements for this sample were done after cycle 25.
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2.3.2 RNA extraction and purification
RNA extractions were carried out using the protocol by Chomczynski and Sacchi
(1987). Following the final dissection the tissues of interest were placed in a 1.5ml
eppendorf using siliconised pipettes before addition of 500pl of solution D (250g
guanidinium thiocyanate (Sigma), 293ml DEPC-treated Water (Ambion), 17.5ml
0.75M sodium citrate (BDH) pH7, and 24.6ml 10% N-laryl sarcosyl (BDH)). 360pl
of 2-mercaptoethanol (Sigma) was added per 50ml of Solution D before use. The
tissue in the solution D was then lysed by passing the solution through a 25 gauge
needle fitted to a 1ml syringe. This was followed by addition of lpl of lOmg/ml E.
coli tRNA (Sigma), 50pl of 2M sodium acetate (BDH) pH4.4, 500pl water-saturated
acidic phenol (Sigma), and 150pl 25/1 chloroform/isoamyl alcohol (Sigma). The
solutions were thoroughly mixed and then incubated on ice for 5 minutes, before
being centrifuged at 15000 rpm for 5 minutes. The aqueous supernatant (~450pl) was
then transferred to a fresh 1.5ml Eppendorf and the RNA precipitated by adding at
least two volumes of ethanol (~lml), before being transferred to a -20°C freezer
overnight. The RNA was then recuperated by centrifuging the ethanol mixture at
15000 rpm for a minimum of 30 minutes. This led to the RNA forming a pellet at the
base of the eppendorf. The absolute ethanol on top was removed and the pellet
washed using 70% ethanol, which was then removed in the same manner before
leaving the pellet to air dry in order to remove any traces of ethanol.
The pellet was then resuspended in a 50pl mixture of 40mM Tris (Sigma) pH7.5,
6mM MgCE (Biogene) 20mM ribonucleoside vanadyl complex (VRC) (Sigma), and
5pl of 10000 units/ml DNase I (Anachem). This solution, made to remove DNA
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(Dnase I) while protecting RNA from RNases (VRC), was incubated at 37°C for 2-4
hrs.
Purification of the RNA was performed using an RNA binding matrix based
technique (RNaid Kit by Bio 101). This was done by adding 200jul of RNA binding
salt (made from 3M NaClCT) to create the right conditions for RNA binding matrix
(RNAMATRIX®) addition. The amount of RNAMATRIX® added was dependent
upon the approximate amount of RNA in the tissue being extracted (approx. l-2pl of
RNAMATRIX®/pg RNA). Because in these experiments a whole ganglion or
target-field was examined, 30pl of RNAMATRIX® was used, although less is used
for extraction ofRNA from cultures as an example.
The solution with the RNA binding salt and RNAMATRJX® was mixed thoroughly
and incubated at room temperature for 30 minutes to 2 hours, while mixing regularly.
RNA was absorbed by the matrix at this stage. After incubation the solution was
centrifuged for 1 minute at 13000 rpm and the liquid phase removed. The solid phase
was then resuspended and washed twice in 600pl fresh RNA wash solution. After
removal of the last traces of RNA wash solution by centrifugation, 100pl of DEPC-
treated water was added to resuspend the matrix, followed by incubation at 60°C for
2-3 minutes, causing the RNA to separate from the matrix. The solution was then
separated from the matrix by centrifugation of the sample at 15000 rpm for 1-2
minutes. The liquid phase was then carefully transferred to a new 0.5pl tube before
storage at -80°C until needed.
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2.3.3 Reverse Transcription
Competitor aliquots of various concentrations were prepared by shaking the
precipitated lng/pl stock and taking a 50pl aliquot from it. These were spun at
15000rpm for a minimum of 15 minutes before removing the ethanol solution and
resuspension with lOOpl DEPC-treated water (Ambion). This gave a 500pg/pl
solution of the competitor. This was diluted step by step by taking lOpl out and
diluting it with 90pl of DEPC-treated water giving a 50pg/pl solution and so forth.
The different concentrations of competitor were stored at -80°C before use.
Reverse transcriptions were carried out in 25pl reaction. The reagents involved in the
reaction were at the following concentrations in the final volume: 1/5 5x reverse
transcription buffer (Invitrogen), 1/10 5mM dNTPs (MBI Fermentas), 1/10 lOOpM
random hexanucleotides (RH) (Anachem), 1/10 0.1M DTT (Invitrogen), and lpl of
Superscript Rnase H" Reverse Transcriptase (Invitrogen). These were added to an
amount of water determined by the volume and concentrations of competitors and
sample added.
As an example a typical mastermix for a reverse transcription for NGF may be made
in the following way: lOOpl 5xBuffer, 50pl dNTPs, RH and 0.1M DTT, 3pl 50fg
NGF competitor, lpl 50pg GAPDH competitor, and 106pl of water. This can be
divided into 20x18pl tubes, to which 6pl of sample can be added, followed by lpl of
reverse transcriptase giving a total volume of 25pl. A mastermix ensures uniformity
of conditions for each sample.
The possibility of DNA contamination in the samples or reagents was assessed by
using samples and reverse transcription mix without adding any reverse transcription
enzyme to some tubes.
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For the reverse transcription, samples (without RT enzyme) were transferred to a
thermal cycler. This was used to initially heat the samples to 90°C for 2 minutes in
order to remove any tertiary structures in the RNA that could interfere with the
transcription, before adding the RT enzyme (on ice) to each sample and incubating at
37°C for 90 minutes. This was followed by 6 minutes at 95°C.
Before doing an RT-PCR reaction for all the samples in a reaction, a small amount of
samples was usually used to do a titration, adding various concentrations of
competitor to determine the one closest to the concentration in the samples. The
concentration of competitor used needed to be close to the sample concentration
because the analysis system was not sensitive enough to quantify differences ofmore
than four fold.
All the samples were then run using the same volume of RNA added to the mixture
with the closest competitor concentrations as determined in the titration. The volume
of each sample was then altered to aim and make it as close as possible to the
concentration of GAPDH competitor used. This calibrated all the samples to the
same concentration of GAPDII, enabling relative estimation of the amount of gene
expression of interest. The variations in added sample volume were compensated for
by addition of more or less water to each sample, so that the total volume added to
each mix remained the same.
2.3.4 PCR
Specific oligonucleotide primers for the cDNA of interest were ordered from MWG.
Primers are listed in table 2.2. Primer stock was made by diluting the oligonucleotide
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powder to lpg/pl and mixing the forward and reverse primer 1/1. This stock was
then diluted by 50 to obtain the working solution of primers.
PCR reactions were performed in 50pl volumes, made up of 45pl of reaction mix
and 5pl of sample. The total mix per reaction was composed of 33.875pl of distilled
water, 5pl of lOxBuffer (Helena Biosciences), 5pl primers (see above), lpl dNTPs,
and 0,125pl taq DNA polymerase (Helena Biosciences). As for the reverse
transcription a mastermix was made to ensure uniformity of conditions for each
sample. After mixing, 2 drops of mineral oil were added to the top of the reaction
mix to prevent evaporation during the cycles of the PCR. The samples were then
transferred to a thermal cycler. The cycles for the PCR reaction were done as
follows: The cDNA was initially denatured at 95°C for 1 minute. This was followed
by a 1 minute annealing step, which varied in temperature depending on the reaction
(figure 2.7), and a 1 minute elongation step at 68°C. After the last cycle a last
elongation step was performed for 10 minutes. The number of cycles required for
each reaction to be able to detect the cDNA without entering the plateau phase of
amplification depended on the initial concentration and nature of the RNA. An
indication of the number of cycles used for each reaction is given in table 2.2.
Following the PCR reaction, 10pl of 6x blue loading dye was added to the products.
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Table 2.2: Primers used for PCR reactions, annealing temperatures and cycle
numbers




GAPDH 5-TCC AGT ATG ACT
CCA CTC AC-3'
5'-TCC TGG AAG ATG
GTG ATG G-3'
51°C 18-27
trkA 5-CGT CAT GGC TGC TTT
TAT GG-3'
5'-ACT GGC GAG AAG
GAG ACA G-3'
56°C 28-33
trkB+ 5-ACG CAG TGC TGA
TGG CAG-3'
5'-TAC CTG CTG CGA TTT
GCTG-3'
52°C 30-32
trkC+ 5-CCC ACC AAA GAC
AAG ATG-3'
5'-TAT CCA GTC CAC ATC
AGG-3'
52°C 30-32
p75 5-CCG ATA CAG TGA
CCA CTG TGA TG-3'
5-AGC AGC CAA GAT
GGA GCA ATA GAC-3'
60°C 27
NGF 5-AGC ATT CCCTTG
ACA CAG-3'
5-GGT CTA CAG TGA
TGT TGC-3'
50°C 24-30
BDNF 5'-ACT TGG CCT ACC
CAG GTG TG-3'
5-TGT CGT CGT CAG
ACC TCT CG-3'
60°C 27-31
NT-3 5-TAC TAC GGC AAC
AGA GAC G-3'
5'-GTT GCC CAC ATA
ATC CTC C-3'
55°C 29-32
2.3.5 Making and running of acrylamide gels
The products of the PCR-reaction were analysed by running them on a 8%
polyacrylamide gel (National diagnostics) in VI5.17 Horizontal gel tanks
(Whatman). The gels were prepared by adding 90pl of 20% Ammonium Persulphate
(APS) (Sigma) per 25ml gel followed by 30pl of TEMED (Sigma). The mixture was
then mixed and poured between two glass-plates before inserting a comb and leaving
it to set for at least half an hour. Once set, the gels were placed in their gel tank and
the samples with loading buffer loaded into the preformed wells together with a
DNA ladder. The gels where then run for 1 hour to Wi hours at -400V. The blue
loading dye served as an indicator for the distance the samples had run, thus telling
when the gels had to be stopped depending on the size of the amplified DNA
fragment. Once run, one of the glass-plates was removed, the gel cut to size, and
stained using Nucleic Acid Stain (Molecular Probes). SYBR®Gold labels the
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amplified cDNA and shines at different brightnesses under a UV light source,
depending on the amount of nucleic acid present. The gels were then washed under
tap water and the DNA visualised using a UV-illuminator connected to a camera,
which allowed pictures to be taken of the bands on the gel using the Phoretix
Grabber computer program.
2.3.6 Analysis of relative mRNA levels
Analysis of the pictures with the endogenous and competitor cDNA bands on them
was done using the Phoretix Quantifier computer program. This program enables the
analysis of the intensity with which the bands were seen under the UV light, hence
enabling quantification of the endogenous cDNA by direct comparison with the
competitor cDNA. The intensity value returned by Phoretix Quantifier for the
endogenous cDNA was divided by the intensity value for the competitor cDNA. This
was then multiplied by the known concentration of the competitor, to give the
amount of endogenous cDNA present. This was done for the mRNA expression of
interest and for the GAPDH mRNA run with all samples. The relative expression of
the gene of interest was then quantified as fg mRNA of interest / pg gapdh mRNA.
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2.4 Origin, breeding and genotyping of knockout mice
This section aims at providing a background as to how the knockout mice used in the
experiments were generated, what their phenotype is, and an explanation of the way
these mice were bred in order to generate the desired knockouts.
2.4.1 Background
Knockout mice, lacking specific regions of the genome containing a gene of interest,
have become extremely useful. They give a valuable insight into the specific function
of a gene and its protein product in vivo.
Knockout animals are usually generated by transfecting a targeting construct into
pluripotent embryonic stem (ES) cells to replace the desired gene or a crucial part of
it. The targeting construct contains two regions of homology that are located at either
end of the 'vector' and are complementary to specific sites on the genome
surrounding the gene of interest. The disrupted gene of interest and antibiotic
selection markers are located between these regions of homology on the targeting
construct. These homologous regions enable the targeting construct to bind to the
genome and allow the exchange of the real gene with the disrupted gene and the
antibiotic selection markers by homologous recombination. Selection for transfected
cells is done by testing antibiotic resistance conferred by the antibiotic selection
markers, and by polymerase chain reaction (PCR) and Southern blotting to certify
homologous recombinants. The successfully transfected ES cells are then injected
into blastocysts, which are inserted into the uterus of a surrogate mother. The
resulting offspring will have some tissues derived from the blastocysts wildtype cells
and other tissues derived from the manipulated ES cells. These mice are known as
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chimera. If the progeny of the incorporated ES cells form germ-line cells, the
mutations contained in them can be passed on to that mouse's offspring. The
procedure involved in generating knockout mice is summarised in Figure 2.8.
2.4.2 trkA knockouts
The trkA knockout was generated by Smeyne et al. in 1994, by ablating the gene in
D3 embryonic stem cells by homologous recombination. 51 amino acids from the
trkA kinase domain were replaced with a phosphoglycerate kinase 1 «eo-cassette in
the opposite orientation. Lack of trkA leads to sensory and sympathetic neuropathies
and most knockout mice die within a month of birth. They fail to respond to
stimulation of their whisker pads and rear paws and develop myotic pupils and slight
ptosis. Their fur becomes mottled and numerous scabs appear over the entire body;
their paws are covered by ulcerations and digits are missing, thought to be due to
self-mutilation. Also, some internal organs are abnormal. The phenotype includes
decrease in the cholinergic basal forebrain projections to the hippocampus and
cortex, and severe cell loss in the sympathetic (severely shrunken by P10), trigeminal
(70-90% at P0) and dorsal root ganglia (70-90% at P0). Mice with this mutation
were used in a CD1 background (Mice obtained from Riidiger Klein, European









Summary of the steps involved in the generation of knockout mice. The general procedure is shown
on the left, while the right column shows events during transfection. Cultured ES cells have two
normal copies of the target gene (A). When a disrupted version of the target gene is introduced (B),
recombination between the related sequences of DNA swaps the disrupted version of the gene into the
mouse genome (C). Successfully transfected ES cells are identified, and microinjected into a host
blastocyst that is transferred to a pseudo-pregnant female. If the mutant gene contributes to the germ
line in the resulting 'chimeric" mice, the next mouse generation will have one non-functional copy of
the gene - these are heterozygous for the mutation. Interbreeding two heterozygous mice will result in
some mice with two non-functional copies of the target gene; these are referred to as knockout mice




The trkB knockout was generated by Klein et al. in 1993, by ablating the gene in D3
embryonic stem cells by homologous recombination. 33bp of K2 (the second exon
of the protein kinase domain of trkB) were replaced with a phosphoglycerate kinase
1 tteo-cassette inserted in the same transcriptional orientation as the trkB gene. Most
knockout animals die by PI, although some survive into the first postnatal week.
TrkB animals appear to lack the sucking reflex observed in their wildtype littermates,
and attempts to manually feed them were unsuccessful due to the animals inhaling
instead of swallowing. These observations indicate sensory deficits as well as deficits
in the swallowing motor system. Neuronal numbers in the trigeminal ganglion were
reduced by -60%, with larger differences in the anterior half of the ganglion. Further
neuronal deficits were observed in facial motor neurons (-70% less), the DRG
(-30% less), and spinal motor neurons (-25% less neurons).
Mice with this mutation were used in a CD1 background (Mice obtained from
Rtidiger Klein, European Molecular Biology Laboratory, Heidelberg, Germany).
2.4.4 Partial p75 knockouts
The p75 knockout was generated by Lee et al. in 1992, by ablating exon III of the
gene in J1 embryonic stem cells by homologous recombination. A phosphoglycerate
kinase 1 /reo-cassette was inserted in the third exon encoding cysteine rich repeats
essential for ligand binding. Knockout mice are viable, although by 4 months they
develop skin alterations on all extremities and tests reveal they are insensitive to
heat. It was discovered that they have decreased sensory innervation of the skin
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explaining some of these observations. In contrast to the observed sensory deficits
there appear to be no effects on sympathetic ganglia and innervation.
Mice with this mutation were used in a C57/BL6 background and referred to as p75L
(Mice obtained from Kuo-Fen Lee, Whitehead Institute for Biomedical Research,
Nine Cambridge Center, USA).
2.4.5 Full p75 knockouts
As described above, Lee et al. generated a p75 knockout by manipulating the third
exon of the gene. Schack et al. (2001) however, demonstrated that there was a
protein isoform arising from alternative splicing of exon three, and that this protein is
left intact in the partial knockouts described above. This s- (short) p75 receptor
differs from the full-length receptor in that it only possesses one of the four cysteine-
rich domains found in the extracellular domain of the full-length receptor.
To assess the role of this receptor, Schack et al. generated a knockout for both the
full length and short p75 receptor by targeting exon four of the p75 receptor locus.
In the first postnatal weeks the knockout mice generated were found to be
substantially smaller than their littermates and had impaired motility due to hind limb
ataxia. Analysis of the knockout mice revealed a greater decrease in cross-sectional
area of the sciatic nerve (-53%) compared to the reduction seen in the partial
knockouts (40%). The authors also noted a greater decrease of neuronal numbers in
P3/P4 DRGs, with a 54% decrease compared to a 39% decrease with just the full
length receptor lacking. Full knockouts also display partial perinatal lethality and
defects in the vascular system, which the partial knockouts do not display.
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Mice with this mutation were used in a C57/BL6 background and referred to p75D
(Mice obtained from Yves-Alain Barde, Max Planck Institute of Psychiatry,
Martinsried, Germany).
2.4.6 ErbB3 knockouts
The ErbB3 knockout was generated by Riethmacher et al. in 1997, by ablating the
gene in El4-1 embryonic stem cells by homologous recombination. The neo cassette
contained termination codons, which directly fused to coding sequences thereby
preventing the production of ErbB3 protein.
Analysis of the phenotype of ErbB3 knockout mice showed that most homozygous
embryos die between El 1.5 and E13.5, while surviving embryos survived to term.
Born knockout pups were slightly smaller than littermates, cyanotic, displayed no
reaction to tactile stimuli, and did not breathe. DRG ganglia in the ErbB3 knockouts
appeared normal in El2.5 embryos, but subsequently displayed a marked neuronal
cell loss (El 4.5: 70%, El 8.5: 82% loss). Motor neurons of the ventral horn appeared
normal up to E16.5, but were reduced by E18.5. Cranial ganglia and nerves were
abnormal from E10, an effect attributed to the absence of neurons derived from
hindbrain neural crest rather than death of neurons.
Mice with this mutation were used in a CD1 background (Mice obtained from




The Bax knockout was generated by Knudson et al. in 1995, by ablating the gene in
embryonic stem cells by homologous recombination. A phosphoglycerate kinase 1
neo-cassette was inserted replacing a 3.7kb fragment containing exons 2 to 4 and part
of exon 5 of Bax, preventing formation of a functional protein. Although externally
indistinguishable from wildtype mice, knockout mice display hyperplasia of
lymphoid tissues and enlarged spleens. Also, Bax knockout males are infertile and
adult testes atrophic with no mature sperm production. Analysis revealed a marked
increase in apoptosis and disorganized spermatogenesis in the testes of Bax
knockouts, in contrast to the lymphoid tissues and spleen, which indicates that the
same molecule can have positive or negative effects depending on the cell type.
Knudson et al. (1995) speculate that the massive apoptosis and disorganized
spermatogenesis may also indicate a role for Bax in regulating the meiotic cycle.
Mice with this mutation were used in a CD1 background (Mice obtained from
Stanley Korsmeyer, Howard Hughes Medical Institute, Washington University
School ofMedicine, St. Louis, USA).
2.4.8 Bad knockouts
The Bad knockout was generated in the laboratory of Stanley Korsmeyer (there are
currently no publications on this mouse and no information on its generation). Mice
with this mutation were used in a CD1 background (Mice obtained from Stanley
Korsmeyer, Howard Hughes Medical Institute, Washington University School of
Medicine, St. Louis, USA).
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2.4.9 Breeding
Mice in a C57/BL6 background were bred into a CD1 mouse background (trkA,
trkB, ErbB3), by breeding heterozygous mice with CD1 wildtype mice, generating
an F1 generation. The heterozygous mice from these litters were then crossed
repeatedly with new CD 1 wildtypes until an F4 generation was reached and the mice
displayed no characteristics of the original C57/BL6 mice (coloured fur, smaller
size). The mice were backcrossed into a CD1 background because these mice have
far greater litter sizes than C57/BL6 mice (14-22 compared to 4-10), which facilitates
obtaining a sufficient number of knockouts for experimental studies, especially when
studying double knockouts. Other mouse colonies used in these experiments had
already been bred into a CD1 background (Bad, Bax) and some were studied in the
original C57/BL6 background (p75Lee, p75 Dechant).
Single knockouts were generated by breeding two mice heterozygous for a mutation
to generate litters containing heterozygotes, wildtypes and knockouts.
Double knockouts were generated by breeding mice heterozygous for one mutation
with mice heterozygous for the other mutation. This would generate mice
heterozygous for one mutation, wildtypes, and mice heterozygous for both mutations.
The latter were paired to produce litters with a variation of genotypes including
wildtypes, single knockouts and double knockouts.
Table 2.3 shows the total number of embryos collected for each of the mutations
studied together with the obtained frequency ofwildtype and knockout embryos.
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Table 2.3: Total number of embryos collected in knockout experiments and
distribution of genotypes
ErbB 3
Age Total number Wildtype ErbB3-Knockout %-Wildtype %-knockout
Ell 87 29 27 33% 31%
E12 139 33 24 24% 17%
E13 109 26 20 24% 18%
E14 30 9 2 30% 6.7%
P75L
Age Total number Wildtype P75L-Knockout %-Wildtype %-knockout
E12 21 7 5 33% 24%
E14 35 8 10 23% 26%
E16 20 7 5 35% 25%
E18 25 8 8 32% 32%
P75D
Age Total number Wildtype P75D-Knockout %-Wildtype %-knockout
E12 29 5 9 17% 31%
E14 30 5 4 17% 13%
E16 19 5 5 26% 26%





















E12 68 8 3 6 3 12% 4% 9% 4%
E14 74 8 4 8 3 11% 5% 11% 4%
E16 74 12 7 6 3 16% 9% 8% 4%





















E12 161 11 12 10 8 7% 7% 6% 5%
E14 77 4 5 8 3 5% 6% 10% 4%
E16 183 11 10 11 4 6% 5% 6% 2%
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Bad
Age Total number Wildtype Bad-Knockout %-Wildtype %-knockout
E12 57 17 14 30% 25%
E14 46 13 15 28% 33%
E16 37 9 8 24% 22%
Bax
Age Total number Wildtype Bax-Knockout %-Wildtype %-knockout
E12 26 9 7 35% 27%
E14 32 6 14 19% 44%
trkA
Age Total number Wildtype trkA-Knockout %-Wildtype %-knockout
E12 60 19 18 32% 30%
E14 53 15 11 28% 21%
E16 57 16 9 28% 16%
trkB
Age Total number Wildtype TrkB-Knockout %-Wildtype %-knockout
E12 46 7 17 15% 37%
E14 45 15 10 33% 22%
E16 56 12 9 21% 16%
2.4.10 Extraction of DNA
The genotype of mice and embryos used in knockout experiments was determined by
tail-tipping the mice and keeping some embryonic tissue left after dissection. These
tissues were digested overnight in 200pl of proteinase K / SDS solution at 56° C.
Lysis could be accelerated by occasional vortexing of the samples. One additional
tube, with the proteinase K mix but without any sample, was added at this stage to
serve as a negative control. The remainder of the extraction was done using a
Nucleospin® Tissue Kit (Macherey-Nagel), based on DNA binding to a silica
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membrane in spin columns. Following digestion 200pl of distilled water (300pl for
embryos) were added to the solution and the mix spun for 5min at 15000g. 200pl of
the solution were then transferred to a new tube, ensuring that residual tissue in the
bottom of the tube was taken up. After addition of a B3 buffer (containing chaotropic
salts) the samples were vortexed and incubated at 70° C for 10 minutes, followed by
addition of 21 Opil ethanol (99%) and further vortexing. The chaotropic salts and
ethanol added in these steps fascilitate DNA binding to a silica membrane. The entire
solution was then transferred to a Nucleospin® Tissue column in a 2ml collecting
tube. The tubes were spun at 1 lOOOg for 1 min and the flow through discarded. Two
buffers, one salt based, one ethanol based, were used to wash the silica membrane,
by spinning the buffers through the spin tube as with the original solution. The silica
was then dried by further spinning, before the spin tube was placed into a 1,5ml
microcentrifuge tube, and 1 OOjul (60-80pl for DNA from very young embryos) of
elution buffer preheated to 70° C was added. The slightly alkaline elution buffer
enabled dissociation of DNA from the silica membrane. Thus when the spin tubes
placed in the microcentrifuge tubes were spun at 11 OOOg for a further minute, the
concentrated DNA was passed into the microcentrifuge tube ready for genotyping.
2.4.11 Genotyping
The extracted DNA was amplified using the polymerase chain reaction (PCR),
allowing the amplification of specific regions of DNA using synthetic
oligonucleotide primers, specifically designed from portions of the gene surrounding
the gene of interest. The DNA is denatured and the primers bind to the DNA and are
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extended in a 5' direction by DNA polymerase, thus producing a copy of the target
sequence and effectively doubling the concentration of DNA in the tube. This is
achieved by alterations in temperature, with denaturation (strand separation), primer
binding and extension by DNA polymerase all requiring specific temperatures to be
at their optimum and to avoid unspecific primer binding. These changes in
temperature are repeated until the DNA is sufficiently amplified for visualisation.
For genotyping three primers were employed, of which one was unique to the wild-
type allele, one to the knockout allele and one was common to both alleles. The
components of the PCR reaction were: Hotstart DNA polymerase (Biogene),
primers (MWG Biotech.) deoxynucleoside triphosphates (dNTPs) (Promega), lOx
Buffer, MgCb (both Biogene) and in some reactions the PCR enhancer MR
(Biogene).
PCR reactions were conducted in 20pl reactions with 1 pi of the DNA concentrate
added to a mix of the above components. The proportions of these ingredients per
PCR reaction are represented in table 2.4, and the primers used are listed in table 2.5.
It should be noted that for the Bad genotyping two separate reactions were used to
amplify the wildtype (Badl) and knockout (Bad2) DNA.
Table 2.4: Volume of reagents (in ul) used per 20ul genotyping reaction
Strain p?5D P75L trkA TrkB Bax Bad 1 Bad 2 ErbB3
dH20 9.35 9.35 13.17 9.55 8.725 9.41 13.57 12.2
MR sol. 3.8 3.8 - 3.8 3.8 3.8 - -
lOx Buffer 2 2 2 2 2 2 2 2
MgCl2 2 2 2 2 2 2 2 2
dNTPs 1 1 1 1 1 1 1 1
Primer 1 0.3 0.3 0.2 0.16 0.45 0.33 0.165 0.6
Primer 2 0.2 0.2 0.2 0.16 0.3 0.33 0.165 0.5
Primer 3 0.2 0.2 0.23 0.23 0.525 - - 0.3
DNA 0.15 0.15 0.2 0.1 0.2 0.13 0.1 0.4
polymerase
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p75D primer 1 mp75ex4s3 5'- OAT GGA TCA CAA GGT CTA CGC - 3'
p75D primer 2 pGK2 5' - AAG GGG CCA CCA AAG AAC GG - 3'
p75D primer 3 2590 5' - TGT TGG AGG ATG AAT TTA GGG - 3'
p75L primer 1 koD2 5' - CCC CTT CCC AGC CTC TGA GC - 3'
p75L primer 2 U1 5" - AGC CGT GCA AGC CGT GCA CC - 3'
p75L primer 3 D1 5' - AGG GTA GGC ACG GGT CCA CG - 3'
trkA primer 1 P095-4 5' - CGG ACC TCA GTG TTG GAC AGC TGG - 3'
trkA primer 2 P096-0 5' - GAC CCT GCA CTG TCG AGT TTG C - 3'
trkA primer 3 P097-0 5' - GCT CCC GAT TCG CAG CGC ATC G - 3'
trkB primer 1 P080-0 5' - AGA CCA TGA TGA GTG GGT CGC C - 3'
trkB primer 2 P048-0 5' - TCG CGT AAA GAC GGA ACA TGA TCC - 3'
trkB primer 3 P081-0 5' - GAT GTG GAA TGT GTG CGA GGC C - 3'
Bax primer 1 In5R 5' - TTG ACC AGA GTG GCG TAG - 3'
Bax primer 2 Ex5F 5" - GCT GAT CAG AAC CAT CAT G- 3'
Bax primer 3 NeoR 5' - GCT TCC ATT GCT CAG CG - 3'
Badl primer 1 BAD 1 5' - ACG GGA TCC CCG AAG GAT GAG CGA
TGA GTT TG-3'
Badl primer 2 BAD 2 5' - AGC GAA TTC TCA GCC TGC GCT CTT TGG
GCG AGG-3'
Bad2 primer 1 BAD 3 5' - TCG TGC TTT ACG GTA TCG CC - 3'
Bad2 primer 2 BAD 4 5" - CAT TGC CCA AGT CAC CTT C - 3'
ErbB3 primer
1








EXA2 5' - ACC TGT ATT CTC CCG ACT GTC CTG AA -
3'
Following addition of 1 jul of DNA concentrate to 19pl of the mix of PCR reagents
and mixing, 40gl of mineral oil was added to the tube in order to prevent evaporation
of the reactants. The samples were then placed in a thermal cycler, which then took
the samples through the temperature-dependent steps described above. Reactions for
each sample were done in duplicate to ensure accuracy of the obtained genotype, and
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run with the negative control (to account for the possibility of contamination) and a
positive control (a heterozygous sample with both the wildtype and knockout allele).
The cycling temperatures for the different strains were as follows (Steps 1 + 2a:
Denaturation ofDNA, Step 2b: Annealing of primers, Step 3 + 2c: Synthesis of new
DNA strands):
p75D reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 59°C - 1 minute 10 seconds
c: 72°C - 1 minute 40 seconds
Number of cycles a-c: 41
Step 3: 72°C - lOminutes
4°C soak
p75L reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 62°C - 1 minute 10 seconds
c: 72°C - 1 minute 40 seconds
Number of cycles a-c: 39




Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 65°C - 1 minute 10 seconds
c: 72°C - 1 minute 40 seconds
Number of cycles a-c: 39
Step 3: 72°C - lOminutes
4°C soak
trkB reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 59°C - 1 minute 10 seconds
c: 72°C - 1 minute 40 seconds
Number of cycles a-c: 37
Step 3: 72°C - lOminutes
4°C soak
Bax reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 45 seconds
b: 50°C - 1 minute 20 seconds
c: 72°C - 2 minute 20 seconds
Number of cycles a-c: 43




Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 62°C - 1 minute 20 seconds
c: 72°C - 1 minute 50 seconds
Number of cycles a-c: 41
Step 3: 72°C - lOminutes
4°C soak
Bad2 reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 45 seconds
b: 64°C - 1 minute 20 seconds
c: 72°C - 1 minute 40 seconds
Number of cycles a-c: 40
Step 3: 72°C - lOminutes
4°C soak
ErbB3 reaction
Step 1: 95°C - 10 minutes
Step2: a: 95°C - 40 seconds
b: 68°C - 1 minute 50 seconds
Number of cycles a-b: 41
Step 3: 72°C - lOminutes
4°C soak
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After the PCR reaction 4jal of 6x gel-loading buffer (0.25% bromophenol blue,
0.25% xylene cyanol, and 30% glycerol in deionized water) were added to the
product.
2.4.12 Electrophoresis and visualisation of DNA
The amplified DNA fragments were separated using electrophoresis through agarose
gels. Due to its negative charge DNA will move towards the positive electrode when
a current is applied. Agarose gels have pores, which when current is applied allow
smaller DNA fragments to travel through the agarose at a quicker pace than heavier
fragments, thus separating the DNA according to size. The size of the fragments was
estimated through comparison with DNA bands of known size known as a DNA
ladder. The DNA fragments on the agarose gel were visualised by incorporating
ethidium bromide in the agarose gel, which binds to the DNA, and glows orange
under ultra-violet (UV) light.
Agarose gels were prepared by dissolving molecular grade agarose (Helena
Biosciences) in lx tris-acetate (TAE) prepared from 50x stock. The 50xTAE stock
was made with 242 grams of Tris base, 57.1 ml glacial acetic acid, and 100ml 0.5M
EDTA (pH8.0) in 1 litre of deionised water. The concentrations of agarose gel used
for the different strains of knockout mice can be seen in Table 2.6, together with the
size of the bands from the wildlype and knockout DNA fragments.
The agarose in TAE was melted using a microwave oven at medium power. This was
followed by the addition of ethidium bromide at 0.5mg/ml. This and the following
steps were carried out in a fume hood due to the dangers of ethidium bromide. The
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agarose solution was then poured into a plastic gel tray sealed at both ends with
masking tape and containing plastic combs to form the wells that the PCR product
can be loaded into. The gels were then left to set for a minimum of 30 minutes.
The gel was then placed in an electrophoresis tank filled with lxTAE with 0.5mg/ml
ethidium bromide. The PCR reaction product with the loading buffer were loaded in
the wells made by the combs together with a DNA ladder for comparison. The tank
was then put under current and the samples were run at 200V and 400mA for 40
minutes to 1 hour depending on the size of the fragments and the difference between
the wildtype and knockout fragments The blue loading buffer gave an indication of
how far down the gel the samples had run.
Finally the gel was visualised under a UV light, revealing the wildtype and knockout
bands thus enabling identification of wildtype, heterozygous and knockout animals.
Figure 2.9 shows examples of genotyping gels illustrating these three genotypes.
Table 2.6: Concentration of agarose gels used and size of bands
Agarose
concentration
Wildtype band Knockout band
p75D 2% 345bp 475bp
p75L 2% 285bp 600bp
trkA 2% 400bp 800bp
trkB 1% 800bp 900bp
Bax 1.5% 307bp 507bp
Badl 2% 550bp
Bad2 2% 550bp
ErbB3 2% 489bp 712bp
160
Figure 2.9 Examples of genotyping gels for the knockout mice studied.
illustrating the appearance of wildtype and knockout bands
ErbB3
«mlt mi rtmmt, mmhih mai" 11 -t'- - onm-i- mm* mmm mmm WP VJHP
*m <* mm
het het het wt het ko het het vvt
B trliA— — — « mm mm -yr'
mm mmrn mm — mmm mwm
wt hct ko vvt wt vvt '""bet-*"* wt
tr
:•»•**»!* - 9Wmm f f • #9V m3













het het ko ko ko het ko vvt ko
m Badl - WT §
m mm 1i m w m m m *•
m Bad2 - KO■
•9i1HI • m m m 1••t«•





Figure showing examples of genotyping gels from litters obtained by breeding two heterozygous miee
from the ErbB3 (A), trkA (B), trkB (C), p75L (D). p75D (E), Bax (F) and Bad (G) colonies together.
DNA moves towards the positive electrode (+) when current is applied, with smaller fragments of
DNA moving through the agarose gel faster than larger ones. In all the knockout mice studied, apart
from the Bad colony, the knockout band is larger than the wildtype band and therefore moves towards
the positive electrode at a slower rate, thus allowing the identification of wildtype (wt), heterozygous
(het) and knockout (ko) mice. In the case of mice in the Bad colony, the wildtype (Badl) and
knockout (Bad2) bands are of the same size and are therefore run on separate agarose gels. One or two
lOObp DNA ladder are shown with each gel.
I6l
2.5 Fixation, processing, cutting and staining of embryos for
histological analysis
2.5.1 Background
The advent of knockout mice has resulted in extensive use of histological techniques
for analysis of the morphological and quantitative changes in various cell types
occurring in a variety of tissues when a particular protein is deleted. Furthermore, the
development of specific, sensitive immunohistochemical techniques has facilitated
this analysis by providing the opportunity to identify particular cells or proteins of
interest.
The general histological stain used in these experiments was Cresyl Violet Acetate,
also known as Cresyl Fast Violet (CFV). CFV is a Nissl stain (staining blue-purple).
Nissl granules are basophilic granules, which represent rough endoplasmatic
reticulum, the RNA of ribosomes, giving rise to the basophilia, which are distributed
in the cell body and dendrites of neurones. The stain is a mixture of 2 or more basic
dyes, which vary in their alkyl groups from the structure. It is based on coulombic
attractions between the coloured cations of the dye and the anions present in the
RNA. Staining is dark violet for nucleoli and Nissl substance and pink for cartilage.
Immunohistochemistry uses antibodies to recognise cellular or tissue constituents
(antigens). This works by using a lock and key principle, with the antibody fitting the
antigen of interest, and, ideally, not binding to any other constituents of the tissue.
Antibodies possess variable and hypervariable domains which bind epitopes on the
antigen to which the antibody was raised against. Antibodies are 'labelled' with an
enzyme or chromogen to permit detection of bound antibody.
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The method used in the experiments described in this thesis is known as indirect
immunohistochemistry, which means that an unlabelled primary antibody was used
to recognise the antigen of interest and the location of bound primary antibody was
detected by a second labelled antibody raised in a different species against the
constant domains of the primary antibody. This method provides a higher sensitivity
than direct recognition of the primary antibody, since more than one secondary
antibody is able to bind to each primary antibody hence increasing the detectability
of antigens. The method also potentially enables the use of the same secondary
antibody to detect a variety of primary antibodies raised in the same species. The
detection system used here employed the avidin biotin system, the glycoprotein
avidin having a high affinity for the vitamin biotin due to four biotin-binding
hydrophobic pockets. A high number of biotin molecules can be linked to any
antibody, thus increasing the amplitude of staining further without losing specificity,
allowing more sparing use of the primary antibody. The visualisation of the above
described complexes is done using biotinylated enzymes, in this case horseradish
peroxidase in combination with a chromogen such as 3,3'-diaminobenzidine
tetrahydrochloride (DAB), giving a brown staining of the protein of interest. The
preformed macromolecular complexes between avidin and the biotinylated enzyme
are referred to as ABC complexes (Hsu et al., 1981).
The primary antibody used in immunohistochemistry experiments is directed against
a peptide corresponding to the C-terminus of P-III-Tubulin, which is synthesized
exclusively by neurons of higher vertebrates (Lee et ah, 1990). The P-III-Tubulin
antibody (Promega) has been tested to perform in immunohistochemistry of frozen
and paraffin-embedded sections and has been found to exhibit excellent signal-to-
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noise ratios in both. It cross-reacts with most mammalian species and does not label
non-neuronal cells (Promega, Neural Notes 11, 1998).
Non-specific binding of the secondary antibody was assessed by omitting the
primary antibody from the staining procedure. This resulted in the absence of
staining on neuronal sections.
2.5.2 Fixation of embryos
Before any staining can be done, freshly collected tissue had to be fixed and
processed to enable it to be cut into thin sections using a microtome.
The aim of fixation is to suppress autolysis and bacterial attack, preserve the tissue
and its constituents as close as possible to its natural size and shape (during fixation
and after), and to enable ease of staining. Different fixatives may be better at some of
these than others, so a fixative should be chosen carefully depending on the tissue
studied and the staining to be performed.
Aftei various tests perlormed by Dr. Lucia Pinon in this laboratory, it was found that
neutrally buffered formalin (NBF) gave the best resolution for CFV staining, and that
Carnoy's fixative was best suited to immunohistochemistry and for identification of
neurons in early embryos using CFV staining. NBF belongs to the aldehydes and
reacts with the basic amino-acid residues of proteins, causing cross-linking between
the proteins. Carnoy's is a mixture of 60% Ethanol, 30% Chloroform, and 10%
glacial acetic acid. The ethanol in Carnoy's coagulates proteins and precipitates
nucleic acids, while the acetic acid minimises shrinkage induced by ethanol. Acetic
acid also decalcifies the tissue, facilitating later processing. The chloroform bleaches
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the tissue, thus improving contrast of subsequent immunohistochemistry. Neuronal
numbers in embryos up to age E14 were counted using immunohistochemistry and
hence fixed in Carnoy's, whereas neurons in older embryos (El6 and El8) were
counted on CFV stained sections and thus fixed using NBF. This was done because
CFV-stained neurons can be quite difficult to differentiate from some non-neuronal
cells before El4, and hence immunohistochemistry was employed to minimise
erroneous counting.
Different ages of embryo required different times in these fixatives for good fixation,
while avoiding tissue shrinkage: Ell embryos were fixed in Carnoy's for 5 minutes
at room temperature, El2 embryos for 15 minutes, and El3 and E14 embryos for 30
minutes. El6 and El8 embryos were fixed in NBF (BDH) for approximately one
week.
2.5.3 Processing and embedding of embryos
Older NBF fixed embryo heads needed to be decalcified prior to further processing,
i.e. the mineral content of bones and other tissues in these embryos needed to be
reduced to soften the tissue enough to be able to section. Acids may be used for this
purpose, but may interfere with the staining of the tissue by CFV, interfering with
nucleic acid staining. Hence ethylene-diaminetetracetic acid (EDTA), a chelating
agent was used, which depletes the outer mineral layer by binding to ionised calcium.
The depleted calcium is replaced by ions from within, which then in turn are also
depleted until there are no ions to replace the depleted ones and decalcification is
complete. This is a slow process and required 5-7 days in 10% EDTA (Sigma) for
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E16 embryos and 7-10 days for El 8 embryos. During this period the samples were
moved to fresh EDTA every 3 days.
After fixation and decalcification the embryo heads were dehydrated through a
graded alcohol series. From absolute alcohol embryo heads were transferred to an
alcohol/chloroform mixture, before being taken through two further lots of
chloroform. This process, known as clearing, prepared the tissue for processing
through paraffin wax for embedding, since alcohol is insoluble in paraffin wax.
Clearing agents such as xylene or chloroform are miscible with both alcohol and
paraffin wax, thus preparing the tissue for the uptake of the wax. Chloroform was
used in these experiments since it bleaches the tissue enabling better resolution in
both CFV and immunohistochemical staining. Clearing was followed by three
changes in Paraffin wax at 56°C. As for the fixation, the time the embryos spent in
alcohol, chloroform and wax was dependent on the age of the tissue. The times at
each step for each age as determined by Dr. Lucia Pinon are displayed in table 2.7.
Finally, the heads of the embryos were embedded in paraffin upside down using
embedding moulds, to allow serial sections to be cut. No wax was used at
temperatures exceeding 62°C, since temperatures above this could have damaged the
antigens required for immunohistochemistry. Also, paraffin wax, alcohols and
chloroform used in the processing of embryos were frequently changed to minimise
build up of chloroform in the wax and to ensure that alcohols and chloroform
remained as close to the intended concentration as possible. Purity of the paraffin
wax used was ensured by filtration of melted Gurr® wax pastilles (BDFI) prior to use
in processing or embedding.
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Ell E12 E13+E14 E16 E18
dH20 - - - 2x1 hr 2x1 hr
75% Ale. - - - Overnight Overnight
96% Ale. 1 min 1 min 2 mins 15 mins 30 mins
96% Ale. 1 min 1 min 2 mins 20 mins 30 mins
96% Ale. - 1 min 2 mins - -
100% Ale. 1 min 2 mins 5 mins 15 mins 30 mins
100% Ale. 3 mins 7 mins 5 mins 20 mins 30 mins
1/1 Alc./Chlor. 5 mins 10 mins 15 mins 30 mins 30 mins
Chlor. I 10 mins 10 mins 15 mins 2 hrs 2 hrs
Chlor. 11 1 hr 1 hr 1 hr Overnight Overnight
Paraffin I 10 mins 30 mins 30 mins 1 hr 1 hr 30 mins
Paraffin II 10 mins 30 mins 45 mins 1 hr 2 hrs
Paraffin III 10 mins 30 mins 45 mins 1 hr 30 mins 2 hrs
2.5.4 Cutting of embryos
After letting the wax harden overnight at 4° C, 8pm sections were cut using a rotary
microtome. The sections were straightened out using a water bath at approximately
30-40° C, and put on Polysine slides (for Cresyl Fast Violet staining) or Gold Seal®
slides (for Immunohistochemistry) (both BDH). Gold Seal® slides are better at
keeping the sections on the slide and were hence used because the tissue is subjected
to a lot of strain during the washes involved in the immunohistochemical staining
procedure. The slides were then dried overnight at 37° C. To be economical with the
antibody and detection kit used for immunohistochemistry, only slides with the
ganglion on them were stained. This was done by cutting the tissue so that there were
always four sections on one slide, used for CFV, and six on another slide, used for
immunohistochemistry (see Figure 2.10). The CFV stained slides were used to
determine the position of the ganglion of interest, hence indicating which of the
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immunohistochemistry slides could be stained.
Figure 2.10: Cutting of sections for immunohistochemistry
©
polysine slide Gold Seal slide
Figure illustrating the way sections were cut for immunohistochemistry. Four sections were cut on a
Polysine slide, used for CFV staining, and six on another slide, used for immunohistochemistry. 1 -4
are the first four sections to be cut and kept on a polysine slide. The following six sections are then
kept on a Gold Seal® slide (5-10). The next 4 are then again kept on a polysine slide (11-14) and so
forth all the way through the tissue.
2.5.5 Staining of sections using cresyl fast violet (CFV)
A 0.01% CFV solution with a few drops of acetic acid was prepared. This was done
using Cresyl Violet Acetate powder (Sigma), which was dissolved to the required
concentration before being mixed at 45° C for 2 hours. After addition of 3
drops/250ml of acetic acid the solution was filtered. Sections were cleared in Xylene
(approx. 2x5 minutes) and rehydrated through a graded alcohol series (2x100%,
1x96%, 1x70%) followed by distilled water (approximately 2 minutes in each
solution) before being transferred into the staining solution. The time the slides had
to remain in the staining solution varied with embryonic age (older = longer),
fixative (Carnoy's longer than NBF), and has even been reported to vary with
genotype of the animal. Thus staining was checked at regular intervals to avoid over-
or understaining. Following the staining and rinsing with distilled water (with 3
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drops of acetic acid), the slides were differentiated using 96% alcohol with a few
drops of glacial acetic acid, followed by absolute alcohol and chloroform. Slides
were considered to be differentiated when the nucleoplasm of the neurons appeared
free of stain, and the cytoplasm and dark nucleoli were clearly stained. The
chloroform was washed out through 2 100% alcohols, before being mounted in DPX
(BDH) after going through xylene. The typical appearance of CFV staining and the
criteria for identifying neurons can be seen in Figure 2.13.
2.5.6 Immunohistochemical staining of sections
Immunohistochemical staining was done with anti-P-III-Tubulin mouse monoclonal
antibody (Promega) as the primary antibody to identify neurons, using the
Vectastain® ABC Kit (Vector Laboratories) as the avidin-biotin detection system.
DAB (Vector Laboratories) was used as the chromogen. For E13 and E14 embryos a
Vector® M.O.M. Immunodetection Kit was used, to minimise background-staining
occurring at these older ages. The primary antibody was used at a concentration of
1/2000 in PBS, while the secondary antibody, complexing solution and chromogen
were used at the manufacturers recommended concentrations.
PBS was used for washing of slides between the steps in the staining procedure. A
quenching solution, made up freshly before use from 10% methanol and 0.3%
hydrogen peroxide in PBS (De Dellis et al., 1979) was used to block any endogenous
peroxidase activity in the tissue prior to staining, since this would interfere with the
peroxidase reaction with the chromogen. A blocking solution was used to block non¬
specific binding of the antibody. Non-specific binding is caused by the affinity of
169
certain parts of the tissue for the immunoglobulins used due to hydrophobic and
electrostatic forces. Non-specific binding can be inhibited by incubating with an
immunoglobulin-rich serum, which will not react or interfere with the primary
antibody. The serum used for blocking is usually from the species that the secondary
antibody was raised in, in this case horse. Low concentration detergents, such as
Triton-X, are usually added to the block in order to improve penetration of the
blocking solution, as well as the penetration of the antibody. Hence the block used in
the staining procedures was made from 10% horse serum, 0.4% Triton-X (both
Sigma) in PBS. Staining solutions such as the block and the antibody dilutions were
kept on the slides using either probe clips or hydrophobic barrier pens in humidity
chambers.
The staining procedure started in the same way as with CFV staining, clearing the
wax using xylene and then rehydrating through a graded alcohol series. This was
followed by a wash with PBS before incubation in the quenching solution for approx.
20 minutes. Following 2x5 minute washes in fresh PBS the sections were incubated
with blocking serum at 37°C for a minimum of 30 minutes. The blocking solution
was then tipped off before adding the primary antibody at 1/2000 in PBS. The slides
were then incubated with the primary antibody at either 37°C for 1 hr or 4°C
overnight. The antibody solution was then washed off before washing the slides for
two times five minutes in fresh PBS. During these washes the secondary antibody
and the complexing solution were prepared: One drop (~50jul) of the secondary
antibody stock supplied was added to 10 ml of PBS (1/200). The complexing
solution was prepared by adding 2 drops of stock solution A (Avidin DH) to 10 mis
of PBS before mixing well. 2 drops of stock solution B (biotinylated horseradish
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peroxidase H) was then added before mixing. This solution was required to stand for
at least 30 minutes before use, for the ABC complexes to from. After the washes the
slides were incubated with the secondary antibody solution for 45 minutes at room
temperature, before being washed as previously. They were then incubated with
ABC solution for 30 minutes at room temperature before another wash and
application of the chromogen. The DAB was prepared following the manufacturers
recommendations, adding two drops of buffer to 5 ml of distilled water, followed by
4 drops of DAB stock and 2 drops of hydrogen peroxide. Sections were incubated
with DAB for the time required for optimal staining, varying between 2 and 10
minutes, before stopping the chromogen reaction using tap water (5 minutes). The
stained sections were then dehydrated as before through alcohols and xylene and
mounted in DPX. The sections were then left to dry for at least two days before
examination under a microscope.
The staining procedure using the M.O.M. Immunodetection Kit (Vector
Laboratories) is similar to the one described above, but blocking occurred in a
supplied mouse IgG blocking reagent, and antibodies were diluted in a special
M.O.M. diluent. A different ABC complex solution was used too. Another difference
was shortened incubation times for the primary antibody (30 minutes at 37°C),
secondary antibody (10 minutes at room temperature) and ABC solution (5 minutes).
Figure 2.11 illustrates the appearance of anti-piII-Tubulin-stained cells, using DAB
as the chromogen, showing (3111-Tubulin antigens stained in the cytoplasm of the
neurons. It also demonstrates the differences in neuronal size between different
ganglia in the peripheral nervous system.
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Figure illustrating piIl-Tubulin-staining in E14 trigeminal (A), nodose (B). superior cervical (SCG)
(C) and dorsal root (DRG) (D) ganglia at lOOOx magnification. Neurons are easily identifiable by the
piII-Tubulin-positive cytoplasm and fibres, and the clear nucleus. While the sensory ganglia
(trigeminal, nodose and DRG) have comparably similarly sized neurons, the neurons in the
sympathetic ganglion SCG are visibly smaller, and also appear more densely packed.
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2.6 Counting of immuno- and CFV-stained neurons and
pyknotic neurons
2.6.1 Background
Quantitative estimation of the neuronal number in the ganglia of interest was done
using a stereology system. Stereology was developed to address two problems
traditionally associated with quantitative microscopy: first, the magnification needed
for counting only enables viewing of a restricted amount of the object of interest.
This makes it difficult to derive a total count from the often tiny fraction of the total
that has been counted. Second, the sectioning necessary to visualise the item of
interest also decreases the dimensionality of the object, making it impossible to
directly quantify the object from cross-sections. Stereology is a branch of
mathematics and probability theory, interested in obtaining three-dimensional
information from two-dimensional sections. It is an accepted unbiased (i.e. it makes
no previous assumptions) method for collecting information about the number,
length, surface area, and volume of objects. In these experiments a computer
program was employed, Digital Stereology' supplied by Kinetic Imaging, for
stereological assessment of the neuronal numbers in the ganglia of interest.
2.6.2 Counting of neurons on CFV and histochemically stained
sections
The first step in the estimation of the neuronal number for the ganglion of interest is
the estimation of the volume of the ganglion. This is done using the Digital
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Stereology program. Two dimensional areas of the sections of the ganglia of interest
were obtained by the computer program placing a point grid over the object in both
dimensions with the same intervals between the points. The number of points in
contact with the area of the ganglion were used to quantify the area in an unbiased
way by multiplying the number of points in contact with the object of interest with
the area associated with each gridpoint (known value). This has been found to be
more accurate than the more traditional method of edge following (Gundersen et al.,
1981). Every tenth section was counted in this way, starting with a random
(unbiased) section. The distance between these sections was known (i.e.: every tenth
8pm section xlO = 80pm), it was thus sufficient to multiply the measured areas of
the examined sections by this distance. The data were expressed in pm3. For the
trigeminal ganglion of E14 and El3 embryos every tenth section was assessed for
volume determination. Volume of trigeminal ganglia of younger embryos, nodose,
dorsal root and superior cervical ganglia were assessed using every fifth section.
The second step in estimating neuronal numbers using Digital Stereology was to
determine the density of neurons per volume by introducing a motorised focus, thus
allowing the position of sampling in a plane of focus to be determined, adding a
depth dimension to the 2 dimensional picture seen and returning a value of
neurons/unit volume. Random samples were taken in every fifth section, using
different starting points, aiming to sample approximately a quarter of the area of
interest in the section. The density data returned by the Digital Stereology Program
was expressed as neurons/pm3. The values from the first and second step were then
multiplied to obtain a value for the total number of neurons/ganglion.
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When counting neuronal nuclei in sections, not all of those visible represent whole
nuclei. There will be a large number of nuclei that lie partly within the examined
section, and it is not possible to distinguish whole nuclei and fragments. "One cannot
therefore extrapolate from the mean apparent number of nuclei within the volume of
a microtome section to the mean number within a given mass of tissue without
exaggeration" (Abercrombie, 1946). The Abercrombie correction is aimed at
rectifying the bias, with Abercrombie stating that the true density of a population can
be regarded as the number of nuclear points within unit volume. The nuclear point is
designated as any geometrical point in the same relative position in all nuclei. "A
nuclear-point cannot overlap two adjacent sections, and the number of nuclear points
can therefore be extrapolated to the number in any volume of tissue without error"
(Abercrombie, 1946). The average number of nuclear points, representing the
r i, p
corrected number, is calculated by the formula: N =N x(T/(P+T)). N being the
corrected number, Nu the uncorrected number, T the thickness of the section (8pm in
this case), and P the mean nuclear diameter of the neurons, which varied depending
on the ganglion, age and genotype of the embryo and was determined tor each
individual count (Range: 6-12pm). Nuclei whose nuclear-points are outside the
section but which are nevertheless represented inside the section, have their nuclear-
points extending through a volume of tissue of (on average) the thickness of the
mean nuclear diameter, as shown in Figure 2.12 (Abercrombie, 1946). Below this
Figure is an explanation of the derivation of the formula for Abet crombie correction.
The mean diameter of the neurons (P) was determined by drawing a minimum of 100
nuclei per ganglion using a camera lucida at x40 magnification, together with a scale
bar of known size. These drawings were then scanned and analysed on a Macintosh
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computer using the public domain NIH Image program (developed at the U.S.
National Institutes of Health and available on the Internet at
http://rsb.info.nih.gov/nih-image/). After setting the scale of the drawing using the
known scale bar as a reference, individual nuclei were selected using the 'magic
wand' tool in the program and measured. This returned the mean nuclear diameter of
the nuclei, enabling correction.
Figure 2.12: Derivation of Abercrombie correction
Diagrammatic side view of a microtome section that lies between the two horizontal lines. Two
spherical nuclei of equal radius are so placed that they touch the surfaces of the sections X and Y. Any
nucleus of this radius will be represented in this section if its center lies anywhere between W and Z
(area designated by dotted line). Since a random distribution of nuclei can be assumed between the
two indicated points, the proportion of all nuclei represented in the section whose centers lie within
the section is given by XY/WZ, i.e. the section thickness/(section thickness + nuclear diameter) (from
Abercrombie, 1946).
2.6.3 Counting of pyknotic cells
Pyknotic neurons were counted using CFV-stained slides. The total number of
pyknotic neurons was counted, as identified by the large purple blebs of clumped
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chromatin in a large pale nucleus surrounded by stained cytoplasm (figure 2.7). All
the pyknotic neurons were counted on every fifth section of the ganglion at x40
magnification. The sum of these was then multiplied by five to obtain an
approximation of the total number of pyknotic neurons in the ganglion. Pyknotic
neurons were not counted in the SCG ganglia, since the density and small size of the
neurons (see Figure 2.13) would make accurate identification of pyknotic neurons
impossible. Due to their relatively small size, the counts of blebs of clumped
chromatin are less likely to be found in more than one section, resulting in little bias
and making Abercrombie's correction unnecessary for pyknotic neuron counts (Dr.
Lucia Pinon, personal communication).
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(A) Appearance of an E12 CFV-stained dorsal root ganglion at x400 magnification. Scale: 200pm (B)
Appearance of E16 CFV-stained neurons at xlOOO magnification. Scale: 100pm (C) Appearance of
El9 CFV-stained neurons at xlOOO magnification. Scale: 20pm (from Pinon, et al.. 1996). Black
arrows indicate the large purple blebs of clumped chromatin in a pale nucleus surrounded by stained
cytoplasm, which identify pyknotic neurons. These can be distinguished from other neurons, with
their less intensively stained nucleolus (red arrows) (Konigsmark, 1970). Also indicated are the




Variables are the different classes of information of a data set. Variables that are
manipulated by the experimenter are known as 'independent variables', and variables
that are measured in an experiment are called 'dependent variables', as they
dependent on the independent ones. In choosing statistical test to evaluate whether
data sets come from different populations or if they do not (null hypothesis), it is
important to identify the type of variable the data represents. Variables can be either
quantitative or qualitative. Qualitative variables are concerned with classes or
categories, such as age or gender. As the name suggests, quantitative variables
measure quantities, i.e. amounts or counts. The data in this thesis are quantitative.
Quantitative data can be further divided into discrete and continuous variables.
Discrete variables consist of isolated points whose values are separated from each
other. Counting variables are an example, as they will always be an integer such as 1,
2, 4, etc. and can never be 2.12 for instance. Continuous variables can take on any
possible value within the limits of the variable range, and includes data such as
length, speed or weight (Cann, 2003).
The first dependent variable measured is the expression of mRNA relative to the
expression of a housekeeping gene. This measurement is quantitative, since it
measures the absolute amount of something (by comparison to known amounts of
competitor). Further, the variable is continuous, since it can take on any possible
value within the limits of the variable range.
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The second dependable variables measured are the counts of neuronal and pyknotic
nuclei. Counts are strictly speaking discrete variables, since one cannot possibly get
half a neuron. However, the counts of neuronal nuclei obtained in these experiments
are estimates of numbers rather than counts, with values such as 4495.817 neurons in
an El3 DRG as an example (following Abercrombie correction). Since the
combination of the estimated numbers with the Abercrombie correction could
theoretically give rise to any value within the limits of the variable range, estimates
of neuronal nuclei can be considered a continuous variable. Pyknotic neuron
estimates by contrast are not corrected and are therefore only able to take on discrete
values.
Before making comparison between groups of data the significance level needs to be
set, where a difference between the groups is considered to be significant. This was
set at p<0.05 (5%).
2.7.2 Parametric versus non-parametric
There are two types of statistical tests, depending on the nature of the data:
parametric and non-parametric tests. Parametric tests depend on estimates of the
parameters of populations or probability distributions. These tests include the
student's t-test, ANOVA (analysis of variance) and correlation analysis. These tests
are only meaningful for continuous data that can be meaningfully added and is
sampled from a population where an underlying normal distribution is assumed, or
whose distribution can be rendered normal by mathematical transformation (Lewis
and Traill, 1999; Cann, 2003). Non-parametric tests use ranks and require fewer
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assumptions about a population or probability distribution and are applicable in a
wider range of situations (Cann, 2003). These tests include the Mann-Whitney test
and the Kruskal-Wallis test. When both parametric and non-parametric tests are
applicable, statisticians usually recommend using parametric methods because they
tend to provide better precision. Parametric tests make use of more of the available
data and are more 'powerful', i.e. they are less likely to reject the null hypothesis
when it is false (Lewis and Traill, 1999; Cann, 2003).
As stated, parametric methods require continuous data, hence the pyknotic neuron
counts, which are discrete data, cannot be analysed using parametric methods and
require the use of non-parametric tests.
Data points need to be suitable for meaningful addition and other calculations (Lewis
and Traill, 1999), which can be problematic with relative measurements, such as the
ones in the competitive RT-PCR experiments. However, such operations can be
performed with relative measurements as long as the denominator (bottom line)
remains the same (Lewis and Traill, 1999), which is the case here, as all
measurements were relative to lpg ofGAPDH.
In the chapters examining neuronal counts some data are expressed as percentages
and ratios. Ratio and percentage measurements are special cases, in that percentages
from 0 to 100% or proportions from 0 to 1 form a binominal distribution, rather than
a normal one. The deviation from normality tends to be greater for small or large
percentages (Zar, 1999). Non-parametric statistics were used on these types of data,
as they do not have a normal distribution.
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2.7.3 Parametric tests
The Student's t-test is a parametric test that compares the means of two groups of
samples by calculating the probability of there being no difference between them
(null hypothesis). The smaller this probability, the higher the likelihood that there is a
difference. This test, devised by William Gosset ('Student') in 1908 (cited in Cann,
2003), has two variations: one for paired samples and one for unpaired or
independent samples. The version used here is the one for unpaired samples.
The t-test can only be used to compare two groups. If more than two groups have to
be compared, other tests must be used, such as the analysis of variance between
groups (ANOVA). A different test is necessary for more than two groups, because
the multiple pair-wise comparisons (such as t-tests) that would have to be used
increase the possibility of committing a type one error (rejection of the null
hypothesis erroneously). ANOVA can compare the means of three or more samples,
thus overcoming this problem (Cann, 2003). ANOVA is similar to the t-test,
calculating the probability of there being no difference between group means. There
are different versions ofANOVA, depending whether more than one type of variable
is being assessed. When more than one type of response to a treatment is assessed, a
two-way ANOVA is used, whereas a one-way ANOVA is performed when only one
type of variable is being considered. In the experiments presented in this thesis only
one type of variable was measured, allowing the use of a one-way ANOVA.
An ANOVA only indicates whether there is a difference between at least one of the
means of groups, not giving information between which of the groups the differences
lie. Post-hoc tests (also known as multiple comparison tests) that make pair-wise
comparisons are required to establish this. There are a variety of post-hoc tests that
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can be used for ANOVA. The post-hoc employed here was the Fisher's LSD (least
significant difference) procedure, which performs all possible comparisons of group
means. Fisher's LSD was preferred to the Tukey FISD (honestly significant
difference) test, as it does not require equal sample sizes (Kirk, 1982).
A parametric statistic used to compare the correlation between variables, such as
nuclear and neuronal size, is the Pearson's correlation coefficient. This test is a
measure of the strength of the association between two variables. It returns a measure
of the linear relationship between two variables, which ranges from r = +1 (perfect
positive linear relationship) to r = -1 (perfect negative linear relationship).
2.7.4 Non-parametric tests
Non-parametric tests are useful in situations where the assumptions required by
parametric tests appear questionable. The non-parametric equivalent to the t-test is
the Mann-Whitney U test. It uses the median as a measure of central tendency, rather
than the mean used by parametric methods, and is based on the ranking of
measurements, with both groups being considered jointly (pooled) for ranking
(Wardlaw, 2000). The non-parametric equivalent to the one-way ANOVA is the
Kruskal-Wallis test, which is a generalisation of the Mann-Whitney U test. If
significant differences are detected using the Kruskal-Wallis test, these need to be
investigated using post-hoc tests. The test used here was the Dunn's Multiple
Comparisons Test.
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The graphs and statistical analysis presented in this thesis were done using the
computer software Minitab® 14.12.0 (Minitab Inc.), StatView® 4.57 (Abacus








Precise temporal and spatial regulation of gene expression are key features of
neuronal development. The timing of neurotrophin responsiveness, for example, is
tightly controlled in developing sensory neurons. Neurotrophin independence and the
timing of neurotrophin survival upon target field innervation appear to be controlled
by an intrinsic timing mechanism in placode-derived sensory neurons (Davies and
Vogel, 1991; Vogel and Davies, 1991). Similarly, other populations of sensory
neurons switch their dependence from one set of neurotrophins to another during an
early stage in development (e.g. Buchman and Davies, 1993; Buj-Bello et al., 1994;
Pinon et al., 1996), the switch being controlled in part by cell-cell interactions within
the ganglion (Enokido et al, 1999).
The trigeminal ganglion comprises populations of neurons and supporting cells that
have been thoroughly studied in relation to the periods of neurotrophin
independence, and dependence on particular neurotrophic factors in relation to the
timing of target field innervation (Davics, 1997). In vitro studies have demonstrated
that these neurons are initially neurotrophin independent, before becoming
transiently dependent on BDNF and NT-3 at the onset of target field innervation.
Subsequent to target field innervation they become dependent on NGF, whose
limited supply is believed to govern developmental cell death in this population of
neurons (Buchman and Davies; Paul and Davies, 1995). The expression of trk
receptors mirrors these changes in neurotrophin dependence. TrkB and trkC (BDNF
and NT-3 high affinity receptors respectively) are highly expressed in the trigeminal
ganglion at early developmental stages, whereas trkA (NGF high affinity receptor) is
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expressed at later stages (Ernfors et al., 1992; Arumae et al., 1993; Wyatt and
Davies, 1993). Consistent with this pattern of expression and the sequential action of
neurotrophins, more neurons undergo cell death in trCB-deficient embryos early in
development, whereas more neurons are lost in trC4-deficient mice at later stages in
development (Pinon et al., 1996; chapter 5).
The trkA receptor is of particular interest since NGF signalling through trkA is
believed to regulate the survival of the majority of neurons during the period of
developmental cell death. The expression of trkA begins shortly after the
commencement of target field innervation (-E11/E12 in the mouse) and increases in
the early stages of target field innervation (Wyatt and Davies, 1993). Some of the
mechanisms controlling trkA have been found to be intrinsic, or regulated by cell-
cell interactions within the ganglion (Wyatt and Davies, 1993; Enokido et al., 1999).
The study presented in this chapter was concerned with establishing whether
mechanisms intrinsic to the ganglion control the entire developmental programme of
trkA expression. The developmental time-course of trkA expression has been
examined previously (Wyatt and Davies, 1993). There has, however, been no
detailed study over the time-period of trkA increase in vitro, assessing the
importance of intrinsic mechanisms. The study presented here addressed this issue by
culturing intact trigeminal ganglia at different ages of development to ascertain
whether the direction and magnitude of changes in trkA expression in culture
mirrored in vivo changes. Using this approach, it appeared that changes in trkA
expression are strongly regulated by intrinsic mechanisms from within the ganglion.
To investigate whether the central (hindbrain) and peripheral (maxillary process)
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target fields of the trigeminal ganglion influence trkA expression, early ganglia were
cultured with or without these target fields. Surprisingly, it was found that the
presence of both the peripheral and/or central target fields reduced trkA expression in
the ganglion at El 1 due to the release of a diffusible substance. Such an effect was
also detected at subsequent ages, although to a lesser extent. The developmental
significance of this effect is unclear.
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3.2 Results
3.2.1 trkA expression in cultured trigeminal ganglia
To assess whether there is an intrinsic mechanism within the trigeminal ganglion that
regulates expression of trkA during development, trigeminal ganglia were grown by
themselves for 24hrs and the expression of trkA mRNA was compared to the
expression seen in vivo at the corresponding age.
The ganglia were grown with the neurotrophins (NGF, BDNF, and NT-3), to
maximize their survival. TrkA mRNA levels were expressed relative to GAPDH
mRNA to correct for any differences in the size/mass of dissected ganglia or
differences in the yield of mRNA from extractions. Examples of gels assessing
relative trkA mRNA levels after 24hrs in culture are shown in Figure 3.1.
Figure 3.2 shows that very similar changes in trkA mRNA expression occurred in the
trigeminal ganglia cultured for 24 hours, as took place over the same 24 hours in
vivo (there were no significant differences in the levels of trkA at the equivalent in
vitro and in vivo stages at all the time points studied (t-test; p>0.05 at El 1, E12, E13,
El4 and El5)). This suggests that trkA expression in the trigeminal ganglion is
regulated at least in part by factors, cell-cell interactions or genetic programmes that
are intrinsic to the ganglion, and are not controlled by extrinsic factors released from
their target fields or tissues. Thus both the increase in trkA expression during the
period of target innervation from Ell to El 3, and the decrease between E14 and El 5
associated with developmental cell death appear to be predetermined within the
ganglion.
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Figure 3.1: Examples of gels showing relative trkA expression in the
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SYBR®Gold (Molecular Probes) stained gels showing the products of RT-PCR reactions amplified
with either GAPDH-specific or trkA-specific primers. (A) Reactions containing 62,5fg of the GAPDH
competitor RNA (132bp) and 2.1fg of the trkA competitor (78bp) plus total RNA from F.10 trigeminal
ganglia (TG-Ohrs) or E10 trigeminal ganglia cultured for 24 hrs (TG - 24hrs) (GAPDH: 128bp; trkA:
75bp). (B) Reactions containing 300fg of the GAPDH competitor RNA (132bp) and 30fg of the trkA
competitor (78bp) plus total RNA from Ell trigeminal ganglia (TG-Ohrs) or Ell trigeminal ganglia
cultured for 24 hrs (TG-24hrs) (GAPDH: 128bp; trkA: 75bp). (C) Reactions containing 520fg of the
GAPDH competitor RNA (132bp) and 104fg of the trkA competitor (78bp) plus total RNA from E12
trigeminal ganglia (TG-Ohrs) or El2 trigeminal ganglia cultured for 24 hrs (TG-24hrs) (GAPDH:
128bp; trkA: 75bp). (D) Reactions containing 625fg of the GAPDH competitor RNA (132bp) and
167fg of the trkA competitor (78bp) plus total RNA from El 3 trigeminal ganglia (TG-Ohrs) or El3
trigeminal ganglia cultured for 24 hrs (TG-24hrs) (GAPDH: 128bp; trkA: 75bp). (E) Reactions
containing 833fg of the GAPDH competitor RNA (132bp) and 208fg of the trkA competitor (78bp)
plus total RNA from E14 trigeminal ganglia (TG-Ohrs) or E14 trigeminal ganglia cultured for 24 hrs
(TG-24hrs) (GAPDH: 128bp: trkA: 75bp). (F) Reactions containing 937fg of the GAPDH competitor
RNA (132bp) and 167fg of the trkA competitor (78bp) plus total RNA from E15 trigeminal ganglia
(TG-Ohrs) (GAPDH: 128bp; trkA: 75bp).
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Figure 3.2: trkA expression in the trigeminal ganglion in vivo compared to































Expression of trkA in trigeminal ganglia after 24hrs in culture with growth factors (purple line), or in
vivo at the age corresponding to 24hrs after the ganglia where put into culture (blue line), (i.e. the first
in vitro data point at El 1 is the level of trkA expressed in E10 ganglia cultured for 24 hrs and so on).
Bars represent the mean ± standard error (n=4-16 per data point).
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3.2.2 Effect of the peripheral and central target fields of the
trigeminal ganglion on trkA expression
To ascertain whether the target fields of the trigeminal ganglion affect trkA
expression, El 1 ganglia were grown with or without their target fields in culture for
24 hours. As above, NGF, BDNF and NT-3 were added to the medium to ensure
maximal survival of neurons in both experimental conditions. Subsequent
experiments demonstrated that these factors have no influence on the results
presented below (preliminary data shown in appendix - Figure A.l). This may be
related to the large proportion of neurons that survive independently of neurotrophins
at this stage (Pinon et al., 1996; chapter 5). The age of Ell was chosen for the
following reasons: 1. Ell is the stage at which a marked increase in trkA receptor
expression is first observed (Figure 3.3). 2. It coincides with the onset of target
innervation in vivo (Davies and Lumsden, 1984). 3. It lies immediately prior to the
main period of 'switching' in neurotrophin dependence of the neurons in the
ganglion (Buchman and Davies, 1993).
The target fields used were the hindbrain, the central target field of the trigeminal
ganglion, and the maxillary process, its most densely innervated peripheral target
field. Ganglia and target fields were dissected with their neural connections intact as
described in chapter 2 (Figure 2.4A, Figure 3.4).
An ANOVA revealed significant differences between the trigeminal ganglion grown
alone and with its target fields attached (p<0.0001). Paradoxically, it was found that
the presence of either of these target fields resulted in a reduction in the expression
levels of trkA (Figure 3.3). Whereas expression in the ganglion reached in vivo
levels when grown alone (TG), the attached maxillary process (TGMX) and
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hindbrain (TGHB) reduced trkA mRNA in the ganglion. The above targets reduced
trkA mRNA levels in the trigeminal ganglion by almost 40% (Fisher's LSD;
p<0.001) and 50% (t-test; p<0.0001), respectively, and with both target fields
attached (TGMXHB) there was a 75% reduction (Fisher's LSD; p<0.0001),
maintaining trkA mRNA to levels observed in ganglia collected prior to cultures
(TG-0).
Figure 3.3: trkA expression in the Ell trigeminal ganglion after 24 hrs in
culture without or with its peripheral and central targets attached
Expression of trkA in El 1 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-
0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX:
Expression in the ganglion grown with the maxillary process. TGHB: Expression in the ganglion
grown with the hindbrain. TGMXHB: Expression in the ganglion grown with both target fields. Bars
represent the mean ± standard error (n=6-l 6 per data point).
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3.2.3 The target fields effect reductions in trkA expression by acting
through a diffusible substance
To determine whether the unexpected in vitro effect of the target fields on trkA
expression was due to physical connections between the trigeminal ganglion and its
targets or due to a diffusible substance being released from the targets, Ell ganglia
and their central and peripheral targets were dissected separately and placed back
into contact (see Figure 2.4B, Figure 3.5) or left at a slight distance of approximately
500pm (figure 2.4C, figure 3.6). This was done by stabilizing the structures in
Matrigel® for the 24 hour culture period.
Figure 3.7: trkA expression in Ell trigeminal ganglia after 24 hrs in culture
without their target fields or with their peripheral and central




















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El 1 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-
0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX:
Expression in the ganglion grown with the maxillary process. TGF1B: Expression in the ganglion
grown with the hindbrain. TGMXHB: Expression in the ganglion grown with both target fields. Bars
represent the mean ± standard error (n=4-16 per data point).
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Figure3.4:Thtrigeminalganglionc lturedbyitselfottachedttsr tfi ldsg re2.8A TrigeminalGanglionTrigeminalattachedtoMaxill ryproc ss TrigeminalattachedtoHindbrainTrigeminalttachedtoM xillarynHindbr in
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Figure3.6:Thetri eminalganglioncultur dbyitselfow thtssepa atedtar tf e dsslig tdi ta ce TrigeminalGangl onandM xil aryprocess
When the target fields were separated and placed back in contact with the trigeminal
ganglion (Figure 3.7), there were still significant effects (ANOVA; pO.OOOl). The
maxillary process still mediated a 40% reduction in trkA mRNA levels (Fisher's
LSD; p<0.05), whereas the hindbrain mediated a 60% reduction (Fisher's LSD;
p<0.001) and both together a 40% reduction (Fisher's LSD; p<0.01). Thus neural
connections to the target field were not needed for the effect to occur. Indeed, effects
were almost as strong as with intact connections. While some of the effect may be
explained by re-growth of axons into the target field, the strength of the remaining
effect would suggests that at least some of it was mediated by a diffusible substance.
When the target fields were separated and left at a slight distance from the trigeminal
ganglion (Figure 3.8), the effects were greatly reduced, although some effect
remained (ANOVA; pO.OOOl). When the ganglion was grown with the hindbrain
(20% reduction; Fisher's LSD; p<0.001) or both target fields (25% reduction;
Fisher's LSD; p<0.05), the reduction in trkA mRNA levels was still within
significance limits. The maxillary process had no significant effect (Fisher's LSD;
p>0.05)
The above results indicate that the substance mediating the effect of the target fields
on trkA expression does not require neuronal connections to the ganglion and is
diffusible. Preliminary studies using conditioned medium support these observations,
with hindbrain homogenate reducing trkA expression in trigeminal ganglia (see
appendix - Figure A.2).
To ensure that the substance reducing trkA expression was expressed in the target
fields in vivo, and not induced in vitro due to some effect of the dissection or the
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culture medium, homogenates of Ell maxillary processes and hindbrains were
prepared as described in chapter 2 (2.2.2). The supernatant was diluted to different
extents in fresh medium. The results of this experiment can be seen in Figure 3.9.
The homogenate supernatant also reduced trkA expression in the trigeminal ganglion
(ANOVA; p<0.0005), indicating that the substance presumably released in vitro
appears to be synthesized in vivo as well. All dilutions of homogenate studied
reduced trkA expression by 40-60%, although these reductions were not significant
for diluted (50% and 10%) maxillary process homogenates (Fisher's LSD; p>0.05).
Both 100% maxillary process and all hindbrain homogenates displayed significant
reductions in trkA expression (ANOVA followed by Fisher's LSD; p<0.05),
Different homogenate concentrations were not significantly different from each other
(Fisher's LSD; p>0.05). The effects of the homogenates suggests that the diffusible
substance mediating reductions in trkA mRNA levels is produced in vivo.
Homogenate studies could provide a starting point for the isolation of such a
substance.
Another interesting observation made in cultures grown with target field homogenate
was the almost complete absence of neurite outgrowth from the ganglion when
grown with homogenate of either target field (Figure 3.10). This was observed in all
the homogenate cultures at every homogenate concentration, and may indicate the
presence of substances in the maxillary processes and hindbrains that would
normally prevent neurons from growing further once they reach their target field.
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Figure 3.8: trkA expression in Ell trigeminal ganglia after 24 hrs in culture
without their target fields or with its peripheral and central target

















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El 1 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-
0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX:
Expression in the ganglion grown with but separated from the maxillary process. TGHB: Expression
in the ganglion grown with but separated from the hindbrain. TGMXHB: Expression in the ganglion
grown with but separated from both target fields. Bars represent the mean ± standard error (n=6-16
per data point).
Figure 3.9: trkA expression in Ell trigeminal ganglia after 24 hrs in culture




















TG-0 TG TG- TG-50%MX TG-10%MX TG- TG-50%HB TG 10%! ID
100%MX 100%HB
Homogenate concentration
Expression of trkA in Ell trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3 in
maxillary and hindbrain homogenate. TG-0: Expression in ganglia before culture. TG: Expression in
the ganglion grown on its own in normal medium. TG-x%MX: Expression in the ganglion grown with
maxillary process homogenate. TG-x%HB: Expression in the ganglion grown with different
concentrations of hindbrain homogenate. Bars represent the mean ± standard error (n=2-ll per data
point).
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Figure3.10:Thetri eminalanglioncultur dbyi selfnorm lm d um,ax llaryproc ssh ndbraiomoge te TrigeminalGangl onTrige in ll niMax llaryprocesshomoge te TrigeminalGanglioniH ndbraihomo e te
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3.2.4 Age-related regulation of trkA expression
To investigate whether the reduction of trkA mRNA by the central and peripheral
target fields was confined to the age of E11 or if it applied to other ages, trigeminal
ganglia were grown with their target fields at E10, and at E12 to El5. These cultures
were performed with intact neural connections between target field and ganglion, as
seen in Figure 2.4A (chapter 2). NGF, BDNF and NT-3 were added to the medium to
ensure maximal survival of neurons in both experimental conditions at all ages.
Figure 3.11 shows trkA mRNA levels in E10 cultures after 24hr incubation. E10
cultures proved difficult to study due to the tendency of the ganglion to dissociate in
culture. Some ganglia could be grown, but parts of the ganglia may have been lost in
some instances, explaining the unusually large variations obtained (large error bars).
The E10 data should thus be considered with caution. It was observed that there was
no significant regulatory effect of the target field on trkA expression at E10
(ANOVA; p>0.05), although as stated, this may be an artefact due to difficult culture
conditions. As already established in section 3.2.2 (Figure 3.3), at Ell there were
-42% and -50% reductions in trkA expression in the maxillary process and
hindbrain, respectively, with both together resulting in a -75% reduction compared
to the trigeminal ganglion alone. Figure 3.12 shows trkA expression in E12
trigeminal ganglia prior to culture and after 24 hours with or without their central and
peripheral targets. An ANOVA indicated there were significant differences between
the sample groups (ANOVA; p<0.0005). No significant effect of the maxillary
process on trkA mRNA levels could be observed at this age (Fisher's LSD; p>0.05),
whereas a -25% reduction was maintained with the hindbrain (Fisher's LSD;
p<0.05) and with both target fields (-50%; Fisher's LSD; p<0.0001). Figure 3.13
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displays trkA expression in cultures from trigeminal ganglia cultured in the same
manner at the age of El 3 (ANOVA; p<0.01). There was no significant effect of the
maxillary process (Fisher's LSD; p>0.05), with a remaining effect with the hindbrain
(Fisher's LSD; p<0.05)) or both target fields attached (Fisher's LSD; p<0.01). At
E14 (Figure 3.14) and E15 (Figure 3.15) no significant effects of the peripheral and
central target field on trkA mRNA levels in the trigeminal ganglion after 24 hrs in
culture could be observed (El4: ANOVA; p>0.05). There was a significant decrease
in trkA expression in the trigeminal ganglion compared to levels before culture
however, an effect that was found both with the trigeminal ganglion alone and with
the trigeminal ganglion grown with its target fields (ANOVA followed by Fisher's
LSD; p<0.05)
Figure 3.11: trkA expression in E10 trigeminal ganglia after 24 hrs in culture



















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in E10 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-
0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX:
Expression in the ganglion grown with the maxillary process. TGHB: Expression in the ganglion
grown with the hindbrain. TGMXHB: Expression in the ganglion grown with both target fields. Bars
represent the mean ± standard error (n=3-4 per data point).
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Figure 3.12: trkA expression in E12 trigeminal ganglia after 24 hrs in culture
























TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El2 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3.
Symbols as above. Bars represent the mean ± standard error (n=4 per data point).
Figure 3.13: trkA expression in E13 trigeminal ganglia after 24 hrs in culture
















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El3 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3.
Symbols as before. Bars represent the mean ± standard error (n=7-8 per data point).
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Figure 3.14: trkA expression in E14 trigeminal ganglia after 24 hrs in culture
without or with their peripheral and central target fields attached
Expression of trkA in E14 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-
0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMXF1B:
Expression in the ganglion grown with both target fields. Bars represent the mean ± standard error
(n=4 per data point).
Figure 3.15: trkA expression in E15 trigeminal ganglia after 24 hrs in culture
—a <■* m ij




















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El5 trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3.
TGMX: Expression in the ganglion grown with the maxillary process. TGF1B: Expression in the
ganglion grown with the hindbrain. Other symbols as above. Bars represent the mean ± standard error
(n=4 per data point).
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The main peripheral and central target field of the trigeminal ganglion thus appear to
down-regulate trkA expression in vitro after 24 hrs. This effect was most pronounced
at El 1, with some less effect at E12 and E13. Earlier (E10) and later (E14 and E15)
in the development of the trigeminal ganglion there appeared to be no effect by the
target fields on trkA mRNA levels. It is possible that this effect was due to the
release of neurotoxic substances from the target field in culture. However, there
appeared to be no effect at later ages, which together with preliminary findings that
the target fields did not significantly affect trkB and trkC expression in the ganglion
(see appendix - Figures A.3 and A.4), would argue against such a neurotoxic
substance (although there was a downregulation of p75 mRNA with the target fields,
Appendix - Figure A.5). Also, homogenates of the maxillary process and the
hindbrain succeeded at inhibiting the increase in trkA. These tissues were
homogenized immediately after collection, making any build up in neurotoxic
substance(s) an unlikely possibility.
206
3.3 Discussion
The effects observed in this study are difficult to explain because one part of the
study seems to indicate that trkA in the trigeminal ganglion is controlled by
mechanisms intrinsic to the ganglion, whereas the studies involving the target field
appear to suggest that target fields are capable of down-regulating trkA expression
during early development. I shall thus discuss each finding in turn before attempting
to find explanations for the contrasting effects observed.
3.3.1 Intrinsic regulation of trkA expression in the mouse trigeminal
ganglion during development
The time-course of trkA expression in vivo in the studies reported here closely
resembles the time-course previously established for the trigeminal ganglion (Wyatt
and Davies, 1993), confirming the accuracy of the methods used. During the initial
development of the trigeminal ganglion between E10 and Ell, very little increase in
trkA expression was observed, consistent with most neurons at this stage in
development being either independent of neurotrophins or depending on BDNF and
NT-3 for survival (Buchman and Davies, 1993; Pinon et al., 1996). TrkA expression
subsequently increased sharply between Ell and El3, which is consistent with
neurons switching their survival dependence from BDNF and NT-3 to NGF.
Interestingly, in vitro, the levels of trkA mRNA expressed by the ganglion alone
precisely mimicked this developmental expression in vivo. This confirms earlier
observations of a switch in survival dependence between Ell and El 2 that requires
cell-cell interactions within the trigeminal ganglion (Enokido et al., 1999).
Preliminary results mentioned in the results section and shown in the appendix
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(Figure A.5) suggest that p75 undergoes a similar sharp increase in expression
between El 1 and El2 in vitro, whereas no significant increases are observed at this
stage in the expression patterns of trkB and trkC in vitro (Figures A.3 and A.4).
Thus, events within the cultured trigeminal ganglion appear to trigger the onset of
NGF dependence and the proportional loss in trkB responsiveness during this stage
in development. Whereas the previous study (Enokido et al., 1999) demonstrated this
by assessing the responsiveness of neurons to the different neurotrophins, the data
presented here shows that this intrinsic change in responsiveness is accompanied by
an intrinsic change in receptor expression in the ganglion. It is unlikely that the
increases in the expression levels of trkA and p75 are related to the expression of
these receptors by non-neuronal cells, since it has been demonstrated that non-
neuronal cells in the trigeminal ganglion at this age do not express either of these two
receptors (Wyatt and Davies, 1993). The finding that trkA increases sharply between
El2 and El3 also confirms previous findings of increasing trkA expression in
dissociated neuronal cultures at these ages, at least during the first 18 hours (Wyatt
and Davies, 1993)
The decreasing levels of trkA expression between El 4 and El 5 in vivo could be due
to a reduction in the number of trkA-dependent neurons as a proportion of other cells
in the ganglion. This could result from death of trkA expressing neurons or a relative
increase in the number of satellite and Schwann cells. The mean level of trkA mRNA
per neuron could also decrease with age. Further ages will need to be assessed to
determine whether this intrinsic decrease in trkA expression continues later into the
period of developmental cell death.
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The observation that cultured ganglia of different ages follow almost exactly the
same changes in trkA expression as seen in vivo, suggests an extremely tightly
controlled intrinsic mechanism in the control of trkA expression. This would confirm
the importance of mechanisms intrinsic to the neurons or the ganglion during
neuronal development. Similar findings have been made in placode-derived sensory
neurons in the chick, where the onset of neurotrophin dependence appears to be
intrinsically pre-set, at least in part (Vogel and Davies, 1991; Davies and Vogel,
1991). The finding that trkA expression in the trigeminal ganglion is intrinsically
regulated also correlates with previous findings suggesting that the maturation of
sensory neurons from the trigeminal ganglion is target independent (Stainier and
Gilbert, 1991); further evidence for the independence of this neuronal population
from their target fields.
3.3.2 Downregulation of trkA by a diffusible substance released
from the target fields
The finding that the target fields of the trigeminal ganglion release a diffusible
substance that has a profound effect on trkA mRNA levels in the ganglion in vitro
seems at odds with the idea that trkA expression is predominantly regulated by
intrinsic mechanisms within the ganglion. The relation between these two sets of
results will be discussed later in this chapter, with this section focusing on the
potential significance of the target field effects in vitro.
The developmental period during which the target field has an effect on reducing
trkA expression in the trigeminal ganglion in vitro appears to be restricted to El 1 to
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E13, with the strongest effects observed at Ell. Thus the diffusible substance
appears to act between the onset of innervation and the period immediately prior to
the onset of developmental cell death. This makes it unlikely that this putative
substance is actively involved in promoting neuronal death. Rather, one could
speculate that the time window of its action in vitro suggests a possible role for this
substance in maintaining neurons alive before the period of developmental cell death
by delaying the onset of trkA expression and NGF dependence. It may ensure low
trkA levels in neurons whose axons have reached their target field prior to
developmental cell death, keeping these neurons independent of NGF and enabling
neurons to compete with later arriving ones for limited supplies of NGF over the
same period of development. This would maximise the 'choice' of the target field,
enabling the selection of neurons on the basis of the appropriateness of their axonal
terminations in the target field.
Of the known substances present in the central and peripheral target fields of the
trigeminal ganglion at this stage in development, only BDNF has been shown to
decrease trkA expression in trigeminal neurons (Wyatt and Davies, 1993). BDNF is
highly unlikely to cause the observed effect however, since it was present in the
culture medium in which trigeminal ganglia grown alone quite readily increased their
trkA mRNA levels. Other substances known to affect trkA expression include
retinoic acid, which has been found to up-regulate trkA in some tissues whereas in
others it down-regulates trkA (e.g. Wyatt et al., 1999; Hoist et ah, 1995; 1997). It is
unlikely to be involved in the effects observed however, since it has been shown to
have no effect on trkA expression in the trigeminal ganglion at the ages of El 1 and
El2, i.e. the stages at which the most significant effect was observed (Wyatt et ah,
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1999). NGF has also been proposed to be involved in alterations in trkA expression
(e.g. Holtzman et al., 1992). However, the levels of trkA mRNA in the trigeminal
ganglion of NGF null mutants appears normal, indicating that NGF has no effect on
trkA expression (Davies et al., 1995). Thus very little is known about factors
influencing trkA expression in vivo or in vitro, making the identification of the
substance involved in the downregulation of trkA by the target field in vitro difficult.
Analysis of the culture medium from homogenised target fields obtained in the
experiments may assist in the identification of such substances.
3.3.3 Conclusion
This conclusion section will attempt to find an explanation for the apparently
contradictory effects observed in the trigeminal ganglion in the studies conducted.
One possible explanation for the observed reductions in trkA expression in the co-
culture experiments is that there are substances in vivo that up-regulate trkA
expression to higher levels than would develop intrinsically. A substance from the
target fields down-regulating trkA would then be necessary to maintain trkA at
appropriate levels. If this were the case, why would there be such a tightly controlled
pre-determined intrinsic mechanism of trkA expression in isolated ganglia in vitro?
However, positive and negative modulators of physiological and developmental
processes are widespread.
It is possible that the release of the putative repressor of trkA expression from the
target fields is normally very tightly regulated in vivo and that the regulatory
mechanisms controlling its release may be absent in vitro, hence causing excessive
release and the pronounced effects observed in vitro.
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Perhaps one of the functions of the putative repressor of trkA expression in vivo may
be to delay the onset of NGF dependence of the early innervating neurons and
thereby sustain their survival until the majority of neurons innervates the target field
so as to maximize competition for NGF and select the most appropriately connected
neurons. This potential function is illustrated in Figure 3.16. The alternative
explanation to the above is that the target field-derived repressor of trkA expression
is an in vitro artefact that has no physiological parallel in vivo. It is curious, however,
that the production and/or response to the repressor appear to be highly
developmentally restricted, arguing in favour of its importance.
In future studies it will be important to carry out heterochronic co-cultures to clarify
to what extent the synthesis/release of the putative repressor and the response of the
neurons to it are developmentally restricted. It will also be interesting to assess
whether the expression of trkA in vitro continues to follow that observed in vivo at
later stages in development. This will be particularly interesting since it could
potentially demonstrate that trkA is intrinsically downregulated as part of
developmental cell death. Secondly, the expression of other neurotrophin receptors
will also need to be assessed, to see whether these are tightly controlled by intrinsic
mechanisms as well. Thirdly, it will be useful to identify the inhibitory substance
released from the target fields in vitro, using the homogenate as a starting point.
Once the substance is identified, it should be possible to assess its significance in
vivo. Hopefully further study of both these observations will lead to an explanation
for the different effects observed in this study.
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Figure 3.16: Potential function of trkA downregulation by the target field




Premature death I I NGF
Reduced competition i ngf Optimal competition ngf
Figure illustrating the potential benefit of trkA downregulation during the phase of target innervation,
before competition for limited amounts of NGF. assuming that trkA expression confers dependence
on NGF for survival. (A) shows the possible situation in the absence of a repressor of trkA expression.
(1) Axons approach their target Held. (2) As axons reach the target field, neurons increase trkA
expression, while the target field begins expressing NGF. (3) As NGF expression is restricted because
of its role as a survival factor in limited supply during developmental cell death (PCD), increasing
trkA expression in neurons prior to PCD may result in excessive numbers of neurons being trkA-
dependent. If too many neurons are dependent on trkA-signalling for their survival prior to PCD
(while axons are still extending to the target fields), neurons that do not receive sufficient NGF will
die at this stage. (4) This results in reduced competition of neurons for survival factors from the target
field during PCD, with some inappropriately connected neurons surviving due to them reaching the
target field at a later stage and not having to compete with more appropriately connected neurons. (B)
shows the benefits of a substance (x, red arrow) that reduces any excessive upregulation of trkA. (1)
Axons approach their target field. (2) As axons reach the target field, increases in trkA expression are
inhibited by a substance that effects a reduced magnitude of IrkA increase. (3) Restricted NGF
expression does not kill neurons prior to PCD. as less neurons express trkA (less neurons are
dependent on NGF for their survival at this stage). (4) This results in maximizing competition for
NGF between all neurons and enabling the selection of the most appropriately connected neurons.
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Chapter IV
Influence of early sensory
innervation on
neurotrophin expression
in the target field
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4.1 Introduction
Neuronal numbers in the developing peripheral nervous system are regulated by
extrinsic growth and differentiation factors. One such factor is nerve growth factor
(NGF). During embryonic development, most cutaneous sensory neurons depend for
their survival on a supply of NGF synthesised in their peripheral targets. NGF
promotes survival by binding to the trkA receptor tyrosine kinase, whose signalling
is modulated by the common neurotrophin receptor p75. In the trigeminal system
trkA is expressed by sensory neurons shortly after axons reach their targets (Wyatt
et al, 1993) and NGF expression begins in the target area with the arrival of the
earliest axons (Davies et al., 1987).
The synthesis of NGF in target fields has been found to coincide with the
commencement of innervation by NGF-dependent neurons (Davies et al., 1987), as
determined in the maxillary target field, a target of sensory neurons from the
trigeminal ganglion. The final innervation density of the target fields of NGF-
dependent neurons is proportional to the amount of NGF synthesised in them.
Cutaneous targets requiring high innervation density have higher levels of NGF
mRNA than targets with lower innervation density (Harper and Davies, 1990).
Classic studies clearly demonstrated a role for the target in governing the number of
neurons supplying it. Complete or partial removal of target fields correlates with a
reduction in the survival of innervating neurons during the period of naturally
occurring cell death in development, most likely due to a reduced production of a
trophic factor, such as NGF, normally synthesized by the target field (Oppenheim,
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1981; 1985; Hamburger and Oppenheim, 1982). Increases in target field availability
during development result in an increase in the number of neurons surviving the
period of naturally occurring cell death, most likely due to increased availability of
trophic factors (Oppenheim, 1981; 1985; Betz, 1987; Lamb, 1984).
However, the relationship between the amount of target field removed / added, and
the number of neurons innervating it undergoing increased / decreased cell death has
often been found to be non-linear. Increasing the target availability by doubling its
size for example might be expected to result in virtually no cell death in neuronal
populations that normally lose half their numbers during the period of naturally
occurring cell death (Oppenheim, 1991). This situation, however, has never been
found, only partial rescue of neuronal numbers with doubled target availability has
been found (Oppenheim, 1981; 1985; Lamb, 1984; Sperry and Grobstein, 1985;
Tanaka and Landmesser, 1986; Sohal et al., 1986). Likewise the reduction in neuron
number following partial target field ablation is not linearly related to the target field
size (Lamb, 1980; Tanaka and Landmesser, 1986; Farel, 1989).
One striking example of such an occurrence comes from experiments carried out in
the hind-limb bud of the frog. Bilateral innervation of a single limb bud, by
amputating the other limb and disrupting the barriers between the two sides, resulted
in motor projections from both sides into the single limb bud. The number of motor
neurons surviving after metamorphosis were normal on both sides, as long as the
operation had been carried out prior to innervation (Lamb, 1980; 1981). This implied
that a single limb bud was able to support twice the normal number of neurons after
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the period of naturally occurring cell death. If there was competition for limited
amounts of factor between the innervating populations of motoneurons, one would
have expected less neurons to survive on each side in bilaterally innervated animals
compared to unilaterally innervated animals. In contrast, sensory neurons innervating
the single limb bud were found to behave in a fashion consistent with the
neurotrophic hypothesis. That is, the number of neurons innervating the hind-limb
bud after innervation and programmed cell death on both sides added up to the
neuronal numbers usually observed on one side (Lamb et al., 1989). This suggests
that neurons had died proportionally to a signal of predetermined strength from the
target field. These findings illustrate how different population of neurons, even
within the same species of animal, may behave differently.
The results of studies demonstrating non-linear relationships between target and cell
death led Purves (1980) to speculate that increased quantity of initial innervation (in
the case of a bilaterally innervated limb bud as an example) may alter the target field,
allowing it to support an extra complement of neurons The extent to which neurons
may be able to do so could vary between different neuronal populations, as appears
to be the case for motoneurons and sensory neurons observed in the experimental
model mentioned above.
In respect of the observations mentioned above, it is interesting that a study
analysing NGF mRNA synthesis in the whisker pad (maxillary target field) found
NGF mRNA synthesis increased rapidly in maxillary explants cultured from El 1.5
onwards, whereas in E10/E10.5 explants very little increase in NGF mRNA synthesis
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was observed (Rohrer et al., 1993). NGF expression in the maxillary target field
begins with the arrival of the first axons at -E10.5/E11 (Davies et al., 1987), i.e. at
the point between these two very distinct observations. Thus, it is possible that initial
innervation may play a role in either initiating or up-regulating expression ofNGF.
The aim of the study presented in this section was to assess the possibility that the
initial innervation density may influence the number of neurons the target field can
support by regulating the level of trophic factor synthesis. The maxillary target field
of the trigeminal ganglion leads itself particularly well to this type of study, due to its
high density of innervation and high levels of neurotrophic factor (Davies et al.,
1987; Harper and Davies, 1990). The time course of innervation is well established,
and developmental changes in the levels of neurotrophic factor mRNA and protein
have been studied intensively (Buchman and Davies, 1993). Prior to innervation,
trigeminal ganglion sensory neurons require BDNF and NT-3, whereas shortly after
innervation they become dependent on NGF for survival (Buchman and Davies,
1993). BDNF and NT-3 mRNA are expressed in the maxillary target field prior to
the arrival of the first axons, with their levels peaking at El2 and El3, respectively
(relative to actin mRNA). NGF mRNA is first detected at El0.5, reaching peak
expression at E13 and NGF protein is also first detected at Ell and peaks at E13
(Davies et al., 1987).
To investigate if the trigeminal ganglion influences the expression of NGF, BDNF
and NT-3 in the maxillary target field, the target field was cultured with and without
trigeminal ganglia at different stages of development. NGF mRNA levels in very
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young target field explants increased to higher levels when grown with the ganglion
compared with target field explants grown alone, raising the possibility that early
target innervation influences NGF expression. No significant differences were
observed in BDNF and NT-3 expression. The effects of neuronal numbers in the
trigeminal ganglion were further investigated by measuring the level ofNGF mRNA
in ErbB3-/- mice, which display a large, early decrease in the number of trigeminal
neurons. Consistent with this possibility, the level ofNGF mRNA was significantly
lower in the early target fields of these embryos compared with wild type. However,
the levels of NGF mRNA were not significantly higher in the target fields of
embryos in which the later period of naturally occurring neuronal death is reduced
(Bax-/- and Bad-/- embryos) compared with wild type embryos, or in which a loss of
neurons occurred during later stages of innervation (trkA-/-, trkB-/-, p75-/-). This
suggests that very early changes in target field innervation may be able to modulate
the expression ofNGF in the maxillary target field, possibly to adjust intrinsic NGF
levels to the timing of innervation or the initial number of neurons reaching the target
fields. Later innervation has no such effect. This possible interaction between the
initial neuronal innervation and the target field is represented in Figure 4.1.






Block diagram illustrating the potential modulation ofNGF expression in the maxillary target field of
trigeminal neurons by early innervation. Early innervating axons (1) modulate intrinsic NGF levels (2)
to adjust the supply to the timing/number of later innervating neurons (3).
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4.2 Results
The methods for dissection and culture of trigeminal ganglia and the maxillary target
field, and determination of neurotrophin expression by competitive RT-PCR are
described in chapter 2.
4.2.1 Expression of NGF mRNA in the maxillary target field in vivo
To ascertain the developmental increase in NGF mRNA in the maxillary target field
of mice in relation to innervation in vivo, maxillary target fields and the whisker
processes to which they give rise were collected and NGF mRNA was assessed using
RT-PCR at stages from E10.5 to El 5. Examples of these gels are shown in Figure
4.2. The expression of NGF mRNA relative to GAPDH mRNA is shown in Figure
4.3. NGF mRNA was detected at E10.5 at low levels and increased significantly
(relative to GAPDH mRNA) by Ell (t-test; p<0.001). This was followed by further
significant increases in NGF mRNA between Ell and E12 (t-test; p<lE-22), E12
and E13 (t-test; p<5E-08), and E13 and E14 (t-test; p<0.05). There was a significant
decrease in NGF mRNA levels between E14 and El6 (t-test; p<5E-13). The
developmental change in NGF mRNA expression observed in this study confirms
previous observations (Davies et al., 1987; Buchman and Davies, 1994), with a
marked increase in NGF mRNA between El0.5 and El2, coinciding with the arrival
of the first axons (Davies and Lumsden, 1984; Buchman and Davies, 1993). This
demonstrates that the competitive RT-PCR method used here was able to replicate
results previously obtained using northern blotting, enabling the use of this more
sensitive technique for the remaining experiments in this section.
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Figure 4.2: Examples of gels showing the relative NGF expression in the










SYBR®Gold (Molecular Probes) stained gels showing the products of RT-PCR reactions amplified
with either GAPDH-specific or NGF-specific primers. (A) Reactions containing 625fg of the GAPDH
competitor RNA (132bp) and 1.6fg of the NGF competitor (103bp) plus total RNA from E10
maxillary processes (GAPDH: 128bp; NGF: 99bp). (B) Reactions containing 1.5pg of the GAPDH
competitor RNA (132bp) and 6.5fg of the NGF competitor (103bp) plus total RNA from Ell
maxillary processes (GAPDH: 128bp; NGF: 99bp). (C) Reactions containing 1.5pg of the GAPDH
competitor RNA (132bp) and 15fg of the NGF competitor (103bp) plus total RNA from E12
maxillary processes (GAPDH: 128bp; NGF: 99bp). (D) Reactions containing 20pg of the GAPDH
competitor RNA (132bp) and 250fg of the NGF competitor (103bp) plus total RNA from E13
maxillary processes (GAPDH: 128bp; NGF: 99bp). (E) Reactions containing 30pg of the GAPDH
competitor RNA (132bp) and 400fg of the NGF competitor (103bp) plus total RNA from El4
maxillary processes (GAPDH: 128bp; NGF: 99bp). (F) Reactions containing 25pg of the GAPDH
competitor RNA (132bp) and 250fg of the NGF competitor (103bp) plus total RNA from E16
maxillary processes (GAPDH: 128bp; NGF: 99bp).
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Figure 4.3: Relative in vivo levels of NGF mRNA in the maxillary target field























E10.5 E11 E12 E13 E14
Developmental age (days)
E16
Mean levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of CD 1 mouse
embryos. A rapid increase in NGF expression between El0.5 and El3 is clearly visible, as is the
decrease in NGF expression between E14 and E16. Bars represent the mean ± standard error (n=16-69
for each data point).
4.2.2 Expression of NGF mRNA in the maxillary target field in vitro
- effects of age and early innervation
Two ages at early stages of development were chosen to assess the effect of
innervation on NGF expression in vitro: E10.5 and El 1. Very few sensory axons are
present in the maxillary target field at El0.5 and none have yet contacted the
maxillary epithelium where the highest levels of NGF mRNA are expressed later in
development. By Ell, the earliest axons make contact with the maxillary epithelium
(Davies and Lumsden, 1984). Maxillary target fields of these two ages were grown
either alone, or with the trigeminal ganglion and its neuronal connections to the
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maxillary target field intact. These explants were grown for 48 hours, (equivalent to
E12.5 in vivo for E10.5 maxillary target field, and E13 for Ell maxillary target
field), thus covering the main period of the increase in the level of NGF mRNA in
vivo and the marked increase in innervation density. Figure 4.4 illustrates NGF
mRNA expression relative to GAPDH mRNA in the Ell maxillary target field of
mouse embryos prior to culture (MX-0) and after 48 hours in culture with and
without the trigeminal ganglion (MX and MXTG respectively), with an ANOVA
indicating significant differences (p<0.0001). The level of NGF mRNA in the Ell
maxillary target field grown alone (MX) increased more than two-fold over the 48 hr
culture period (Fisher's LSD; p<0.0001). The level of NGF mRNA in the maxillary
target fields grown with the trigeminal ganglion attached was significantly higher
than in processes grown alone (14% higher, Fisher's LSD; p<0.05). This suggests





















Relative levels of NGF mRNA in the Ell maxillary target field
after 48 hrs in culture
MX-0 MX MXTG
Mean levels of NGF mRNA relative to GAPDH mRNA in maxillary target fields at El 1 (MX-0), after
48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n=12-16 for each
data point).
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Figure 4.5 illustrates the level of NGF mRNA relative to GAPDH mRNA in the
El 0.5 maxillary target field of mouse embryos prior to culture (MX-0) and after 48
hours in culture with (MXTG) or without (MX) attached trigeminal ganglia, with an
ANOVA indicating significant differences (pO.OOOl). The level of NGF mRNA in
maxillary target fields grown alone increased by over three-fold compared to its level
in freshly collected tissue (Fisher's LSD; pO.OOOl). The level ofNGF expression in
maxillary target fields grown with the trigeminal ganglion attached was greatly
increased compared to the level in explants grown without the ganglion (52%
increase, Fisher's LSD; p<0.0005). This not only suggests that innervation of the
target field is able to modulate the synthesis of NGF, but together with the data in
Figure 4.4 it suggests that early target innervation has more influence on NGF

























Relative levels of NGF mRNA in the E10.5 maxillary target field
after 48 hrs in culture
MX-0 MX MXTG
Mean levels of NGF mRNA relative to GAPDH mRNA in maxillary target fields at E10.5 (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n=8-12 per data
point).
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To compare NGF mRNA levels in cultured E10.5 and Ell maxillary target fields at
the equivalent in vivo stage, El0.5 maxillary target fields were grown for 60 hours
(equivalent to El3 in vivo and El 1 explants grown for 48 hrs). The results obtained
from these cultures are shown in Figure 4.6, with an ANOVA indicating significant
differences (p<0.0001). Although the increase in NGF mRNA expression in El0.5
explants after 60 hours in culture was slightly less than the increase observed in
El0.5 cultures after 48 hours, the difference in NGF mRNA expression in El0.5
explants grown with and without attached trigeminal ganglia was still highly
significant and relatively greater than in Ell cultures after 48 hrs (37% increase,
Fisher's LSD; p<0.005). To ascertain whether the increase in NGF mRNA in
maxillary target field co-cultured with trigeminal ganglia was due to innervation,
El0.5 maxillary target fields were grown with 6 unattached trigeminal ganglia
surrounding each process (MX6TG). As shown in Figure 4.6, no significant
difference in NGF mRNA level was observed in these co-cultures compared with
maxillary target fields grown alone (Fisher's LSD; p>0.05). This would strengthen
the assumption that the initial innervation influences the levels ofNGF mRNA rather
than some diffusible substance from the ganglion.
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Figure 4.6 Relative levels of NGF mRNA in the E10.5 maxillary target field




























MX-0 MX MXTG MX6TG
Mean levels of NGF mRNA relative to GAPDH mRNA in maxillary target fields at E10.5 (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n=8-12 per data
point).
Since target field innervation appeared to have an effect on NGF expression, the
relative levels of BDNF and NT-3 mRNA were also assessed in the same samples
used for NGF mRNA analysis.
Figure 4.7 shows the level of BDNF mRNA relative to GAPDH mRNA in the Ell
maxillary target fields of mouse embryos immediately after dissection and after 48
hours in culture with and without attached trigeminal ganglia), with an ANOVA
indicating significant differences (p<0.001). Although the level of BDNF mRNA in
the Ell maxillary target field grown by itself (MX) increased over the 48 hour
culture period compared to the level at the time the tissue was harvested (MX-0,
Fisher's LSD; p<0.0005), this increase was not as substantial as that observed for
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NGF mRNA (<50% compared to >200% for NGF mRNA). Furthermore, the level of
BDNF mRNA in the maxillary target field grown with the trigeminal ganglion
attached (MXTG) was not significantly different to the level in explants grown
without the ganglion (Fisher's LSD; p>0.05).
Figure 4.8 shows the level of BDNF mRNA relative to GAPDH mRNA in the E10.5
maxillary target field ofmouse embryos before and after 48 hours in culture with and
without attached trigeminal ganglia (ANOVA; p<0.0001). Although the level of
BDNF mRNA in the El0.5 maxillary target field grown by itself (MX) increased
over the 48 hour culture period compared to the level at the time the tissue was
harvested (Fisher's LSD; p<0.0001), just as with El 1 target fields, the presence of
the trigeminal ganglion did not significantly alter the level of BDNF mRNA
(Fisher's LSD; p>0.05). This suggests that early innervation of the maxillary target
field has no effect on BDNF expression in vitro, suggesting that BDNF expression is
either regulated by other factors, or is intrinsically regulated in the target field.
Figure 4.9 shows the level of NT-3 mRNA relative to GAPDFI mRNA in the Ell
maxillary target field ofmouse embryos before and after 48 hours in culture with and
without attached trigeminal ganglia (ANOVA; p<0.0001). Like NGF mRNA and
BDNF mRNA, the level ofNT-3 mRNA increased in the maxillary target field over
this culture period (Fisher's LSD; pO.OOOl). The relative levels of NT-3 mRNA in
maxillary target fields grown with and without attached trigeminal ganglia were not
significantly different (Fisher's LSD; p>0.05).
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Figure 4.7: Relative levels of BDNF mRNA in the Ell maxillary target field



























Mean levels of BDNF mRNA relative to GAPDH mRNA in maxillary target fields at Ell (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n= 11-16 per data
point).
Figure 4.8: Relative levels of BDNF mRNA in the El0.5 maxillary target field




























Mean levels of NGF mRNA relative to GAPDH mRNA in maxillary target fields at E10.5 (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the



























Relative levels of NT-3 mRNA in the Ell maxillary target field
after 48 hrs in culture
MX-0 MX MXTG
Mean levels of NT-3 mRNA relative to GAPDH mRNA in maxillary target fields at Ell (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n=12-16 per data
point).
Figure 4.10 shows the level of NT-3 mRNA expression relative to GAPDFl mRNA
in the El 0.5 maxillary target field ofmouse embryos after 48 hours in culture with or
without the attached trigeminal ganglia (ANOVA; p<0.0001). Like NGF mRNA and
BDNF mRNA, the level of NT-3 mRNA increased in the maxillary target field over
this culture period (Fisher's LSD; p<0.0001), and just as with Ell maxillary target
fields, the presence of the trigeminal ganglion did not significantly alter the relative
expression ofNT-3 (Lisher's LSD; p>0.05). This suggests that, like for BDNF, early
innervation of the maxillary target field has no effect on NT-3 expression in vitro.
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Figure 4.10: Relative levels of NT-3 mRNA in the El0.5 maxillary target field
after 48 hrs in culture
MXTG
Mean levels of NT-3 mRNA relative to GAPDH mRNA in maxillary target fields at E10.5 (MX-0),
after 48 hrs in culture without the trigeminal ganglion attached (MX), or after 48hrs in culture with the
trigeminal ganglion attached (MXTG). Bars represent the mean ± standard error (n=8-12 per data
point).
The above results suggest that early innervation of the maxillary target field in vitro
selectively modulates the expression of NGF but not other neurotrophins.
Furthermore, the lack of effect of the trigeminal ganglion on the expression of BDNF
and NT-3 mRNAs argues against the effect on NGF mRNA expression being caused
by some kind of survival effect of the trigeminal ganglion on neurotrophin secreting
cells in the maxillary target field, since this would be expected to affect the level of
all neurotrophins.
In vitro studies provide only limited insight into the events occurring in vivo. The
elevated level of NGF mRNA in El 0.5 and Ell maxillary target fields co-cultured

























in vivo. Indeed, in the co-culture models used in this study, the level of NGF
expression does not increase to exactly the same levels seen at an equivalent stage in
vivo. In Ell (figure 4.4), the levels of NGF mRNA in maxillary target fields co-
cultured for 48 hours with the attached trigeminal ganglia rose above in vivo E13
levels (figure 4.3), whereas in El0.5 co-cultures grown for 60 hours (figure 4.5) it
rose to levels almost exactly matching El3 in vivo levels (figure 4.3). This could be
due to a variety of factors, such as slight variation in the ages the maxillary target
fields were collected, or differences in the way explants of the two ages studied
develop in culture. It is impossible to collect embryos at 'exact' stages, due to the
difficulty in determining the exact time of mating. Only approximations based on the
plug date and the visual developmental stage of the embryos can be made. Another
potential complication of co-cultures is the elimination of adjoining tissues from the
experimental system, which, in vivo, may have multiple effects on the development
of the trigeminal ganglion and its target field.
To assess whether there is an effect of innervation on NGF mRNA expression in
vivo, knockout mice with either elevated or reduced neuronal numbers during
development were used. This study was restricted to NGF mRNA, since it was the
expression of this neurotrophin that was apparently affected by early innervation in
vitro.
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4.2.3 Expression of NGF mRNA in the maxillary target field of
knockout mice with increased neuronal numbers in the
trigeminal ganglion during development
NGF mRNA was assessed using competitive RT-PCR in two mutants with increased
neuronal numbers during embryonic development, bax-l- and bad-l- mice, to
ascertain whether this would result in increased levels ofNGF mRNA in the target
field.
Ablation of the bax gene of the mouse (Knudson et ah, 1995) results in reduced death
of neurons in the trigeminal ganglion (Middleton and Davies, 2001). NGF expression
in the maxillary target field of wildtype and bax null mutant mice was assessed at
E12, E14 and E16. The results are shown in Figure 4.11.
Figure 4.11: Relative levels of NGF mRNA in the maxillary target field of
































Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype mice (WT-blue) and bax-l- mice (KO-red) at E12, E14 and E16. Bars represent the mean ±
standard error (n=7-29 per data point).
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A slight increase in NGF expression in the maxillary target field of the Bax null
mutants compared to their wildtype littermates was observed at El2, although this
was statistically insignificant (t-test; p>0.05). No differences in NGF mRNA were
observed at the other ages examined.
Ablation of the bad gene of the mouse (provided by Stanley Korsmeyer,
unpublished) has similarly been found to result in increased neuronal numbers in the
trigeminal ganglion (Victoria Barker and Gayle Middleton, personal communication
- not verified). NGF expression in the maxillary target field of wildtype and bad null
mutant mice was assessed at the ages of El2, El4 and El6. The results can be
observed in Figure 4.12.
Figure 4.12: Relative levels of NGF mRNA in the maxillary target field of







Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype mice (WT-blue) and bad-l- mice (KO-red) at E12, E14 and E16. Bars represent the mean ±
standard error (n=12-30 per data point).
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A slight increase in NGF expression in the maxillary target field of the bad null
mutants compared to their wildtype littermates was observed at El4, although this
was statistically insignificant (t-test; p>0.05). No differences in NGF mRNA were
observed at the other ages examined.
Finally, an attempt was made to collect bad/box double mutant mice. This was
hampered by the very low occurrence of double mutant mice, and especially the very
low occurrence of wildtype and double mutants in the same litters, making a precise
comparison difficult. The data for these double mutants can be seen in Figure 4.13,
showing no significant differences in the levels ofNGF mRNA.
Figure 4.13; Relative levels of NGF mRNA in the maxillary target field of






Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype mice (WT-blue) and bad-/-; box-/- mice (KO-red) at El2, El4 and El6. Bars represent the
mean ± standard error (n=2-30 per data point).
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The results using null mutant mice with higher neuronal complements in the
trigeminal ganglion did not appear to have any significant effect on NGF expression
in the maxillary target field, in vivo. This may suggest that the observations in vitro
do not replicate events in vivo. However, it appears that neuronal numbers in both
the bax and the bad null mutants are not actually higher than in wildtype embryos
until E14 at the earliest (Victoria Barker and Gayle Middleton, personal
communication). The differences in NGF mRNA expression detected in vitro were
most significant in much earlier co-cultures. Thus, if neuronal numbers in the
trigeminal ganglion of bax and bad null mutants are only increased in the later stages
of naturally occurring cell death, one would not expect these null mutants to display
significantly different levels ofNGF mRNA.
4.2.4 Expression of NGF mRNA in the maxillary target field of
knockout mice with reduced neuronal numbers in the
trigeminal ganglion during development
NGF mRNA was assessed using competitive RT-PCR in four mutants with reduced
neuronal numbers at different stages of embryonic development, to ascertain whether
this would result in decreased levels ofNGF mRNA in the target field.
Ablation of the trkA gene in the mouse (Smeyne et al., 1994) causes increased
neuronal death and decreased neuronal numbers in the developing trigeminal
ganglion after the age of E13 (Pinon et al., 1996; chapter 5). NGF expression in the
maxillary target field of wildtype and trkA null mutant mice was assessed at the ages
of E12, E14 and E16. The results are shown in Figure 4.14. These results showed
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that the reduction in neuronal numbers in the trigeminal ganglia of trkA null mutants,
occurring during the later stages of target field innervation, had no effect on NGF
mRNA levels in the maxillary target field. No significant differences were observed
at any of the ages studied.
Figure 4.14: Relative levels of NGF mRNA in the maxillary target field of






























Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype mice (WT-blue) and trkA-/- mice (KO-red) at E12, El4 and E16. Bars represent the mean ±
standard error (n=9-16 per data point).
Like the study on trkA null mutants, embryos with a mutation in p75 (Lee et al.,
1992), which results in lower neuronal numbers in the trigeminal ganglion during the
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latter stages of embryonic development (chapter 5), where found to have normal
levels ofNGF mRNA expression at E14 (t-test; p>0.05) (Figure 4.15).
Figure 4.15: Relative levels of NGF mRNA in the E14 maxillary target field of
wildtype and p75 null mutants
16
Mean relative levels ofNGF mRNA relative to GAPDH mRNA in the E14 maxillary target field of
wildtype mice (WT-blue) and p75-/- mice (KO-red). Bars represent the mean ± standard error (n=3-6
per data point).
Ablation of the trkB gene in the mouse (Smeyne et al., 1994) causes increased
neuronal death in the developing trigeminal ganglion at the age ofEll (Pinon et al.,
1996). Prior to this stage, neurons appear to survive independently of trkB signalling
(Buchman and Davies, 1993). The trkB null mutant thus looses neurons during the
main period of target field innervation. NGF mRNA expression in the maxillary
target field ofwildtype and trkB null mutant mice was assessed at El 2, El 4 and El 6.
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Figure 4.16 shows that there were no significant differences in NGF expression
between trkB null mutants and wildtype embryos at El2 and E14 (t-test; p>0.05).
Paradoxically, a difference in NGF mRNA levels emerged at El6, with the trkB null
mutants displaying a significant 20% decrease in NGF mRNA levels in the maxillary
target field compared to wildtype embryos (t-test; p<0.001). This effect is unlikely to
be related to initial innervation density, since NGF expression at previous ages
appeared normal. This may identify a novel function of trkB in regulating NGF
expression in the maxillary territory later in development during the period of
naturally occurring cell death. The lack of effect of the trkB mutation on NGF
mRNA expression in the early maxillary target field, suggests that the loss of
neurons during the earliest stages of innervation by the trigeminal ganglion neurons
does not affect NGF expression. This does not necessarily conflict with the idea that
early innervation can modulate NGF expression for at least two reasons: First, some
neurons reach the trigeminal ganglion prior to this stage (Stainier and Gilbert, 1991).
Second, the magnitude of neuron loss at El 1 in trkB-/- mice may be insufficient to
have a significant effect on NGF mRNA expression. Although the number of dying
cells in the trigeminal ganglion of trkB-/- embryos increases three-fold compared
with wildtype, the number of surviving neurons at this stage is not known, and by
El3 when total neuron counts were made there was only a 40% reduction (Pinon et
al„ 1996).
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Figure 4.16: Relative levels of NGF mRNA in the maxillary target field of











Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype mice (WT-blue) and trkB-/- mice (KO-red) at E12, E14 and E16. Bars represent the mean ±
standard error (n=7-17 per data point).
Ablation of the erbB3 gene in the mouse (Riethmacher et al., 1997) causes deficits in
migration and differentiation of cranial neural crest cells, resulting in a very
substantial reduction in neuronal numbers in the trigeminal ganglion from the earliest
stages of neurogenesis. As reported in chapter 6, the neuronal complement of the
trigeminal ganglion of erbB3-/~ is reduced by 60% at El 1 and by over 90% at El3.
NGF expression in the maxillary target field of wildtype and ErbB3 null mutant mice
was assessed at Ell, El2 and El3. Assessments could not be made later in
development, because very few erbB3-/- embryos survive.
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Figure 4.17 shows that although no decrease in NGF expression was observed in
erbB3-/- mice at Ell, NGF mRNA levels were significantly lower (18%) at El2 (t-
test; p<0.05). No difference would necessarily be expected at Ell, due to the low
levels of NGF mRNA at this stage preceding the major increase in NGF expression
seen between Ell and E13. A small decrease (10%) in NGF mRNA was also
observed in erbB3-/- mice at El3 as well, although this was not statistically
significant (t-test; p>0.05). This study suggests that changes in early innervation of
the target field may, to some extent, modulate NGF mRNA expression in vivo,
although the lower insignificant decrease in NGF mRNA by E13 may suggest that


























Relative levels of NGF mRNA in the maxillary target field of









Mean relative levels of NGF mRNA relative to GAPDH mRNA in the maxillary target field of
wildtype (WT-blue) and ErbB3-l- mice (KO-red) at Ell, E14 and El6. Bars represent the mean ±
standard error (n=T2-22 per data point).
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4.3 Discussion
In vitro studies using E10.5 or El 1 maxillary target fields, cultured either together or
without the trigeminal ganglion neurons innervating them, revealed that early target
field innervation can positively influence NGF mRNA expression in vitro. This
effect was greater in earlier (El0.5) explants than in later (El 1) explants, suggesting
that initial early innervation is potentially more effective at inducing this change than
later innervation.
The concept that innervating axons can control NGF expression is not new, with
several in vivo studies suggesting such an effect in adult animals. In the adult rat,
denervation of sympathetic fibres projecting to vascular tissue results in decreased
levels ofNGF in these targets four days after the operation (Liu et al., 1996). Further,
experiments in the adult rat demonstrate that the proximity of some sympathetic and
parasympathetic neurons (closely juxtaposed within a common Schwann cell sheath)
maintains NGF expression in the latter, thus promoting sympathetic neuron survival
through prejunctional interactions. This was demonstrated by removal of the superior
cervical ganglion, which results in reduced levels of NGF expression in the
pterygopalatine cranial parasympathetic ganglion in vivo (Hasan and Smith, 2000).
These experiments in adult animals are the more significant for demonstrating such
interactions in vivo. The explant experiments described in this chapter are the first to
demonstrate such modulation of NGF expression by innervating neurons during
embryonic development and initial innervation.
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The findings of a descriptive study in the mouse trigeminal system are consistent
with the notion that initial innervation might influence NGF expression. The main
peripheral cutaneous target territories of the trigeminal ganglion (maxillary,
mandibular and opthalmic territories) were found to synthesize NGF in proportion to
the final innervation density they receive from neurons in the trigeminal ganglion
(Harper and Davies, 1990). The relative proportions of neurons in the ganglion
innervating the maxillary, mandibular and opthalmic territories are the same
preceding and following the period of embryonic cell death (Davies and Lumsden,
1984). That is, the proportion of neurons lost among those subsets of neurons that
innervate each territory is the same (-50%). This indicates that some sorting of
neuronal innervation in relation to final innervation density of the target field occurs
prior to neurons reaching their target fields, and that regional differences in NGF
synthesis are not responsible for sculpting out these differences. This is consistent
with the idea that the required level ofNGF synthesis in each territory is regulated by
the number of arriving axons (Davies et al., 1987). The in vitro observations in this
section would support such a mechanism, suggesting that the initial number of axons
contacting the target field may influence the level ofNGF synthesis to some extent.
Many of the results in vivo can be explained by the timing of neuronal death or
improved survival in the null mutants employed. In Bax, Bad, trkA and p75 null
mutants, changes in neuronal numbers do not occur until FI3/F14, which is well
beyond the early period of innervation of the maxillary process by trigeminal sensory
neurons. The results obtained for trkB-l- embryos do not necessarily conflict with the
idea that early innervation can modulate NGF expression, due to some neurons
242
reaching the trigeminal ganglion prior to this stage (Stainier and Gilbert, 1991), and
the magnitude of neuron loss at El 1 being insufficient to have a significant effect on
NGF mRNA expression (Pinon et al., 1996).
ErbB3-/- embryos have a very early loss/absence of neural crest-derived neurons.
They lack two-thirds of the normal neuronal complement in the trigeminal ganglion
at Ell. The other knockout displaying early neuronal loss, the trkB knockout,
displays a 40% loss of neurons in the ganglion by El2. However, neuronal numbers
in the trigeminal ganglion at El 1 are unknown.
Some effects of neuronal numbers in the trigeminal ganglion on NGF mRNA in the
maxillary process were observed in ErbB3-/- embryos, but they were not maintained
by El3. Although neuronal numbers are greatly reduced in the trigeminal ganglion of
ErbB3-/- mice, the outgrowth towards the maxillary process initially appears to be
normal (see chapter 6), suggesting that initial innervation of the maxillary process is
less affected by the large loss of neurons in this ganglion. This could explain the
relatively small differences in NGF mRNA levels observed. Additionally, pioneer
axons were proposed to be placode-derived (Stainier and Gilbert, 1991), a neuronal
population in the trigeminal ganglion less affected in the ErbB3 null mutant (chapter
6). Together, the in vitro and in vivo data appear to suggest some effect of neuronal
innervation on NGF expression in the maxillary target field.
There is evidence, however, that this may not be the case in all tissues. Rohrer and
colleagues demonstrated that levels of NGF mRNA of intact chick leg skin and leg
skin denervated prior to the arrival of the earliest axons were identical, which would
suggest that NGF synthesis in the skin of chick embryos is independent of its
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innervation (1988). Similar studies have suggested that innervating sympathetic
neurons do not influence NGF mRNA production in the heart, even though the onset
ofNGF expression in this target coincides with innervation (Clegg et al., 1989). The
aforementioned study on sensory neurons in the frog limb would also argue against
such a mechanism, since the number of neurons innervating the hind-limb bud after
bilateral innervation and programmed cell death on both sides added up to the
neuronal numbers usually observed on one side (Lamb et al., 1989). This has led to
the assumption that NGF synthesis is not dependent on nerve-target contact but
appears to occur as part of an intrinsic developmental program in the target field
(Davies, 1990). The above-presented findings in vitro do not contradict that increases
in NGF mRNA levels are intrinsically regulated. The substantial increases in NGF
expression observed in the E10.5 and El 1 maxillary processes grown alone suggest
that NGF expression may indeed be significantly controlled by intrinsic mechanisms.
A factor to consider, however, is the difference in the sensitivity of the methods
employed. Competitive RT-PCR is likely to detect more subtle differences in NGF
mRNA than the northern blotting technique used in previous experiments. If one tries
to integrate the in vitro results in this section with previous literature suggesting that
NGF expression is regulated by intrinsic mechanisms, it could be hypothesized that,
at least for the maxillary process and its innervating axons: 1. Expression ofNGF in
the target field develops as part of an intrinsic developmental program in the target
field. 2. Initial regional differences in innervation density are intrinsically regulated.
3. This intrinsic developmental program ofNGF expression in the target field may be
modulated by the innervating axons, to account for developmental differences in the
number of innervating axons or the timing of arrival of the innervating axons. Thus
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initial innervation may not be involved in directly controlling whether the target field
synthesises NGF or not, but it may be able to modulate the onset/rate of increase in
NGF expression, depending on the timing of innervation and/or the numbers of
innervating neurons.
Thus, early innervation could modulate the levels ofNGF mRNA, ensuring adequate
supply ofNGF as the innervating axons arrive in greater numbers at the target field,
which normally would be about Ell. This might create a safety net for axonal
processes arriving within a time-window where NGF can be modulated by the first
arriving axons and for neurons arriving in slightly higher numbers than intrinsically
'set' in the target field. If NGF expression was strictly intrinsically set, small
differences in the onset of innervation could produce dramatic differences in the
numbers of neurons surviving the periods of neurogenesis before E13. If one
imagines innervation occurring slightly early or at slightly increased numbers, before
the intrinsically regulated increase in NGF expression, this could potentially cause a
significant proportion of neurons to die due to the levels ofNGF not being adequate
as these carly-comers arrive.
'Fine-tuning' interactions between the innervating axons and their target field(s)
have previously been suggested in some placode-derived sensory neurons, which
undergo an intrinsically regulated period of trophic factor independence (Vogel and
Davies, 1991). Nodose neurons, for example, survive independently of trophic
factors for intrinsically pre-determined periods in vitro, correlating with the distance
their axons grow to their target fields before becoming dependent on the survival
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factor released from their target fields in vivo (BDNF). The onset of responsiveness
of early nodose neurons to BDNF, however, can be accelerated by transiently
exposing them to BDNF within 24 hrs of the time they normally start responding to
BDNF (Vogel and Davies, 1991). This was interpreted as an indication that the
intrinsic programme in early neurons can be fine-tuned, and that the target field
could provide the final adjustment by its provision of the requisite neurotrophin. In
line with the results presented above, it is conceivable that such fine-tuning of
intrinsic mechanisms occurs in the other direction, with the first axons reaching the
target field adjusting the timing/rate of increase of the intrinsic mechanism that
controls NGF synthesis. Axons could regulate the expression of NGF in the target
field to be 'ready' to support the second wave of axons that follow, thus ensuring that
enough NGF is available as neurons arrive at the target fields. Such a mechanism
would allow for slight variations of the time point of arrival of sensory neurons at the
target field, as well as slight variations in number, ensuring that optimal numbers of
neurons are maintained prior to naturally occurring cell death. This hypothesis would
not necessarily imply that higher numbers of neurons would be supported later in
development, it may be that the modulation ofNGF levels achieves an optimal level
of support at the peak of NGF expression at E13/E14, an effect that may not be
maintained when NGF levels decrease later in development.
An interesting observation in this context is that the difference between the El0.5
maxillary target field grown with its innervation intact, or not, was smaller after 60
hrs in culture than after 48 hrs in culture. Also, the effect observed in the ErbB3 null
mutants was larger at El2 than it was at El3. This may suggest that, even though
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initial innervation appears to influence NGF expression in the maxillary process
during the period of NGF mRNA increase, the effect observed may not be
maintained as the levels ofNGF expression approach their peak levels at E13/E14.
The extent to which early arriving neurons may be able to modulate NGF mRNA
expression in vitro will need to be determined using younger ages, which would also
clarify the extent to which induction of NGF expression is intrinsically regulated in
the maxillary process. This is made difficult by the problems encountered when
growing such young ganglia in culture, however (see chapters 2 and 3). Also, it will
be necessary to establish whether such differences are maintained at later stages in
vivo. Finally, additional mouse mutants may become available to confirm and extend
the results of the experiments reported here. It is possible that the differences in NGF
mRNA levels observed in ErbBS-1- embryos may not be primarily due to reductions
in neuronal numbers in the trigeminal ganglia of these embryos but to some unrelated
effect of the mutation. Hence it would be beneficial to study NGF expression in
embryos that display a marked early reduction in trigeminal neurons (such as SoxlO-
/- mice). It may also be beneficial to study the effects of mutations that affect early
innervation in vivo by interfering with the early growth and branching of axons from
the trigeminal ganglion to the maxillary process. Such models include semaphorin
III/D (Kitsukawa et al., 1997; Taniguchi et al., 1997), Neuropilin-2 (Chen et al.,
2000; Giger et ah, 2000), netrin-3 (Loes et ah, 2003), or Brn3a (Eng et ah, 2001)
null mutants, all of which display deficits in sensory axon growth to the maxillary
process.
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If further evidence for modulation of NGF expression by innervation could be
confirmed, the main question would be to identify the mediators of such modulation.
IL-1, EGF, FGF, TGF-a and TGF-pl have all been found to increase NGF mRNA
expression in astrocytes (Spranger et al., 1990; Linholm et ah, 1990; 1992).
Cholecystokinin-8 has recently been found to increase NGF mRNA and protein in
peripheral tissue of adult mice (Manni et ah, 2000). Rohrer and colleagues have also
discovered an activity produced in older maxillary processes (El 1.5) that was able to
increase NGF mRNA levels in younger maxillary processes (E10/E10.5) far more
efficiently than when these were cultured in normal medium (Rohrer et ah, 1993).
Thus it is possible that a developmentally regulated inducer of NGF is produced in
the older maxillary process. This inducer has been suggested to be TGF-p, since it is
present in the maxillary territory at the stage that NGF mRNA expression begins, and
increases in vivo during the early stages of innervation. TGF-P also increases NGF
mRNA levels in early maxillary territory cells in vitro (Buchman et ah, 1994).
During development, TGF-p is produced and released by neurons, an event that was
thus far mainly linked with its function as an inhibitor of Schwann cell proliferation
and myelination (Einheber et ah, 1995). However, in view of the evidence presented
above, it is conceivable that it may be involved in modulating NGF mRNA
expression in the target field as well. Further studies in vitro, using inhibitors to
substances known to increase NGF expression, may provide more insight into the
substances responsible for the effect of early innervation on NGF expression in the
target field.
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Even though I have argued for a modulatory role for early innervation in regulating
NGF mRNA expression, there are other possible explanations for the effects
observed in the maxillary/trigeminal co-culture experiments.
First, it is possible that the increase in mRNA expression in the maxillary process is
not intrinsically regulated, but entirely controlled by the early innervating neurons.
As illustrated in the introduction, different neuronal populations or target fields may
interact in different ways. This would need to be assessed using younger explants or
null mutants with complete absence of early maxillary innervation.
Second, the lesion of neuronal connections involved in setting up the cultures may
have caused the alterations in NGF mRNA in the maxillary process, making this
more of a model of peripheral nerve injury than of the effects of early target field
innervation. However, NGF has thus far generally been found to be up-regulated in
non-neuronal cells upon nerve lesion (e.g. Dethleffsen et al. 2002), although this has
only been studied in postnatal animals.
Third, another explanation is that the prevention of innervation of the early maxillary
process somehow interfered with the survival of its NGF secreting cells.
Conclusion
The data presented in this chapter, together with previous studies, suggest a model in
which the timing and rate of increase in NGF expression is regulated by two
mechanisms: An intrinsic developmental programme in the target field (Rohrer et al.,
1988; Clegg et al., 1989) and modulation of this programme by the earliest
innervating axons. This latter modulatory influence of sensory axons can fine-tune
the onset of neurotrophin synthesis upon target field contact, in a similar manner in
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which the onset of neurotrophin dependency can be fine-tuned by target field contact
(Vogel and Davies, 1991; Davies, 1994). The in vitro studies presented here suggest
that such a mechanism may be mediated by pioneer axons, the first to reach the
target field.









too late in development
earlier increase in
NGF expression Innervation occurs before
intrinsic NGF expression
Illustration of the way in which NGF expression may be controlled by an intrinsic developmental
programme in the target field, and how the modulation of this intrinsic programme by the earliest
innervating axons can adapt NGF supply to differences in the timing of innervation. The right column
shows two different time points in target field innervation (timepoint x), and the left column shows
NGF expression over time and the effect exerted on it by different innervation timing or lack of
innervation (x). (1) If neuronal processes arrive at the target field at an unusually late point in
development (or not at all) and the target field has received no signal from the pioneer axons (P), an
intrinsic programme of NGF expression is executed that will ensure that any neurons that are still
growing towards the target field have sufficient survival factors to maintain them in the last stages of
innervation (should they become survival-dependent while still growing). (2) When neurons arrive at
the target on time or even too early in development, the pioneer axons signal this to the target field,
and the programme of NGF expression is initiated carliei (red line, the black shows intrinsic
programme that would occur with late/absent innervation). The intrinsic programme could thus be
seen as a 'safety net' for late arriving neuronal processes. Neurons that reach the target field on time
or before they are due need a supply ofNGF earlier, which is initiated by the pioneer axons reaching
the target field. This may not necessarily mean that more neurons will survive the period of naturally
occurring cell death (PCD) if they arrive early. Although NGF synthesis begins earlier, the maximum
level of NGF expression and the amount of NGF that neurons are supplied during PCD may be the
same in both cases, resulting in similar neuronal numbers after PCD. Such an intrinsic programme
modulated by early arriving axons may thus serve to maximise survival before PCD and therefore
optimise competition during it. TG: Trigeminal ganglion; TF: Target field; P: Pioneer axons.
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An advantage of such a system would be to provide a safety net for innervating
neurons (Figure 4.18). The arrival of pioneer axons would provide an advance signal
to the target of the arrival of the second, main wave of axons, enabling it to fine-tune
its levels of NGF expression for their arrival. This would ensure that NGF levels are
adequate for the actual timing of arrival by innervating axons. Should the main wave
of axons reach the target field late, neurons may have started 'switching' their
survival dependence from BDNF and NT-3 to NGF due to target unrelated cell
interactions within the ganglion (Buchman and Davies, 1993; Pinon et ah, 1996;
Enokido et ah, 1999). Should this occur for some reason, intrinsically up-regulated
levels of NGF would be able to support these neurons as their axons grow the
remainder of the way to the target field. Such a hypothesis would thus ensure









Neuronal survival in the developing vertebrate nervous system has been found to
depend on several trophic factor families. One such family, the neurotrophins, plays
a major role in the nervous system, supporting a variety of sensory and sympathetic
neurons (e.g. Davies, 1994; Farinas, 1999; Davies, 2003). The neurotrophin family
members in birds and mammals are nerve growth factor (NGF), brain derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and -4 (NT-4). They exert their
actions through the Trk tyrosine kinase receptors and another receptor, p75
(Barbacid, 1994). TrkA is the preferred receptor for NGF, TrkB for BDNF and NT-4,
and TrkC for NT-3, although some signalling of NT-3 can occur through trkA and
trkB. The p75 receptor has a similar affinity for all neurotrophins.
Most developing sensory neurons initially appear to be independent of neurotrophins
at the early stages of outgrowth towards their targets (Davies and Lumsden, 1984;
Ernsberger and Rohrer, 1988; Vogel and Davies, 1991). Many cranial ganglion
neurons then become dependent on BDNF or NT-3 as they approach their target
fields (Vogel and Davies, 1991). Although many neuronal populations maintain
dependence on these factors at later stages of development, including the phase of
naturally occurring cell death, the neurons of other ganglia subsequently become
dependent on NGF during the early stages of target innervation (Buchman and
Davies, 1993; Buj-Bello et al., 1994). Some populations of neurons thus appear to
switch their dependence from one neurotrophic factor to another during embryonic
development. This observation was termed 'neurotrophin switching' (Davies, 1994).
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One of the most extensively studied populations of neurons in which this
neurotrophin switching takes place is the trigeminal ganglion. At approximately E10
trigeminal neurons start growing axons towards their peripheral target fields (Davies
and Lumsden, 1984). When they are removed at this point and grown in culture, they
become survival-dependent on BDNF or NT-3 after 24 to 48 hours following a brief
phase of neurotrophin independence, i.e. they died if neither of these neurotrophins
were added to the culture medium. This coincides with the point at which the first of
the axons approach their peripheral target fields in vivo. Very few neurons are
dependent on NGF at this stage. Flowever, neurons cultured at successive stages of
development become more and more dependent on NGF and less on BDNF and NT-
3, until almost all neurons are dependent on NGF by El3. At intermediate stages the
number of surviving neurons in cultures is not significantly higher in medium
containing NGF plus BDNF or NT-3 than in medium containing the factors alone,
suggesting that the neurons are able to respond to all three neurotrophins at this stage
(Buchman and Davies, 1993; Paul and Davies, 1995). A recent study has suggested
that much of the switching effect found may be due to sequential generation of
BDNF and NGF-dependent neurons (Huang et al., 1999). However, BrdU labelling
experiments have shown that at least some of the neurons do switch their response
form one neurotrophin to another in vivo (Enokido et al., 1999).
In vitro results are supported by expression studies of the neurotrophins and their
receptors. BDNF and NT-3 mRNA are already expressed in the mesenchyme, when
the earliest trigeminal axons are growing through this tissue to the periphery,
whereas NGF mRNA expression begins in the target field epithelium slightly later
with the arrival of the first axons (Buchman and Davies, 1993; Wilkinson et al.,
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1996; Arumae et al., 1993; Davies et al., 1987). Early in development the levels of
trkB and trkC mRNA are much higher than trkA, whereas later, as most neurons
become NGF dependent, the level of trkA mRNA is much higher (Ernfors et al.,
1992; Arumae et al., 1993; Wyatt and Davies, 1993). Also, there is a relative increase
in the expression of a truncated form of trkB, which lacks the kinase domain, and
which can act as a negative modulator of BDNF signalling (Ninkina et al., 1996).
Another study found that mRNA for more than one of the trk receptors is present in
developing rat trigeminal neurons during the switchover period (Moshnyakov et al.,
1996).
Knockout studies of neurotrophin receptors also support the concept of neurotrophin
switching in vivo. In trkB-deficient embryos, the number of early neurons
undergoing apoptosis is greatly increased compared with wildtypes, whereas in trkA-
deficient embryos, the number of apoptotic neurons is increased later in
development. In trkC-deficient embryos, apoptosis is not increased as much as in
tnFfi-deficient embryos early in development (Pinon et al., 1996). Also, it was found
that the non-catalytic trkC receptors outnumber the catalytic ones in early trigeminal
ganglia (Wyatt et al., 1999). In AT-5-deficient embryos, however, there is a decrease
of neuronal numbers in the trigeminal ganglion before the peak of naturally
occurring cell death, suggesting that NT-3 may be acting through a different receptor
(ElShamy and Ernfors, 1996; Wilkinson et al., 1996; Huang et al., 1999). It has been
demonstrated that NT-3 in trkC-deficient mouse trigeminal neurons acts via trkA and
trkB receptors in vitro (Davies et al., 1995), and the possibility that NT-3 acts via
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these two receptors in addition to trkC in vivo has recently been supported (Huang et
al„ 1999).
Although it is not quite clear what induces neurons to switch their responsiveness
from BDNF and NT-3 to NGF, it has been hypothesised that this occurs due to a
signal the neurons receive in vivo, since E10 neurons do not lose their
responsiveness to BDNF in vitro (Paul and Davies, 1995). It has been demonstrated
that this signal does not originate from the target field, and it is thus likely that the
switch depends on cell interactions within the ganglion (Enokido et al., 1999).
The trigeminal ganglion appears to undergo further changes in its survival
requirement later in development. During the late fetal period, trigeminal ganglion
neurons are supported by GDNF, CNTF, LIF, OSM, CT-1 and MSP in vitro, several
days after the neurons have become NGF-dependent (Buj-Bello et ah, 1995; Horton
et ah, 1998; Forgie et ah, 2003).
Since the discovery of neurotrophin switching in the trigeminal ganglion a number of
other instances of trophic switching have been identified. In DRG, for example,
neurons dependent on NGF or NT-3 during early development may become
dependent on LIF, GDNF, NTN, ART or bFGF later in development (Molliver et ah,
1997; Baudet et ah, 2000; Acosta et ah, 2001). Sympathetic neurons have also been
reported to change their survival dependence during development. Cells from early
sympathetic ganglia could be maintained alive by neurotrophin-3 (NT-3) in a serum-
free medium, but not by NGF. By birth, these sympathetic neurons were supported
by NGF, whereas NT-3 supported survival only weakly and at very high doses
(Birren et ah, 1993). This was associated with a reciprocal switch in the expression
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of trkC and trkA mRNAs in vivo (e.g. Birren et al., 1993; Wyatt and Davies, 1995).
In NT3 knockout mice, however, a decrease in the number of SCG neurons was only
observed at later stages in development, when the neurons were also dependent on
NGF for survival (Wyatt et al., 1997; Francis et al., 1999). In addition to
neurotrophins, artemin is able to enhance sympathetic neuron survival at distinct
stages of embryonic and postnatal development, in this case just after terminal
mitosis and just before the neurons acquire neurotrophin independence in the adult.
Between these stages, no survival effect of artemin was observed. Thus some
neurons may switch their survival requirement from artemin to NGF and/or NT-3
and then back to artemin at later stages before finally becoming neurotrophin
independent (Andres et al., 2001).
The p75 receptor shares no sequence similarity to the trk receptors and utilises
distinct neurotrophin-dependent signalling pathways (reviewed by Roux and Barker,
2002; Hempstead, 2002). The p75 receptor is expressed in the peripheral nervous
system from the earliest stages in development, being already present in migrating
neural crest cells (Heuer et al., 1990). Levels then increase substantially as the
ganglia form and the crest cells differentiate. In the trigeminal ganglion, p75 is
initially expressed at low levels, and like trkA increases simultaneously with the
acquisition of the NGF survival response (Wyatt and Davies, 1993). The function of
p75 is less well understood than the functions of the trk receptors. For trigeminal
ganglion neurons, in vitro studies have demonstrated that the dose response of p75
null mutant neurons to NGF is shifted to higher NGF concentrations (Davies et al.,
1993). A similar effect has since been observed in other ganglia of the peripheral
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nervous system, such as the DRG and SCG (Lee et al., 1994). This indicates that p75
enhances the sensitivity ofNGF-dependent neurons to NGF, a hypothesis reinforced
by the finding that mutant NGF which binds trkA but not to p75 is less efficient at
promoting the survival of sensory trigeminal and SCG neurons (Horton et al., 1997).
Although it has been shown that overexpressing trkA or trkB with p75 increases the
binding affinity of trkA for NGF and trkB for BDNF, NT-3 and NT4/5 (Mahadeo et
al., 1994; Bibel et al., 1999), other studies suggest that the sensitising effect is
restricted to NGF, since p75 deficient neurons do not display decreased sensitivity to
other members of the neurotrophin family for survival (Davies et al., 1993; Lee et al.,
1994). The rate at which NGF can associate with trkA has been shown to increase
25-fold when p75 is co-expressed (Mahadeo et al., 1994), which may explain the
increased activation of trk receptors by low concentrations of neurotrophins when
p75 is also present (Hantzopoulos et al., 1994; Verdi et al., 1994). This binding- and
survival-enhancing role of p75 is confirmed by neural losses observed in p75-
deficient mice in embryonic and postnatal trigeminal, SCG and DRG (Lee et al.,
1992; 1994). A recent study has additionally demonstrated that p75 increases the
specificity of trkA for NGF. The survival-promoting effect of NT-3 via trkA is
impaired by p75 in sympathetic neurons (Brennan et al., 1999).
In addition to this role in enhancing survival, p75 has a prominent role in inducing
cell death in neurons upon NGF binding in the absence of trk receptors (Frade et al.,
1996; Bamji et al., 1998; Davey & Davies 1998). This mechanism is unlikely to
occur in the developing trigeminal ganglion since p75 and trkA are co-expressed in
development (Wyatt and Davies, 1993) and neurons expressing the p75 receptor
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alone are rare during the phase of neurogenesis in the trigeminal ganglion
(Moshnyakov et al., 1996).
Some experiments suggest that p75 provides a constitutive cell death signal in
sensory neurons in the absence of ligands, since the death ofDRG neurons following
neurotrophin withdrawal can be partially prevented by reducing p75 levels (Barrett
and Bartlett, 1994). The mediators of the opposing actions of the p75 receptors are
poorly understood, but it is likely that different adaptor proteins within the cell
provide a bifunctional switch for cell survival or cell death decisions mediated by the
receptor (Khursigara et al., 2001).
The aims of the experiments in this chapter were two-fold:
First, to assess the role trkA and trkB play in the development of the trigeminal
ganglion by using mice with null mutations in the genes encoding these receptors,
singularly and in combination. The aim was to establish whether there are periods
during development where neurons require either or both trk receptors.
Second, to establish the stage in development at which p75 begins to influence
neuronal survival in the trigeminal ganglion. Previous histological studies in p75-
deficient mice have only quantified effects on neuronal numbers late in embryonic
development or postnatally. Furthermore, the original deletion mutation of the p75
gene (Lee et al., 1992) was generated by removal of the third exon in the gene.
However, it has since been demonstrated that there is a naturally occurring p75
isoform resulting from removal of exon 3 by alternative splicing, and this protein is
left intact in the original mouse mutant (von Schack et al., 2001). This protein (s-
(short) p75) differs from the full-length receptor in that it only possesses one of the
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four cysteine-rich domains found in the extracellular domain of the full-length
receptor. To assess the role of this receptor, Schack et al. (2001) targeted exon four
of the p75 receptor locus, generating null mutants missing both isoforms (referred to
as p75D). In the present study the effect of this null mutant was compared with the
mutant lacking only the full-length p75 receptor (referred to as p75L).
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5.2 Results
trkA/trkB double mutant embryos and p75 mutant embryos were collected at El2,
E14, E16 and E18. No trkA/trkB double mutants could be obtained from E18 litters,
suggesting that the double mutation is lethal past the E16 developmental stage. The
embryos were processed and the neuronal and pyknotic numbers quantified as
described in chapter 2.
5.2.1 Neuronal counts in the trigeminal ganglion of trkA/trkB double
knockouts
Neurons were counted on piII-Tubulin and CFV-stained sections using the criteria
outlined in chapter 2. The appearance of trigeminal neurons in sections of the
knockouts at El2 and El4 are shown in Figures 5.1 and 5.2.
Neuronal loss in the trigeminal ganglion was observed in trkB and double null
mutant embryos at E12 (Figure 5.3) (ANOVA; p<0.01). The neuronal numbers in the
wildtype and -knockout embryos were not significantly different, whereas the
tr^-knockouts (Fisher's LSD; p<0.005) and double knockouts (Fisher's LSD;
p<0.005) had significantly less neurons than wildtype embryos (38% and 42% less
respectively). There was no significant difference between the /r£2?-knockout and the
double knockout embryos. Taken together, the findings suggest that trkA has no
effect on survival at this early stage in development. Also, it appears that at this early
stage 58% of neurons were independent of either trk receptor for their survival. By
El4 (ANOVA; p<0.0001), there was a significant 38% reduction in the neuronal
numbers in the trigeminal ganglion of trkA-knockout embryos compared to wildtype
(Fisher's LSD; p<0.0001). Interestingly, the neuronal numbers in tr^-knockout
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embryos were now not significantly different to the ones in wildtypes (5% less
neurons; not significant), suggesting that trkB had no more significant effect on
neuronal survival at this age. It is possible that more neurons were generated in the
/rTfi-knockouts since the neuronal deficit observed at El2 was not present by El4.
However, double mutant embryos displayed a significant 68% reduction in neuronal
numbers compared to wildtype (Fisher's LSD; p<0.0001), which, when compared
with the 38% reduction observed in the single trkA mutant, suggests that some
neurons rely on either trkA or trkB signalling for survival between El2 and E14 in
vivo. The difference in neuronal numbers between /r^-knockout embryos and
double mutant embryos was significant (Fisher's LSD; p<0.0001). At this stage in
development it appears that just 32% of neurons survive independently of these two
receptors.
By El6 (ANOVA; p<0.0001) the neuronal numbers in the trigeminal ganglion of
trkA-knockout embryos had further decreased by 79% compared to wildtype
numbers (Fisher's LSD; p<0.0001). Interestingly, frTS-knockout embryos displayed
a 21% reduction in neuronal numbers compared to wildtype embryos (Fisher's LSD;
p<0.0001). This raises the possibility that some neurons that were supported by
either trkA or trkB receptor signalling (singularly or in combination) at El4, depend
solely on trkB signalling at El 6. The neuronal loss occurring in the double knockouts
(81%) was less than the combined loss of neurons in the single knockouts (79% for
trkA and 21% for trkB). This suggests that approximately 10% of the neurons require
both trkA and trkB signalling between El4 and E16 in vivo.
262
Figure 5.1: El2 trigeminal ganglia of wildtype, single and double trkA/trkB
knockout embryos
trkB - knockout Double knockout
Wildtype
Bright-field view of Li 12 trigeminal ganglia ofwildtype (A), single (trkA (B) and trkB (C)) and double
null mutant (D) embryos clearly identified by cytoplasmic staining for pilI-Tubulin (Promega) and
detected using DAB-peroxidase substrate (see chapter 2). TrkB - knockout and double knockout
ganglia were found to be slightly smaller than wildtype and trkA - knockout ganglia. Scale bar:
100pm.
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Figure 5.2: E14 trigeminal ganglia of wildtype, single and double trkA/trkB
knockout embryos
Wildtype trkA - knockout
trkB - knockout Double knockout
Wildtype trkA - knockout
Bright-field view of Li 14 trigeminal ganglia of wildtype (A), single (trkA (B) and trkB (C)) and double
null mutant (D) embryos clearly identified by cytoplasmic staining for (3111-Tubulin (Promega) and
detected using DAB-peroxidase substrate (see chapter 2). As can be seen, whereas there appears to be
no difference in the size of the trigeminal ganglion between wildtypes (A) and trkB-knockouts (C),
both the trkA- (B) and the trA/trkB double (D) knockouts are significantly reduced in size. The
bottom row illustrates the differences in the number of pyknotic nuclei that can be seen between
wildtype (E) and trkA-knockouts (F) on CFV-stained sections, with more pyknotic nuclei observed in
trkA and trkA/trkF3 knockout animals at E14. Refer to Figure 2.13 for a high power image of a
pyknotic neuron. Scale bar: 100pm.
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Figure 5.3: Mean neuronal numbers in the trigeminal ganglia of single and

























Mean neuronal numbers in trigeminal ganglia of El2, E14 and El 6 embryos with no mutations (blue),
a homozygous null mutation for trkA (red), a homozygous null mutation for trkB (yellow), or
homozygous null mutations for both trkA and trkB (turquoise). Bars represent the mean ± standard
error (n=6-12 per data point).
5.2.2 Mean nuclear areas in the trigeminal ganglion of trkA/trkB
double knockouts
As described in chapter 1, the trigeminal ganglion is composed of different
subpopulations of neurons. There is a strong positive correlation between the size of
the nucleus and the size of the neuronal body in the trigeminal ganglion at both El4
and El6 in both wildtype and trkA knockout animals (Figure 5.4 and 5.5; correlation







that were a by-product of the Abercrombie corrections used to correct neuronal
numbers, can be seen as an indicator of cell size. To investigate whether the
populations of trigeminal neurons that depend on particular trks for their survival
have distinct cell sizes, the mean nuclear area of trigeminal ganglion neurons
obtained from Abercrombie corrections was examined. The mean nuclear areas for
the trigeminal neurons of wildtype, single and double mutant embryos can be seen in
Figure 5.6.
An ANOVA revealed that there were no significant differences in the mean nuclear
areas of the different knockouts at E12. Nuclear areas of neurons remaining in the
trigeminal ganglion of trkA and trkA/trkB knockout embryos at El4 however
(ANOVA; p<0.01) were found to be significantly smaller on average (-28% and -
17% respectively) than the nuclear areas in the neurons of wildtype embryos (trkA:
Fisher's LSD; p<0.001; trkA/trkB: Fisher's LSD; p<0.05). The mean nuclear areas in
the trigeminal ganglia of the trkB- knockouts were not significantly different to the
wildtypes. The nuclear areas of neurons in the trigeminal ganglia of /r^-knockout
embryos at El6 (ANOVA; p<0.05) were significantly larger than the ones in
wildtype embryos (+23%) (Fisher's LSD; p<0.01), whereas the nuclear areas of
neurons in the trigeminal ganglion of trkB and trkA/trkB double knockout embryos
were not significantly different.
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Figure 5.4: Correlation between nuclear area and cell area of neurons in the















10.000 30.000 50.000 70.000 90.000 110.000
nuclear area (Mm3)
Nuclear area and cell area measurements of 100 neurons in the trigeminal ganglion at El4. Area
measurements were obtained by randomly drawing neurons from wildtype (blue) and trkA-/- (red)









Figure 5.5: Correlation between nuclear area and cell area of neurons in the















10.000 30.000 50.000 70.000 90.000 110.000 130.000
Nuclear area (|jm3)
Nuclear area and cell area measurements of 164 neurons in the trigeminal ganglion at El6. Area
measurements were obtained by randomly drawing neurons from wildtype (blue) and trkA-/- (red)
animals and analysing the drawings using NIH Imager.
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Figure 5.6: Mean nuclear areas of neurons in the trigeminal ganglion of
































Mean nuclear area of neurons in the trigeminal ganglia of El2, El4 and El6 embryos with no
mutations (blue), a homozygous null mutation for trkA (red), a homozygous null mutation for trkB
(yellow), or homozygous null mutations for both trkA and trkB (turquoise). Bars represent the mean ±
standard error (n=6-12 per data point).
5.2.3 Mean numbers of pyknotic nuclei in the trigeminal ganglion of
trkA/trkB double knockouts
Pyknotic nuclei were identified and counted on CFV-stained sections as specified in
chapter 2. As can be seen in Figure 5.7, consistent with the reduced number of
neurons observed in the trigeminal ganglion of trkB and double knockout embryos at
El2, these ganglia also had significantly increased numbers of pyknotic neurons
(Kruskal-Wallis; p<0.005) at that age (91 and 82% more respectively; trkB
knockout: Dunn's; p<0.001; double knockout: Dunn's; p<0.005). trkA-knockout
ganglia in contrast displayed no difference in the number of pyknotic neurons
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compared to wildtype ganglia. In El4 ganglia the change in neuronal number was
again reflected in the number of pyknotic neurons counted in the trigeminal ganglion
Kruskal-Wallis; p<0.005). Pyknotic neurons in tr^-deficient embryos and double
mutants now showed a drastic increase (-600% and -500% respectively) compared
to wildtype counts (Dunn's; both p<0.05). There was no significant difference in the
number of pyknotic neurons in trkB trigeminal ganglia compared to wildtype
embryos. By El6 (Kruskal-Wallis; p<0.005), the number of pyknotic neurons was
actually significantly lower in trkA and trkA/trkB double knockouts (83% and 90%
less pyknotic nuclei respectively; Dunn's; p<0.05), which is most likely due to most
neurons in the trigeminal ganglion having already undergone apoptosis in these
animals. In the trkB knockout, less pyknotic neurons (32%) than in the wildtype
trigeminal ganglion were observed at E16 (Dunn's; p<0.01).
There were no obvious differences in the appearance of pyknotic nuclei in the
trigeminal ganglia of the different genotypes examined in this experiment (Figure
5.2).
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Figure 5.7: Mean numbers of pyknotic neurons in the trigeminal ganglion of

































Mean number of pyknotic neurons in trigeminal ganglia of El2, E14 and El6 embryos with no
mutations (blue), a homozygous null mutation for trkA (red), a homozygous null mutation for trkB
(yellow), or homozygous null mutations for both trkA and trkB (turquoise). Bars represent the mean ±
standard error (n=4-8 per data point).
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5.2.4 Neuronal counts in y75L-/~ and p75D-l- mutant embryos
Neurons were counted on [lIII-Tubulin and CFV-stained sections following the
criteria laid out in chapter 2. Figure 5.8 shows representative micrographs of
wildtype, p75L-/~ and p75D-/- embryos at E12 and E14. Whereas at E12 and E14,
neuronal numbers in the trigeminal ganglion appeared normal in p75L-/- embryos
(Figure 5.9) and were not significantly different from wildtype numbers, by El 6 a
22% loss in neurons was observed in the p75L-t- embryos compared to wildtype (t-
test; p<0.0001). This loss was not further increased between E16 and E18 (16% loss
compared to wildtype, t-test; p<0.005). This suggests that p75 has a transient effect
on supporting the embryonic survival of trigeminal sensory neurons.
In contrast to p75L-t- embryos, p75D-t- embryos displayed a reduced number of
neurons in the trigeminal ganglion at El4 (t-test; p<0.005; Figure 5.10). This loss of
14% of neurons occurred between El2 and El4 since no differences between
mutants and wildtypes was observed at E12. This loss increased further to 22% at
El6 (t-test; p<0.0001) and 24% at El 8 (t-test; p<0.0005) compared to wildtypes. The
difference between the two p75 mutants was significant at E14 (t-test; p<0.01), but
not at other developmental ages.
The nuclear areas of neurons in the trigeminal ganglion of these embryos were also
assessed. Flowever, no major differences in the mean nuclear area were found in
either the p75L-/- or p75D-/- embryos compared to wildtype embryos, apart from a
slight, 8% increase in the mean nuclear area of p75D-/- embryos compared to
wildtypes late in embryonic development at El 8 (t-test; p<0.005).
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Figure 5.8: E12 and E14 trigeminal ganglia of wildtype, p75L and p75D
knockouts
A
E14 wiidtype E14 p75L - knockout
E14 wiidtype E14 p75D - knockout
Bright-field view of E12 and E14 trigeminal ganglia of wiidtype (A, C, E, G) and mutant embryos
(p75: B, F; p75D: D, H) clearly identified by cytoplasmic staining for (3111-Tubulin (Promega) and
detected using DAB-peroxidase substrate (see chapter 2). Whereas there appears to be no difference in
the size of the trigeminal ganglion between wildtypes and knockouts at E12, at E14 there is a slight
decrease in neuronal number, but it is too slight to show up on these images. Scale bar: 100pm.
E12 p75L - knockout





Figure 5.9: Mean neuronal numbers in the trigeminal ganglion of wildtype



























Mean neuronal numbers in trigeminal ganglia of El2, E14 and El 6 embryos with no mutations (blue)
or homozygous for the p75 receptor mutation (red). Bars represent the mean ± standard error (n=6-8
per data point).
Figure 5.10: Mean neuronal numbers in the trigeminal ganglion of wildtype









Mean neuronal numbers in trigeminal ganglia of El 2, E14 and El 6 embryos with no mutations (blue)
or homozygous for the p75 receptor null mutation (red). Bars represent the mean ± standard error
(n=4-8 per data point).
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5.2.5 Mean numbers of pyknotic nuclei in the trigeminal ganglion of
p75L and p75D mutants
Pyknotic nuclei were identified and counted on CFV-stained sections as specified in
chapter 2. It should be noted that, because of the strict criteria for classifying
pyknotic cells as neurons, the actual proportion of dying cells is likely to be greater
than the estimates suggest. Counts of pyknotic neurons have previously been shown
to be comparable to the numbers achieved by double-labelling neuron markers and
apoptotic nuclei immunohistochemically (Pinon et al., 1996).
Although there was no difference in the number of pyknotic neurons in p75L-/~
embryos at El2, by E14 30% more pyknotic neurons could be observed in the p75L-
/- embryos (Mann-Whitney; p<0.05), suggesting that enhancement of neuronal
survival by full-length p75 begins at this stage (Figure 5.11). By E16 there were still
slightly more pyknotic neurons in p75L-/- embryos than in wildtypes, although this
difference was not statistically significant (Mann-Whitney; p>0.05). By El8, hardly
any pyknotic neurons could be found in either wildtype or mutant animals.
In agreement with the earlier onset of neuronal loss in p75D-/- embryos, there was a
slightly significant increase (28%) in pyknotic neurons observed at El2 (Mann-
Whitney; p<0.05, Figure 5.12), i.e. before significant increases in pyknotic neurons
were observed in p75L-/- mutants. Similar percentage increases in the number of
pyknotics, relative to wildtype numbers, were observed in p75L-/- and p75D-/-
embryos at E14 (30% and 31% respectively; Mann-Whitney; p<0.05). At El6,
however, there were still significantly more (21%) more pyknotic neurons in p75D-/-
embryos compared to the number of pyknotics in wildtype embryos (Mann-Whitney;
p<0.005). By El8, hardly any pyknotic neurons could be found in either wildtype or
p75D-/- embryos.
274
Figure 5.11: Mean numbers of pyknotic neurons in the trigeminal ganglion of
























Mean number of pyknotic neurons in trigeminal ganglia of El2, El4 and El6 embryos with no
mutations (blue) or homozygous for the p75L mutation (red). Bars represent the mean ± standard error








Mean numbers of pyknotic neurons in the trigeminal ganglion of




















Mean number of pyknotic neurons in trigeminal ganglia of El2, El4 and El6 embryos with no
mutations (blue) orp75D-/- (red). Bars represent the mean ± standard error (n=4-6 per data point).
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5.3 Discussion
The use of combined null mutants lacking both the trkA and trkB receptor genes, and
their comparison with single null mutants, has for the first time enabled a direct
comparison of the effects the combined signalling of these receptors has in relation to
their individual survival-promoting actions in the mouse trigeminal ganglion in vivo.
Stages have been identified at which trigeminal neurons are predominantly
dependent on trkB signalling or trkA signalling for survival as well as a period when
some neurons can signal via either receptor and some neurons require both receptors.
Although initial studies of p75 mutant embryos have established the importance of
this receptor for the survival of trigeminal neurons, the onset of p75 dependence in
this neuronal population has been unknown thus far. The present study shows that a
subset of trigeminal neurons becomes dependent on p75 signalling between El 2 and
El4 (p75D). This dependence is delayed slightly in embryos that express a truncated
p75 that lacks most of the extracellular domain of the receptor (p75L).
The data in this chapter replicate earlier evidence that trigeminal neurons require
functional trkB receptors at an early stage in their development in vivo (Pinon et al.,
1996). This is suggested by the reduced numbers of trigeminal neurons and increased
number of pyknotic neurons in the ganglion of trkB-deficient mice at E12. It is likely
that the trkB ligands important for mediating this survival effect in vivo are BDNF
and NT-3 because embryos lacking these neurotrophins display reduced numbers of
neurons in the trigeminal ganglion during this period of development (Ernfors et al.,
1994; Davies et al., Huang et al., 1999) and the majority of early trigeminal neurons
are supported by BDNF and NT-3 in vitro (Buchman and Davies, 1993; Davies,
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1993; Paul and Davies, 1995). The present study also confirmed the previous finding
(Pinon et ah, 1996) that the survival of trigeminal neurons depends on functional
trkA receptors at later stages in development. Accordingly, I found no difference in
the number of surviving or pyknotic neurons in the trigeminal ganglion of trkA-
deficient embryos at El2 compared with wildtypes, whereas by El4, trkA-deficient
mice displayed a 38% decrease in neurons and a six-fold increase in the number of
pyknotic neurons.
The results presented above thus replicate the genetic proof for the switch in survival
dependence of early trigeminal ganglion neurons (Pinon et al., 1996). However, in
addition to replicating previous findings, this study used double null mutants for trkA
and trkB. These double knockouts confirm in vivo that neurons can be
simultaneously dependent on either trkA or trkB-mediated trophic support.
The ratio of neurons missing in trkA and trkB mutant embryos at El4 (38% and 5%
respectively) compared to the ratio missing in double mutants (68%) suggests that in
the absence of trkA 25% of neurons could utilize trkB-signalling for their survival
and, similarly, in the absence of trkB signalling 25% of neurons could use trkA/NGF
signalling for survival. This indicates that at least 25% of neurons before E14 not
only expressed both receptors simultaneously at some stage of development, but
were able to respond through either receptor to induce survival. The sequential action
of distinct neurotrophic factors is a recurring theme for many neuronal populations
(Verdi and Anderson, 1994n; Davies, 1997). It is hence important to identify the
proportion of neurons that undergo such a developmental switch in order to assess its
importance for the continued development of particular neuronal populations. This
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experiment has enabled the quantification of the proportion of neurons that are able
to respond to trkA- or trkB-signalling in vivo in the embryonic mouse trigeminal
ganglion. Quantifying the number of neurons 'switching' from complete dependence
on trkB-signalling to complete dependence on trkA-signalling early in development
is not possible, however, since these die before E12 due to the trkB-deficiency. The
neurons detected here are thus the ones generated at intermediate stages that can
respond to both NGF and BDNF (Enokido et al., 1999). The losses in the trigeminal
ganglion seen in the double mutant embryos most likely account for all of the
survival-promoting effects of the three major neurotrophins, since most of the
survival mediated by NT-3 is thought to occur through trkA and trkB. It is unlikely
that trkC plays a major role at these early stages, since trkC knockouts do not display
a loss of sensory neurons in the trigeminal ganglion, at least not until later in
development (Pinon et al., 1996).
The effect of the double mutation on neuronal survival in the ganglion at El4 most
likely requires both sets of receptors to be expressed by the same cell. This
contradicts a previous study finding little such co-expression, with each neuron
expressing only one receptor type by El3.5 (Huang et al., 1999). However, the
immunohistochemical technique used in that study may not be sensitive enough to
detect low, albeit functionally significant levels of trk receptors. In support of my
findings, neurons generated at intermediate stages have been shown to respond to
both NGF and BDNF in vitro (Enokido et al., 1999). Also, the more sensitive method
of single-cell RT-PCR found mRNA expression for two or all three trk receptors in
neurons of the developing rat trigeminal ganglion (Moshnyakov et al., 1996).
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The additive effect of trkA- and trkB-deficiency induced cell loss at El6 (79% and
21% respectively) ought to account for 100% of neurons in the trigeminal ganglion at
this stage. However, 11% of neurons remained in trkA/trkB double mutants. Since
the sum of the single trk knockout neuron losses (100%) was higher than the loss in
the double mutants (89%), it would appear that approximately 11% of neurons in the
ganglion require combined trkA- and trkB-signaling for their survival. Such a dual
support requirement has been found in a variety of neuronal populations. For
example, many sympathetic neurons appear to require both NGF and NT-3, as
almost all sympathetic neurons are eliminated in the absence of NGF and around
50% are eliminated in the absence of NT-3 (Francis et al., 1999). Also, in the
nodose-petrosal complex, neuronal losses in BDNF/GDNF double mutants are not
additive to losses in single BDNF or GDNF null mutants, indicating that many cells
require both for survival in vivo (Erickson et al., 2001).
Although it has previously been shown that trigeminal neurons are able to survive in
the presence of different trophic factors, this is the first time that such a dual
embryonic requirement for two simultaneous trophic factors has been found in this
neuronal population. This further contradicts previous evidence suggesting that
trigeminal neurons express only one trk type (Huang et al., 1999), as some neurons
require both receptors to be expressed to survive between El4 and El6.
Furthermore, the results show that the number of neurons surviving independently of
trk receptor signalling is reduced with development. At El2, 58% of neurons in the
trigeminal ganglion survive independently of neuronal support through the trk
receptors. This proportion of trk-receptor signalling independent neurons decreases
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with age (32% at E14 and 19% by E16). The importance of trk-receptor signalling
for trigeminal neuron survival thus increases with age. Since NT-3/trkC signalling
appears to be required for survival by a subset of trigeminal neurons at E16 (Pinon et
al., 1996), some of the neurons still present in the trkA/trkB double knockouts may be
NT-3/trkC dependent. It would be interesting to compare NT-3 and trkC mRNA
levels in the mutant embryos as opposed to wildtype embryos, to ascertain whether
there is compensation ofNT-3 signalling via trkC for trkA and trkB signalling loss in
vivo. Culturing trkA/trkB trigeminal neurons with NT-3 may also enable the
assessment of survival mediated via the trkC receptor alone.
More information is emerging on the factors able to support/enhance neuronal
survival in the trigeminal ganglion at later stages in development (Horton et al.,
1998; Forgie et al., 2003). However, it is currently not well known what alternative
factors may be involved in the survival of earlier trigeminal neurons.
It is noteworthy that the numbers of neurons in the trigeminal ganglion of the trkB
knockout studied in this experiment were reduced by 38% at E12 and an insignificant
5% at El4, which is in contrast to the 42% reduction in neuronal numbers at El3 in
previous studies, with -33% neuronal deficit at El5 (Pinon et al., 1996). At El7 the
previous study still found a 33% deficiency in trkB-/- ganglia, whereas I found a 21%
decrease at El6. Part of the reason for the different proportion of loss seen in this
experiment may be due to the previous study using mice in a 129xC57Bl/6
background, whereas mice in a CD1 background were used here. Differences in
background have previously been reported, with neuronal numbers in the DRG of
BDNF-deficient mice, for example, being normal prenatally in one background
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(Farinas, 1999), and decreased in a different background (Liebl et al., 1997). This,
however, still does not explain the recovery in the proportional numbers of
trigeminal neurons at E14 in this study.
Something appears to cause a proportional increase in neuronal numbers of trkB-
knockouts between the developmental stages of E12 and E14. Similar observations
to the ones made in this experiment were made in the dorsal root ganglion, where
there is a significant loss of DRG neurons of AT-3-deficient mice at El 1. However,
neuronal numbers at E12 appear to be normal compared to wildtype embryos
(Farinas et al., 1996). This study also found that AfT-3-deficient ganglia have fewer
precursor cells by El 2, suggesting that neurogenesis occurs at an abnormally higher
rate in mutant embryos during the Ell-El 2 interval and that precursors differentiate
into neurons prematurely. Neurons in the trigeminal ganglion are still generated at
~E13. It is possible that the normal neuronal numbers observed in /r£5-deficient
mice at E14 are due to a depletion of the precursor pool and premature neuronal
differentiation between E12 and El4. Alternatively enhanced precursor proliferation
with trkB knockouts between these ages may yield a bigger number of precursors
that can differentiate into neurons at a normal rate. Further experiments would
necessitate checking the number of precursor cells in the trigeminal ganglion of trkB-
deficient mice, to ascertain whether such events may take place in these embryos.
As demonstrated above, there is a strong positive correlation between the size of the
nucleus and the size of the neuronal body in the trigeminal ganglion at the ages
studied. Nuclei in the trigeminal ganglia of trkA-deficient mice are smaller than in
wildtype ganglia at El4. However, by E16 they are significantly larger. The smaller
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nuclear size of neurons at El4 may be explained by the incredibly high amount of
apoptotic death occurring in the ganglia of trkA-deficient mice at this stage. The
decrease in nuclear area observed in -deficient mice at E14 may be due to the
high proportion of apoptotic neurons. Apoptosis has cell shrinkage as one of its
symptoms. Neurons of trkA/trkB double null mutants also have smaller nuclei, but
the difference is less than that observed for trkA mutants.
The larger nuclear area in trigeminal neurons of trkA-deficient mice at El6 may be
due to the selective loss of small nociceptive neurons. These are mainly trkA-
dependent in the DRG, whereas larger diameter neurons tend to depend on BDNF
and NT-3 (Crowley et ah, 1994; Silos-Santiago et ah, 1995; Jones et ah, 1994;
Farinas et ah, 1994). A similar selective loss could be occurring in the trigeminal
ganglion. No difference was seen in trCfi-deficient embryos, which would not be
expected, since the trkA-dependent neurons outweigh trkB-dependent neurons by far
at this stage. Thus a loss in the relatively small proportion of larger neurons may not
significantly alter the average nuclear size, predominantly determined by the larger
proportion of trkA-responsive neurons. Mean nuclear size in trigeminal neurons of
the double mutant was not much different from wildtypes. One would not expect as
strong an effect as for trkA-deficient trigeminal neurons in these embryos, since they
loose neuronal subpopulations dependent on both receptors. It will be interesting to
use specific markers for neurotransmitters and neuropeptides found in the trigeminal
ganglion (reviewed by Lazarov, 2004), to establish if there are neuronal
subpopulations lost preferentially in the different knockout mice.
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Although numerous studies have indicated neuronal losses in the trigeminal ganglion
of /?75-deficient mice in vivo, it is not known when in development this deficit
develops. It has not been shown in vivo whether this loss is due to decreased
proliferation and/or differentiation of these neurons or simply due to dependency on
p75-signalling later in development. Analysis of neuronal numbers in the trigeminal
ganglion of the well-studied p75L-/- mutant (Lee et al., 1992) indicates that neuronal
loss occurs between E14 and El6, thus after the phase of neurogenesis. This onset
correlates with in vitro evidence, with dose-responses of /?75-deficient trigeminal
neurons to NGF shifting to higher concentrations at El4, with less of a shift at El2
(Davies et al., 1994). Although the neuronal complement in the trigeminal ganglion
of p75L-/- embryos is not reduced at E14, the significantly higher number of
pyknotic neurons indicates that increased neuronal death is initiated at this stage. E14
is also the stage at which a shift in dose-response is observed in mouse trigeminal
neurons in response to an NGF mutant able to bind only trkA (Horton et al., 1997).
Neuronal losses inp75D-l- null mutant embryos occur earlier between E12 and El4,
and relative pyknotic counts at E14 are higher. This would indicate that the short-p75
receptor isoform expressed by p75L-l- mice mediates improved survival early in
development in vivo. This would correlate with the slightly higher loss of lumbar
DRG neurons found in the p75D-/- embryos compared to p75L-/- embryos (von
Schack et al., 2001).
High affinity binding sites have been shown to be created by the interaction of the
transmembrane and the cytoplasmic domain of p75, indicating that these are
sufficient to convert trkA to a higher affinity (Esposito et al., 2001). Also, a p75
mutant deficient in neurotrophin binding increases the affinity of NGF for trkA,
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showing that direct interaction between neurotrophins and p75 is not essential for the
formation of high affinity binding sites. Because short-p75 possesses the
transmembrane and cytoplasmic domains of the full-length receptor, it could still
enhance NGF binding to trkA with the result that p75L-l- may be more sensitive to
NGF than p75D-/-. This would need to be assessed by examining the dose-response
of the p75D-/~ versus p75L-/- trigeminal neurons in culture, which may give a clearer
indication whether such a mechanism may occur. An alternative explanation is that
the short p75 isoform may be able to mediate survival independently of neurotrophin
binding (as it cannot bind due to its truncated extracellular domain, von Schack et al.,
2001). The p75 intracellular domain is able to enhance neuronal survival in a variety
of cells (Roux et ah, 2001). Also, a recent study demonstrated that proteolytic
cleavage of p75 receptors results in the release of the cytoplasmic domain into the
cell cytoplasm (Kanning et ah, 2003). Since such soluble intracellular domains of
p75 were shown to activate NFkB, this may identify an additional pathway through
which the short p75 receptor induces survival in the absence of neurotrophin binding.
At later stages in development there appears to be no additional loss in neuronal
numbers ofp75D-/- compared to p75L-/~ trigeminal ganglia, which may suggest that
the role of the short p75 receptor isoform at later stages of development is negligible.
This is in contrast to the DRG, where further neuronal losses are still observed at
P3/4 in null mutants (von Schack et ah, 2001). An in depth study of the full- and
short-length forms of p75 and of trkA in the trigeminal ganglion and DRG, along
with NGF expression in the target field of both neuronal populations in wildtype and
p75 mutants, may help resolve the reasons behind this difference.
284
The beginning of survival dependence on p75-signalling coincides with the
beginning of survival dependency on trkA-signalling. This is in line with the p75
mutation causing a selective decrease in the sensitivity of sensory neurons to NGF,
but not apparently affecting the response of sensory neurons to either BDNF or NT-
4/5 (Davies et al., 1993; Lee et ah, 1994). The present study does not indicate
whether particular subtypes of neurons are lost in the trigeminal ganglion is response
to a p75 mutation. The significantly larger neurons present in this ganglion at El8,
however, may suggest that the neurons lost are the small trkA-dependent nociceptive
neurons.
Conclusions
Trigeminal neurons can thus potentially undergo five stages in their trk-signalling
dependent survival during development. Firstly, they are mostly independent of trk-
signalling for their survival (Davies and Lumsden, 1984). Secondly, some neurons
become critically dependent on trkB-signalling for their survival. Thirdly, some of
these neurons become able to survive in response to either trkA or trkB signalling,
while new neurons are generated that are able to signal via either receptor as well.
Further, some neurons loose their dependency on trkB and become entirely trkA-
signalling dependent, while new neurons being generated respond solely to trkA-
signalling. Finally, some neurons later in development necessitate combined trkA-
and trkB-signalling for their survival. It is not clear from this study whether these are
neurons that were able to respond to either trophic factor at earlier stages of
development, or whether there may be a conversion of neurons solely dependent on
trkA-signalling to neurons requiring additional trkB-signalling.
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For neurons to switch survival-dependence, there must be a biological significance to
this process. One of the explanations suggested for the intermediate dependence of
trigeminal neurons on trkB ligands during the early stages of ganglion development,
is that this sustains the survival of early generated neurons until the majority of late-
born neurons are generated, and all the generated neurons can compete for NGF
released by the target during the same period of development (Davies, 1994). The
survival responses of trigeminal ganglia to the 'early' survival factors BDNF and
NT-3 have almost disappeared by E13-E14, the time of onset of naturally occurring
cell death, mediated by the limited supply of NGF (Buchman and Davies, 1993).
This is supported by the observation that trigeminal neurons are generated up to E13
(Davies and Lumsden, 1984; Enokido et al., 1999), consistent with the recruitment of
axons to the trigeminal nerve up to this time point (Davies, 1987). 'Early' trophic
factors may thus assist in maintaining survival before NGF dependency and the onset
of developmental cell death. All the neurons competing for NGF at the same stage in
development would optimise innervation to the specific requirements of the target
fields, maintaining the neurons with the best axon terminations at the target (Davies,
1994). Later in development (as seen at El6 in this study), trigeminal neurons appear
to regain dependency on additional trophic factors apart from NGF. By analogy with
the differences in trophic factor requirements of postnatal subpopulations of DRG
neurons (e.g. Smeyne et al., 1994; Crowley et al., 1994; Ernfors et al., 1994;
Molliver et al., 1997; Acosta et al., 2001), it is conceivable that the different trophic
requirements of trigeminal neurons at these later stages of development serve to
support distinct populations of trigeminal neurons which will develop distinct
sensory modalities. Further study may reveal that a subpopulation of postnatal
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trigeminal neurons do indeed become dependent on NGF, BDNF, NT-3, GDNF,
FGF, a LIF/cytokine or a combination ofmany factors.
The studies examining the effect of p75 receptor mutations revealed that, in support
of in vitro evidence, the stage at which neurons begin to respond to NGF signalling
via p75 for improved survival is approximately E14. Further, this study revealed
some significance of p75-signalling prior to El4, with truncated p75 receptors being
able to improve survival compared to a complete null p75 mutation, possible utilising
mechanisms of intracellular cleavage and NFkB activation (Kanning et al., 2003) or
the formation of high-affinity binding sites (Esposito et al., 2001).
The exact variations in neuronal development in vivo due to the actions of isoforms
of trk and p75 receptors are still poorly understood. The generation of knockout mice
including these 'missed' receptors is starting to clarify the functions of some of them,
as seen in the p75 study presented in this chapter. A recent study has observed
functional significance for a truncated form of trkB for example: the presence of
truncated trkB receptors in the original full-length trkB knockouts (Klein et al., 1993)
results in more severe sensory neuronal losses in sensory ganglia than seen when this
isoform is eliminated as well (Luikart et al., 2003). These results suggest that
truncated trkB receptors negatively influence neuronal survival in these ganglia. In
vivo, the truncated receptor may thus bind BDNF and NT-3, and reduce the amount
of ligand available for binding to trkB (BDNF-receptor) and trkA, trkB, and trkC
(NT-3 receptors). TrkB mice used in these experiments presented above were the
mutants lacking only the full-length trkB receptor (Klein et al., 1993). Flowever, the
above-mentioned study found no differences in survival between these different trkB
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knockouts in the trigeminal ganglion at PO (Luikart et al., 2003), suggesting that as
far as the trigeminal ganglion is concerned, the function of this particular isoform of
trkB receptor is negligible during its development.
The sequential nature of the survival-dependence of trigeminal sensory neurons on
trk and p75 receptors is summarised in Figure 5.13.








Developmental sequence, from left to right, of the changing requirements of embryonic mouse
trigeminal ganglion neurons on neurotrophin receptor signalling. After a period of independence
(yellow), many trigeminal neurons become dependent on trkB-signalling for their survival (blue). This
is followed by a period in which many neurons can be supported by either trkB- or trkA-signalling,
with truncated p75 improving the survival response (orange), probably by forming high affinity
binding sites with trkA. The full-length p75 receptor performs a similar function later in development
(red), with most of the neurons dependent on trkA-signalling (green). After programmed cell death
there seems to be a diversification in the survival-dependence of trigeminal ganglion subpopulations,
with some neurons becoming dependent on trkB-signalling again (blue), on trkC-signalling (purple),
with others remaining trkA-dependent. For some subpopulations, signalling through two or more
receptors may be required for survival, as has been shown for trkA and trkB in this study. The
different trophic requirements of trigeminal neurons at these later stages of development may serve to
support neurons that will develop distinct sensory modalities. At early stages in development the
different requirements would serve to sustain the survival of neurons until the majority of later-born
neurons are generated, so that all neurons can compete for NGF released by the target during the same
period of development (adapted from Davies, 1997).
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Chapter VI






The timing of neuronal dependency on trophic factors for survival has traditionally
been associated with target-derived factors, which are secreted by the target fields of
neurons immediately prior to, or upon innervation, with the neurons being
neurotrophin independent prior to this. Whilst some neuronal populations are indeed
independent during the period of growth to their target fields (Vogel and Davies,
1991), this traditional view is increasingly challenged by the discovery that other
neuronal populations need to be supported by factors released from intermediate
tissue en route to their target fields (Buchman and Davies, 1993).
One such mode of intermediate trophic support is believed to arise from glial cells. In
the peripheral nervous system, both sensory and motor neurons are in an intimate
relationship with glial cells, with myelinating and non-myelinating Schwann cells as
well as satellite cells in close contact or surrounding neurons and their processes.
Various glial cell types have been implicated in the maintenance of neurons, since
these have been found to synthesize trophic factors (Davies, 1998; Saarma and
Sariola, 1999; Lemke, 2001). Indeed, "the development of neurons is likely to
depend equally on factors from the target fields they innervate and on factors from
the glia that surround them" (Mirsky et al., 2002). The importance of Schwann cells
for neuronal development was first identified by the discovery that they mediated the
morphological transformation of embryonic sensory neurons, from an immature
bipolar form to a mature pseudounipolar form (Mudge, 1984). Schwann cells have
since been reported to synthesize neurotrophic factors important for neuronal
survival, including NGF (Matsuoka et ah, 1991), BDNF (Acheson et ah, 1991), NT-3
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(Cai et al., 1999), CNTF (Sendtner et al., 1991), L1F (Matsuoka et al., 1997), GDNF
(Henderson et al., 1994), FGF (McGeachie et al., 2001), PDGF (Oya et al., 2002),
and TGF (Eccleston et al., 1989) (Bunge, 1993 for review). Schwann cells are ideal
candidates for intermediate trophic support, as their progenitors can be observed very
early in development, associating with outgrowing axons (Riethmacher et al., 1997).
In embryos lacking Schwann cell precursors due to mutations in neuregulin or one of
its receptors, there is widespread loss of sensory and motor neurons during
development (Meyer and Birchmeier, 1995; Gasmann et al., 1995; Lee et al., 1995;
Riethmacher et al., 1997).
The pattern of generation and migration of neural crest cells giving rise to Schwann
cells has been covered by in Chapter 1. After this migratory phase, Schwann cells are
generated in three phases: transition of neural crest to precursors (El2 to El3 in the
mouse), transition of precursors to immature Schwann cells (~E15), and the
formation of mature myelinating and non-myelinating Schwann cells (postnatal).
Neuronal derived neuregulins play a major role in controlling the development and
survival of satellite and Schwann cell precursors (Riethmacher et al., 1997; Hagedorn
et al. 2000; Mirsky et al., 2002). Neuregulins signal through members of the ErbB
family of receptor tyrosine kinases, namely ErbB 1, 2, 3 and 4 (Gassman and Lemke,
1997; Garratt et al., 2000). Since ErbB 1 and 2 are not as efficient at binding
neuregulins as ErbB 3 and 4, they rely on these other receptors to form heterodimers
with functional signalling capacity. As well as these heterodimers, ErbB4 can signal
by forming homodimers. ErbB3 can form homodimers as well, but since ErbB3 lacks
kinase activity, it cannot signal neuregulin binding without heterodimerisation.
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Among other functions, (3 neuregulin released from axons has been found to act via
ErB2/ErbB3 heterodimer receptors to control the survival of Schwann cell precursors
(Neuregulins and receptors reviewed in Garratt et ah, 2000).
Elucidating the influence of neuregulins on Schwann cell survival in vivo was made
difficult by the finding that neuregulin-1, ErbB2 and ErbB4 null mutants have an
embryonic-lethal cardiac phenotype at ~E10. Some evidence from these short-lived
embryos suggested an important role of neuregulin-1 and ErbB2 for the development
of Schwann cell precursors and cranial ganglia as well as in heart development
(Meyer and Birchmeier, 1995; Lee et ah, 1995). ErbB4 mutant embryos, albeit
having generally normal cranial ganglia, displayed aberrant targeting of cranial
sensory and motor axons (Gassman et ah, 1995). The early lethality of these null
mutants made further analysis of the importance of Schwann cell precursors difficult.
However, the phenotype observed in ErbB3 null mutant mice, which interestingly
exhibit satellite glia but not Schwann cell precursors along their peripheral nerves,
enabled the examination of the role of Schwann cells in neuronal development
(Riethmacher et ah, 1997). Dorsal root ganglion neurons in these mutant mice
appeared to develop normally up to El 2.5, before losing over 70% of their neuronal
complement by E14.5 and 82% by E18.5. Most of this loss was due to apoptosis of
post-mitotic neurons, as demonstrated by TUNEL staining at El3.5. In the DRG of
the mouse, sensory neurons are the first detectable population of differentiated cells,
differentiating slightly before satellite glia and Schwann cells are detectable (Lawson
and Biscoe, 1979). This, together with the above data, indicates that Schwann cells
and their precursors have no immediate effect on the differentiation and initial
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development of DRG neurons. Other neuronal population in the ErbB3 null mutant
embryos, such as spinal motoneurons, were also found to initially develop normally
before undergoing cell death. Riethmacher and colleagues demonstrated that the loss
of neurons was due to the lack of Schwann cell precursors, and not due to a direct
effect on neuronal survival. ErbB3 null mutant stem cells injected into blastocysts of
wildtype animals resulted in normal distribution of the mutant cells in neuronal
populations and other tissues, but lack of them in Schwann cell precursors. This
clearly suggests that the effect observed is related to the lack of Schwann cell
precursors, and not to a direct effect on neuronal survival, implicating trophic
support of neuronal populations by Schwann cell precursors. This effect of Schwann
cell precursors does not necessarily precede other modes of trophic support, since
neuronal loss in the DRG of ErbB3-deficient embryos occurs later in development
than the one observed in trkB and NT-3 knockouts. However, the death observed in
the DRG of ErbB3 null mutants still occurs in a period where axons are growing
towards their target fields, suggesting that Schwann cell precursors and Schwann
cells provide trophic support prior to the stage of target field innervation. The
survival of motoneurons is influenced by the absence of Schwann cell precursors
post-innervation, suggesting that Schwann cells play an important role after muscle
innervation as well. The scale of cell death in dorsal root ganglia and motoneurons
pools of ErbB3 null mutants raises the possibility that Schwann cell precursors are
crucial in providing multiple essential trophic factors to the neurons early in their
development, since neuronal losses in the DRG and in spinal motoneurons far
outweigh those observed in any single neurotrophic factor knockout (Davies, 1998).
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Another interesting observation in ErbBS-deficient mice was the abnormal
appearance of neural crest-derived cranial ganglia and nerves as early as E10, when
these structures form. This mirrored observations in neuregulin-1 (Meyer and
Birchmeier, 1995) and ErbB2 null mutants (Gassman et al., 1995) and was attributed
to an almost complete absence of neuronal migration and differentiation from the
neural crest rather than the death of post-mitotic neurons. ErbB2 null mutants were
found to have greatly reduced numbers of cranial neural crest derived neurons and
lacked both sensory and motor innervation connecting cranial ganglia to their
corresponding rhombomeres. Indeed, studies of the ErbB3 expression pattern in the
cranial ganglia suggested that neuregulin might be required as a survival factor for
neurogenic cells of the cranial crest (Meyer and Birchmeier, 1995). In summary, in
the cranial neural crest neuregulin signalling via ErbB3/ErbB2 appears to be essential
for the neurogenic lineage, whereas in the trunk neural crest it affects the early steps
in Schwann cell development and consequently neuronal survival in the trunk.
Signalling via the ErbB4 receptor appears to be more concerned with axonal
guidance.
Many neural crest-derived neurons require intermediate trophic support both in vivo
and in vitro at stages when they are growing towards their target fields. NT-3 has
been found in tissues on the trajectory of DRG axons during development as an
example (Farinas et al., 1996; White et al., 1996; Liebl et al., 1997).
In contrast, placode-derived neurons at similar stages in their development survive in
vitro for varying lengths of time without neurotrophins, a neurotrophic factor
independent period varying according to the distances the axons of these populations
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have to grow to their targets in vivo (Vogel and Davies, 1991). Neurotrophin
independence and the timing of the neurotrophin survival response in these neurons
appear to be controlled by an intrinsic timing mechanism in the neurons (Vogel and
Davies, 1991). An interesting issue arising from this study is that these populations
of neurons may not depend on intermediate support before reaching their targets and
may therefore not be lost in ErbB3 deficient embryos.
To assess this, the study presented in this chapter was aimed at analysing the
interesting question of Schwann cell derived support for placode-derived neurons, in
comparison with neural crest-derived neurons like the dorsal root ganglion. ErbB3-
deficient mice were used to assess the differences between placode-derived neuronal
populations (nodose ganglion), trunk neural crest-derived neuronal populations
(dorsal root ganglion) and cranial neural crest-derived neurons (trigeminal ganglion).
Neuronal numbers in cranial dorsal root ganglia were slightly decreased at El2, with
a drastic reduction of neuronal numbers by El3, confirming previous findings in
lumbar DRGs of ErbB3-deficient mice (Riethmacher et ah, 1997). In contrast to
these neural crest derived neuronal populations (which are believed to require
intermediate trophic support), the placode-derived neurons of the nodose ganglion
appeared to undergo little cell death, with only a slight reduction in neuronal
numbers ofErbB3-deficient mice by El4.
As expected from the phenotype of the neuregulin and ErbB2 null mutant mice, the
trigeminal ganglion was greatly reduced in the ErbB3 null mutants at the first age
studied (Ell) with the remaining cells presumed placode-derived cells due to their
spatial location in the ganglion. These remaining cells, however, although displaying
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normal outgrowth of their ophthalmic and maxillary branches, appeared to undergo a
higher rate of apoptosis between E12 and E14 compared to wildtype neurons,
suggesting they required intermediate support.
Rather than being related to differences between placode-derived neurons and neural
crest-derived neurons, the effect of Schwann cell precursors appears to be correlated
to the requirement of neurons on intermediate trophic support from surrounding
tissues, of which Schwann cell precursors are a part. An interesting observation was
that the onset of neuronal dependence on intermediate trophic support by Schwann
cell precursors appears to be intrinsic to different neuronal populations, with all cell
losses observed in this study coinciding with the time point of Schwann cell
precursor generation, but not preceding it. A further observation suggests an
excessive loss of non-neuronal cells in the nodose ganglia of ErbB3-deficient mice
(compared to that observed in other ganglia), although the identity of the cells lost
and the time point at which the loss occurs remains to be determined. Results further
suggest that the proportional reliance of neurons on trophic support from Schwann
cell precursors compared to other trophic support modes may be dependent on the
particular mouse strain examined. This is related to the magnitude of trophic support
by Schwann cells, and not the presence or absence of trophic support itself.
296
6.2 Results
ErbB3 mutant embryos were collected at daily intervals from Ell to El4. The
proportion of null mutant embryos obtained from heterozygous matings was in
agreement with previously found ratios, with a drastic reduction in frequency of
homozygous null mice from E13 onwards. The embryos were processed for
histology and the neuronal and pyknotic numbers in sensory ganglia quantified as
described in chapter 2. Because of the strict criteria for classifying pyknotic cells as
neurons, the actual proportion of dying cells shown in this results chapter is likely to
be greater than the estimates suggest. Differences in counts of pyknotic neurons have
previously been shown to be comparable to differences observed by double-labelling
neuron markers and apoptotic nuclei immunohistochemically (Pinon et al., 1996).
The phenotype of the sectioned trigeminal, nodose, DRG and SCG ganglia in ErbB3
knockout embryos at E14 is shown in Figure 6.1. Figure 6.2 shows the trigeminal
ganglion at the stages of El 1, E12 and El 3.
6.2.1 The nodose ganglion
The phenotype of the nodose ganglion in ErbBS knockout embryos at El 4 is shown
in Figure 6.1. Analysis of neuronal numbers revealed no significant differences in
neuronal numbers of the nodose ganglion of ErbBS-l- embryos compared with
wildtype embryos early in development (Ell and E12), with slight differences
emerging at El3 and E14 (20% and 14% reductions compared to wildtype
respectively, t-tests: p<0.005 and p<0.0005) (Figure 6.3). Neurons of ErbB3
knockouts were tightly packed during the initial phase of development.
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Figure 6.1: Comparison between E14 trigeminal, nodose, DRG and SCG
ganglia of wildtype and ErbB3 knockout animals
Nodose Wildtype Nodose Knockout
Trigeminal Wildtype Trigeminal Knockout
SCGWildtype SCG Knockout
Bright-field view of El 4 ganglia of the peripheral nervous system in wildtype or ErbB3 receptor null
mutants. The trigeminal (A-wildtype. B-knockout). nodose (C-wildtype. D-knockout), dorsal root (E-
wildtype, F-knockout) and superior cervical (G-wildtype, H-knockout) ganglia are depicted. The
massive neuronal loss observed in the trigeminal ganglion (B) can clearly be seen, in stark contrast to
the just slightly smaller than normal nodose ganglion (D). The almost halved size of the dorsal root
ganglion (F) and more than halved superior cervical ganglion (H) can also be seen.
DRG Wildtype DRG Knockout
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E12 - wildtype E12 - knockout
E13 - knockout




Bright-field view of El 1 -El 3 trigeminal ganglia of wildtype (A-El 1. C-E12, E-E13) and ErbB3-/- (B-
Ell, D-E12, F-E13) embryos clearly identified by cytoplasmic staining for piII-Tubulin (Promega)
and detected using DAB-peroxidase substrate (see chapter 2). The difference in size of ErhB3-/-
ganglia can be seen clearly (B, D and F), as well as the very densely packed neurons in the knockout
at El 1 (B).
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Neuronal density in the nodose was only restored to the equivalent of wildtype
animals by El4, being significantly denser before. Although the mean size of the
nodose is reduced from E12 onwards, this does not affect neuronal numbers due to
the increased neuronal density at this age.
The number of pyknotic neurons in the nodose ganglion as a proportion of the total
number is shown in Figure 6.4. The proportion of pyknotic neurons in the nodose
ganglion of ZsWtfiJ-deficient embryos was not significantly different from the
proportion seen in wildtypes at all ages studied. Although there may well be subtle
differences in apoptosis, these were not large enough to be detected. Alternatively, it
may be that neurogenesis in the nodose ganglion is slightly affected, giving rise to
the neuronal complement of the nodose ganglia ofErbB3-/- mice at El 3 and El 4.
Figure 6.3: Mean neuronal numbers in the nodose ganglion of wildtype and



























Mean neuronal numbers in nodose ganglia of Ell - E14 embryos with no mutations (blue) or a
homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ± standard error (n=6
for each data point).
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Figure 6.4: Mean percentage of pyknotic neurons as a proportion of total


















Mean percentage of pyknotic neurons in nodose ganglia of E12-E14 embryos with no mutations
(blue) or a homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ±





Figure 6.5 illustrates the trkA mRNA levels relative to GAPDH mRNA in the nodose
ganglion of El2 ErbB3-/- embryos and wildtype littermates. Consistent with the
normal numbers of neurons at this stage of nodose development, relative trkA
mRNA expression in ErbB3 null mutants was not significantly different from
wildtype littermates.
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Figure 6.5: Relative levels of trkA mRNA in the nodose ganglion of wildtype



























Mean relative levels of trkA mRNA relative to GAPDH mRNA in the nodose ganglion of wildtype
(WT) and ErbB3-l- embryos (KO) at E12. Bars represent the mean ± standard error (n=6 for each data
point).
Figure 6.6 and 6.7 illustrate the trkB and trkC mRNA levels relative to GAPDH
mRNA in the nodose ganglion of El2 ErbB3-l- embryos and wildtype littermates.
Consistent with the normal numbers of neurons at this stage of nodose development,
relative trkB and trkC mRNA expression in ErbB3-l- mice was not significantly
different from wildtype littermates.
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Figure 6.6: Relative levels of trkB mRNA in the nodose ganglion of wildtype



















Mean relative levels of trkB mRNA relative to GAPDH mRNA in the nodose ganglion of wildtype
(WT) and ErbB3-/- embryos (KO) at E12. Bars represent the mean ± standard error (n=6 for each data
point).
Figure 6.7: Relative levels of trkC mRNA in the nodose ganglion of wildtype





















Mean relative levels of trkC mRNA relative to GAPDH mRNA in the nodose ganglion of wildtype
(WT) and ErbB3-l- embryos (KO) at El2. Bars represent the mean ± standard error (n=6 for each data
point).
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6.2.2 The Dorsal root ganglia
The phenotype of the dorsal root ganglion in ErbB3 knockout embryos at El4 is
shown in Figure 6.1. Analysis of neuronal numbers revealed a small but significant
17% decrease in the neuronal complement of ErbB3-deficient C2 and C3 cranial
dorsal root ganglia at E12 (t-test; p<0.05) (Figure 6.8). There was an increase in
neuronal numbers between E12 and El3, but the increase in wildtypes was much
greater than in ErbB3-deficient mice. Neuronal numbers in the mutant were 37% of
wildtype by El3 in £W?53-deficient mice (t-test; pO.OOOOl). Between El3 and El4
there was little additional loss with a difference of 42% between knockout and
wildtype by El4 (t-test; p<0.00001).
Figure 6.8: Mean neuronal numbers in the dorsal root ganglion of wildtype



















Mean neuronal numbers in dorsal root ganglia of E12 - E14 embryos with no mutations (blue) or a
homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ± standard error











The number of pyknotic neurons in the dorsal root ganglion as a proportion of the
total number is shown in Figure 6.9. Early in development at E12 there was no
significant difference in the number of pyknotic neurons in ErbB3-/- mice (Mann-
Whitney; p>0.05). At El3 and El4, the number of pyknotic neurons decreased in
both wildtype and knockout, but the proportion of pyknotic neurons in ErbB3-/- mice
was significantly increased compared to wildtype numbers, by 65% and 165%
respectively (Mann-Whitney; both p<0.0001).
Figure 6.9: Mean percentage of pyknotic neurons as a proportion of total
neuronal number in the dorsal root ganglion of wildtype and



























Mean percentage of pyknotic neurons in dorsal root ganglia of E12-E14 embryos with no mutations
(blue) or a homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ±
standard error (n=4-12 for each data point).
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6.2.3 The trigeminal ganglion
Analysis of neuronal numbers revealed a very marked reduction in the trigeminal
ganglion of ErbB3-/- mice from Ell, the first age studied onwards (Figure 6.10). The
lack of neurons in the trigeminal ganglia of ErbB3 knockout embryos throughout
early development is shown in Figure 6.2. The difference between the knockout
animals and the wildtype animals grew with age, up to the last studied age of El4.
Neurogenesis in the trigeminal ganglion was evident in wildtype animals, with
increases in piII-Tubulin positive cells by 76% from El 1 to E12, 185% from E12 to
E13 and 24% from E13 to E14. In the ErbB3 null mutant, however, there was only
one obvious stage of neurogenesis in the ganglion (ANOVA; p<0.05), with a 56%
increase in neurons between E12 and El3 (Fisher's LSD; p<0.005) and no
significant differences between the other stages assessed.
Figure 6.2 demonstrates how the size of the trigeminal ganglion reflects the
differences between the neuronal numbers in ErbB3-/- and wildtype mice. At El 1 the
density of the trigeminal ganglion was greatly increased (t-test; p<0.0001; Figure
6.11) making up for some of the reduced size observed. At subsequent stages in
development the size of the ganglion increased, at the expense of the density, which
restored itself to the equivalent ofwildtype animals by El 2. The significance of these
events is not currently understood, but may be related to the absence of Schwann cell
precursors. Tissue shrinkage may be another explanation for the differences in cell
density, but as wildtypes and ErbB3-/- littermates were processed and stained at the
same time and in the same solutions, this is unlikely. As can be observed in the
slightly more distanced view of the trigeminal ganglion (El4) in figure 6.1, the
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position of the neurons present in the ganglion tended to be in the ventrolateral
region of the trigeminal ganglion. Neurons at prior ages appeared to be localised in
the same region.
Figure 6.10: Mean neuronal numbers in the trigeminal ganglion of wildtype



























Mean neuronal numbers in trigeminal ganglia of Ell - El4 embryos with no mutations (blue) or a
homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ± standard error
(n=6-8 for each data point).
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Figure 6.11: Mean neuronal density of the trigeminal ganglion ofwildtype and




















E11 E12 E13 E14
Embryonic age (days)
Mean neuronal density in trigeminal ganglia of Ell - E14 embryos with no mutations (blue) or a
homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ± standard error
(n=6-8 for each data point).
The number of pyknotic neurons in the trigeminal ganglion as a proportion of the
total number can be seen in figure 6.12. Whereas the proportional levels of apoptosis
seemed equal at the early stages of trigeminal ganglion development (Mann-
Whitney; Ell: p>0.2), the number of pyknotic neurons in the trigeminal ganglion
were subsequently higher than in wildtype embryos, being 66% higher at El2
(Mann-Whitney; p<0.05), 87% higher at El3 (Mann-Whitney; p<0.005) and 195%
higher at E14 (Mann-Whitney; p<0.005). These observations suggest that some of
the reduction in the neuronal complement of the trigeminal ganglia of ErbB3-/- mice
is related to a higher proportion of neurons undergoing apoptosis. As there are no
significant differences between the neuronal numbers in knockout animals at the ages
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studied (apart from the significant increase in numbers between E12 and El3),
increased cell death must be compensated by neurogenesis in the ganglion to some
extent.
Figure 6.12: Mean percentage of pyknotic neurons as a proportion of total
neuronal number in the trigeminal ganglion of wildtype and




















Mean percentage of pyknotic neurons in trigeminal ganglia of E11-E14 embryos with no mutations
(blue) or a homozygous null mutation for the ErbB3 receptor (red). Bars represent the mean ±
standard error (n=6-8 for each data point).
Relative levels or trk expression in the nodose and trigeminal ganglia were assessed
using quantitative RT-PCR as outlined in chapter 2. Figure 6.13 compares the trkA
mRNA levels relative to GAPDH mRNA in trigeminal ganglia of E12 ErbB3-l-
embryos and wildtype littermates. ErbB3 mutants displayed a 98% reduction in trkA
mRNA levels compared with wildtype littermates (t-test; p<0.00001). An attempt
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was made to quantify the relative trkB mRNA levels in El2 ErbB3 null mutants,
however, the levels were below the limits of detection.
Figure 6.13: Relative levels of trkA mRNA in the trigeminal ganglion of




















Mean relative levels of trkA mRNA relative to GAPDH mRNA in the trigeminal ganglion of wildtype
(WT) and ErbB3-/- embryos (KO) at El2. Bars represent the mean ± standard error (n=6 per data
point).
Figure 6.14 shows the trkC mRNA level relative to GAPDH mRNA in the trigeminal
ganglia of E12 ErbB3-/- embryos and wildtype littermates. ErbB3 mutants displayed
73% lower levels of trkC mRNA expression than their wildtype littermates (t-test;
p<0.00001). RT-PCR-gels showing differences in trkC mRNA in wildtype and
knockout animals are shown in Figure 6.15.
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Figure 6.14; Relative levels of trkC mRNA in the trigeminal ganglion of




Mean relative levels of trkC mRNA relative to GAPDH mRNA in the trigeminal ganglion of wildtype
(WT) and ErhB3-/- embryos (K.O) at E12. Bars represent the mean ± standard error (n=6 per data
point).
Figure 6.15: Gels showing the relative levels of trkC mRNA in the trigeminal
ganglion ofwildtype and ErbB3-l- embryos at E12
A - wildtype B - knockout
GAPDH GAPDH
SYBR'DGold (Molecular Probes) stained gels showing the products of RT-PCR reactions amplified
with either GAPDH-specific or trkC-specific primers. (A) Reactions containing 500fg of the GAPDH
competitor RNA (132bp) and 6.7fg of the trkC competitor (72bp) plus total RNA from wildtype El 2
trigeminal ganglia (GAPDH: 128bp; trkC: 68bp). (B) Reactions containing 83fg of the GAPDH
competitor RNA (132bp) and 0.83fg of the trkC competitor (72bp) plus total RNA from ErbB3-/- E12
trigeminal ganglia (GAPDH: 128bp; trkC: 68bp).
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6.2.4 The superior cervical ganglion
Although the main focus of this section is the survival of sensory neurons, the
superior cervical ganglion was also assessed at El4 to determine whether any
changes could be observed in sympathetic neurons. The phenotype of the superior
cervical ganglion in ErbB3 knockout embryos at E14 is shown in Figure 6.1.
Analysis of neuronal numbers revealed a major difference between ErbB3-/- and
wildtype embryos (Figure 6.16). In null mutants, there were 59% fewer neurons than
in the wildtype littermates (t-test; p<0.00001). Pyknotic neurons were not counted in
the SCG due to the small size and high density of the neurons, making adequate
identification of pyknotic nuclei impossible using CFV-staining (see chapter 2).
Figure 6.16: Mean neuronal numbers in the E14 superior cervical ganglion of



























Mean neuronal numbers in the superior cervical ganglion at E14. Wildtype embryos (blue) and
homozygous null mutants (red) are represented. Bars represent the mean ± standard error (n=6 per
data point).
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6.2.5 Non-neuronal cells in the nodose, DRG and trigeminal ganglia
To assess the effect of the ErbB3 null mutation on non-neuronal cells in the ganglia
studied, the total number of visible cells in CFV-stained sections at E14 (neuronal
cells, identified by their large pale nucleus surrounded by stained cytoplasm, and
non-neuronal cells, identified as all cells not displaying neuronal criteria) were
quantified and corrected as described for neuronal cells (chapter 2). The number of
non-neuronal cells was then expressed as a proportion of the number of neuronal
cells. In all the sensory ganglia studied the proportion of non-neuronal to neuronal
cells in wildtype mice was approximately 1:1 (Figures 6.17 - 6.19). In the trigeminal
ganglion, this proportion remained unchanged in ErbB3-/- embryos (Figure 6.17;
Mann-Whitney; p>0.1). In the DRG and the nodose ganglia there were significantly
less non-neuronal cells per neuronal cell than in the wildtype embryos. In the DRG,
the ratio was reduced by approximately 20% to 0.8 non-neuronal cells per neuronal
cell (Figure 6.18; Mann-Whitney; p<0.05), whereas in the nodose ganglion the ratio
was reduced by over 60% to 0.4 non-neuronal cells per neuronal cell (Figure 6.19;
Mann-Whitney; p<0.005).
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Figure 6.17: Mean proportion of non-neuronal to neuronal cells in the







































































Mean proportion of non-neuronal to neuronal cells in the dorsal
root ganglion of wildtype and ErbB3-/- embryos
Wildtype
Genotype



































Mean proportion of non-neuronal to neuronal cells in the nodose
ganglion of wildtype and ErbB3-l- embryos
Wildtype ErbB3-/-
Genotype
Bars represent the mean ± standard error (n=6 per data point).
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6.3 Discussion
The aim of this study was to establish the importance of Schwann cell precursors for
the survival of populations of embryonic sensory neurons using ErbB3-/- mice which
lack these cells. The number of neurons in the nodose ganglia of ErbB3-deflcient
embryos remained normal until El3 and E14, where only a slight reduction in
number was observed. No differences in the number of pyknotic neurons were found
at any of the ages studied, and the relative levels of trkA, trkB and trkC mRNA in the
ganglion were unchanged in El2 ErbB3-/- mice. Dorsal root ganglia of ErbB3-/-
mice displayed little loss of neurons at El2, followed by a large loss in the neuronal
complement by El 3 and El4. This was reflected by increased numbers of pyknotic
neurons at these ages. Neuronal numbers in trigeminal ganglia of ErbB3 knockouts
were greatly reduced from the earliest age studied (Ell), remaining low throughout
the normal period of neurogenesis of this population of neurons. Reduced neuronal
numbers appeared to be most prevalent in the dorsomedial part of the ganglion. The
number of pyknotic neurons expressed as a proportion of total neuron number was
normal in the trigeminal ganglion at Ell, but at subsequent ages there were higher
proportional amounts in ErbB3-/- compared to wildtype embryos. The relative levels
of both trkA and trkC mRNA were greatly reduced in E12 £Wr63-deficient
trigeminal ganglia compared to wildtype ganglia. Neuron numbers in the superior
cervical ganglia were also reduced in ErbB3-deficient mice at El4 compared to
wildtype mice. The number of non-neuronal cells approximately matched the number
of neurons in the trigeminal and DRG ganglia of wildtype and ErbB3-l- mice. In
wildtype nodose ganglia the number of non-neuronal cells also matched the number
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of neurons, however, in ErbB3-/- nodose ganglia the ratio of non-neuronal to
neuronal cells was greatly reduced.
These results indicate that nodose neurons are less dependent on intermediate trophic
support from Schwann cell precursors while growing to their target field than
trigeminal, DRG and SCG neurons. However, non-neuronal cells in the nodose
ganglion appear to be more sensitive to the ErbB3 mutation than non-neuronal cells
in the other ganglia, indicating different survival requirements. The nature of the
non-neuronal cells lost preferentially in the nodose ganglion is unknown at present.
Nodose neurons have previously been found to survive for long periods of time in
culture independently of trophic factors at the stage when their axons are growing to
their target fields (Vogel and Davies, 1991). This prolonged period of neurotrophin
independence appears to be related to the long distance the peripheral and central
axons of these neurons are required to grow to their target fields, further than other
sensory neuron population. This period of neurotrophin independence appears to be
intrinsically programmed in nodose and other placode-derived neurons (Vogel and
Davies, 1991). Nodose neurons may thus not depend on intermediate neurotrophic
support from cells and tissues lying en route to their targets before these targets are
reached. The unchanged proportion of pyknotic neurons, together with the unaltered
expression of trk receptors further suggests that nodose neurons are independent of
intermediate support from Schwann cell precursors. The slight decrease in neuronal
numbers in ErbB3 null mutants suggests that some intermediate support by Schwann
cell precursors is required by a minority of nodose neurons while their axons are
growing towards their target fields. In summary, most nodose neurons appear to be
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independent of intermediate support by Schwann cell precursors during the period of
growth to their target fields, consistent with their independence on trophic factors
during this period.
Findings in the DRG confirmed that neurogenesis in ErbB3-/~ mice initially occurs
normally in this neuronal population (Riethmacher et al., 1997), with little loss of
neurons at El2. The massive subsequent loss of neurons in the ganglion, however,
coincides with a significant increase in pyknotic neurons at E13 and El4. This period
of enhanced neuronal loss during which neuronal loss in the DRG of ErbB3-/-
embryos coincides with the stage of development when many axons are still growing
towards their targets, suggesting that this neuronal population is dependent on
intermediate trophic support from factors released by Schwann cell precursors. The
increased neuronal death coincides with the period of Schwann cell precursor
generation between E12 and El3 in the mouse embryo (Mirsky et al., 2002).
However, the extent of neuronal loss observed in the DRG of ErbB3-/- animals
studied here (-42%) is less than previously reported (-70%) (Riethmacher et al.,
1997). There are two possible explanations for this. First, there may be differences in
the background strain of the mice used. The previous study was carried out in a
C57/BL6 background, whereas mice used in the current study had been bred into a
CD1 background. This raises the interesting possibility that neurons in different
strains of mouse could be affected differently by deficits in Schwann cell precursors.
Differences in background strains have previously been reported to affect the number
of DRG neurons in JSEWF-deficient mice (Farinas, 1999; (Liebl et al., 1997). Second,
the effect observed may be due to the rostral-caudal position of the DRG counted. In
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the present study, the C2 and C3 DRG were counted, whereas the previous study
assessed L3 and L4 DRG (Riethmacher et al., 1997). It is possible that neurons in the
DRG follow the same rostral-caudal phenotype seen with the sympathetic chain, with
neuronal loss being more severe in caudal areas (see below).
The neuronal deficit observed in the trigeminal ganglion of ErbB3-t- mice early in
development confirms non-quantified deficits observed earlier in the development of
neuregulin-l- and ErbB2-/- mice (Meyer and Birchmeier, 1995; Lee et al., 1995).
These deficits were attributed to neuregulin signalling through ErbB2/ErbB3 being
essential for the neurogenic lineage of the cranial neural crest.
In birds, neural crest-derived neurons occupy a dorsomedial position in the
developing trigeminal ganglion, whereas those of placodal origin lie in the peripheral
rim of the ganglion, forming a ventrolateral 'cap' (Noden, 1980; Davies and
Lumsden, 1990). Also, avian trigeminal ganglion neurons of different embryonic
origins tend to make contact with different target tissues (Davies, 1988). Therefore,
an interesting observation in the ErbB3-/- mice studied was that the remaining
neurons occupied a ventrolateral position in the ganglion (see Figure 6.6). This may
suggest that the remaining cells in the trigeminal ganglion of ErbB3-l- embryos were
of placodal origin, and that the neural crest-derived complement was reduced or
missing, in accordance with previous observations in neuregulin-l- and ErbB2-/-
embryos (Meyer and Birchmeier, 1995; Lee et al., 1995).
The strongly decreased levels of trkA mRNA observed in ErbB3-l- trigeminal
ganglia would support this hypothesis. In the chicken, neurons expressing trkA
transcripts are confined to the dorsomedial portion of the early trigeminal ganglion,
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representing the neural crest-derived portion of the ganglion. Neurons expressing
trkB and trkC are located ventrolaterally, representing the placode-derived portion of
the ganglion (Williams et al., 1995). This would explain the massively reduced levels
of trkA mRNA observed in the trigeminal ganglion of ErbB3-l- embryos at El2,
whereas reductions in trkC mRNA levels were less drastic. However, if one assumes
that trkA-expressing neural crest-derived neurons are lost in the trigeminal ganglion
at this stage with little effect on the placode-derived neuronal complement, one
would expect a proportional increase of trkB and trkC relative to GAPDH mRNA in
the ErbB3-/- embryo. This would be a consequence of the relative reduction in
absolute GAPDH mRNA levels in the ganglion of ErbB3-/~ mice following the loss
of neurons of neural crest origin. TrkB mRNA, although detectable in wildtype
ganglia, was below detectable levels in ErbB3-/- mice, with trkC mRNA greatly
reduced too. Schwann cells, but not Schwann cell precursors have been shown to
express trkC. This makes it unlikely that the reductions in trkC receptor expression
were related to the absence of Schwann cell precursors. This suggests that, even if
the cells seen in the ganglion were of placodal origin, they were still affected by the
ErbB3 null mutation.
In early ErbB2 null mutants, the maxillary and ophthalmic nerves of the trigeminal
ganglion appear normal, which appears to be the case for the ErbB3 mutants as well,
at least at Ell (see figure 6.10). This would suggest that early trigeminal,
presumably placode-derived, neurons extend ophthalmic and maxillary axons
normally. At later ages in ErbB3-t- embryos, few projections were observed from the
trigeminal ganglion (Figures 6.10 and 6.6), suggesting that the initially normal
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outgrowth is not maintained later in development. This correlates with the increased
proportion of pyknotic neurons observed from El2 to El4. The increased neuronal
death correlates with the onset of Schwann cell precursor generation in the mouse
between El2 and El3 (Mirsky et ah, 2002). This would rule out any direct
implication of Schwann cell precursors in the initial deficit observed in the
trigeminal ganglion at Ell, but suggests that they mediate trophic effects on the
remaining population of neurons later in development. It is thus possible that many
placode-derived neurons of the trigeminal ganglion develop normally initially, but
subsequently die due to a lack of Schwann cell precursor-mediated trophic support.
Neurons extending axons to the maxillary process are known to require intermediate
trophic support by BDNF and NT-3 during axonal growth (Buchman and Davies,
1993; Paul and Davies, 1995). The results suggest that at least some placode-derived
neurons in the trigeminal ganglion initially extend axons to the maxillary process
independently of intermediate trophic support, but subsequently become dependent
on such trophic support from Schwann cell precursors.
Neuronal numbers in the SCG at E14 were reduced in ErbB3 null mutants in
comparison with wildtype embryos. Severe hypoplasia of the primary sympathetic
chain has previously been reported in ErbB3-/~ mice, as well as in ErbB2 and
neuregulin-1 null mutants at E10.5 (Britsch et al., 1998). This was attributed to an
impaired migration of neural crest cells to the anlage of the primary sympathetic
chain. Normal migration of neural crest cells was observed to the anlage of DRG,
followed by a severe reduction in the cells migrating beyond this point towards the
sympathetic anlage. This previous study found only small changes in the size of the
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SCG at El2.5, with effects being more severe in the caudal portion of the
sympathetic chain, illustrating a rostral-caudal phenotype. This would suggest a
migration pattern closer to wildtype in the rostral part of the embryo. There are
indeed indications that the migration of neural crest cells to the SCG occurs
differently from other ganglia in the sympathetic chain, and may thus not require the
neuregulin signalling system required by trunk sympathetic neural crest cells for
migration. The SCG is predominantly generated from sympathogenic neural crest
cells from the hindbrain rather than trunk crest cells (Durbec et al., 1996).
Reduction in the number of SCG neurons observed at El 4 would likely be related to
neuronal death due to the lack of Schwann cell-derived support rather than to deficits
in migration. By El7.5 a 50% reduction of the SCG was observed in previous
studies, whereas the remainder of the sympathetic chain was almost completely
absent (Britsch et al., 1998). Interestingly, in the CD1 background mutants of this
study, a reduction in neuronal numbers in the SCG of ErbB3-/- mice of
approximately 60% was found at E14 already, suggesting potential differences in the
support mediated by Schwann cells depending on the mouse strain examined.
The results of non-neuronal cell counts at El4 are interesting, because of the
apparent deficiency in non-neuronal cells in relation to neurons in the nodose ganglia
of ErbB3-/~ mice. In the other ganglia studied, the trigeminal and the DRG, the
number of non-neuronal cells appears to match the number of neurons (or vice-
versa). It will be important to establish the type of cell excessively lost in the nodose
ganglia of ErbB3-/~ mice, since these appear to be more vulnerable to this mutation
than the neurons in the ganglion and non-neuronal cells in other sensory ganglia. Of
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the glial cells within the ganglion, satellite cells have been detected in the trigeminal,
DRG, nodose and SCG of ErbB3-l- mice (Britsch et al., 2001). These measurements
were made at the earlier developmental stage of E12.5, however, allowing for the
possibility of an excessive loss of this cell type in the nodose ganglion after this
period of development. It will be necessary to establish whether the number of
satellite cells within the nodose and other ganglia studied remains unaffected in
ErbB3-/- mice by El4, using antibodies such as B-FABP (Brain-specific fatty acid
binding protein; Kurtz et ah, 1994). Should it be found that there is a deficiency in
satellite cells in the nodose ganglion, this would further illustrate the ability of this
population of neurons to survive in the absence of intermediate trophic support, since
other sensory neuron populations undergo more severe losses in mice lacking both
Schwann cell precursors and satellite cells (Britsch et ah, 2001).
In summary, normal neuronal numbers were observed in the dorsal root and nodose
ganglia of ErbB3-/- mice at El2. Both the losses observed in the trigeminal ganglion
and the SCG can be partially explained by deficits in migration of the neurogenic
neural crest lineage. The DRG and nodose ganglia subsequently lost a proportion of
neurons between El2 and El3. However, neuronal deficiency in the DRG was
double that seen in the nodose ganglion. Additionally, increases in the proportion of
apoptosis were observed in the DRG, whereas none were seen in the nodose ganglion
at later stages. Together these data suggest that neural crest-derived neurons in the
DRG are more reliant on intermediate trophic support by Schwann cell precursors
than placode-derived neurons in the nodose ganglion. This correlates with the
requirement of the majority of neural crest-derived sensory on intermediate trophic
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support, whereas most placode-derived sensory neurons at similar stages survive for
varying lengths of time without neurotrophins in vitro that are correlated with target
distance. Interestingly, the remaining neurons in the trigeminal ganglion, lying in a
placodal location, appear to be dependent on Schwann cells. The apparently normal
ophthalmic and maxillary projections in ErbB3-/- embryos at El 1 suggest that these
neurons extend axons to these target fields. However, these projections subsequently
appear to be reduced, which together with the increased proportion of pyknotic
neurons and the decreases in relative trkB and trkC mRNA levels suggests a loss of
neurons extending axons towards these targets during the period of Schwann cell
precursor generation. Neurons extending axons to the maxillary process are known to
require intermediate trophic support from surrounding tissue, which is likely to be
derived at least in part from Schwann cell precursors.
Analysis of pyknotic neuron counts revealed that the proportion of dying neurons in
the trigeminal and dorsal root ganglia of ErbB3-/- embryos started increasing at
E12/E13, compared with wildtype embryos, coinciding with the generation of
Schwann cell precursors. This suggests that prior to this period the neurons were
independent of factors released by Schwann cell precursors, consistent with the
differentiation of sensory neurons preceding Schwann cell precursor generation in
the DRG (Lawson and Biscoe, 1979). Since there can be no signal from the Schwann
cell precursors to trigger this dependency in ErbB3-/- embryos, it is possible that this
increased neuronal death is due either to an intrinsic programme in the neurons or to
signals from other cells which govern the onset of Schwann cells precursor
dependence.
324
Some aspects of this study will require further investigation. Lee et al. (1995)
determined that it was the neural crest derived portion of the trigeminal ganglion
missing in ErbB2 knockout mice (see Figure 6.1 for an indication of this in ErbB3
null mutants). This was done on the assumption that the dorsomedial region of the
ganglion was missing and the ventrolateral region of the ganglion still present, a line
of thought adopted in the analysis of this study. However, even though the
indications suggest that the neurons remaining in older ganglia are of placodal origin,
this will have to be determined with certainty. It could be that the neurons are neural
crest derived but misplaced in relation to their normal position. Neuregulin signalling
has been shown to be important for the positioning of neurons into distinct ganglia.
For example, ErbB4 null mutations result in near-fusion of the trigeminal and the
geniculate ganglia (Gassman et al., 1995). No such effect has been reported in
ErbB3-/- mice, however, which signifies that this receptor is not involved in such
processes. The degree of absence of neural crest-derived neurons and the presence of
placode-derived neurons will need to be assessed using specific markers, which are
currently only available for the chick (Covell and Noden, 1989; Stark et al., 1997). It
would be interesting to examine whether placode-derived sensory neuron populations
that have closer targets than nodose neurons, such as the geniculate ganglion,
become dependent on Schwann cell support earlier in development than nodose
ganglion neurons.
To study more fully the influence of Schwann cells and their precursors on neural
crest-derived neurons, it will be necessary to look at alternative methods, since all of
the null mutants studied thus far have deficits in neurogenic neural crest migration
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and differentiation. Conditional mutations, eliminating ErbB3 purely in sensory
ganglia and thus allowing normal migration of neural crest cells, may provide an
alternative approach to solving this problem.
Regulation of the onset of Schwann cell precursor dependence will need to be
addressed, possibly using co-cultures of neurons with Schwann cell precursors, a
strategy that would be suitable to study the effects of Schwann cell precursors on
neural crest-derived neurons as well. Methods for culturing Schwann cell precursors
have recently been identified (Dong et al, 1999; Lobsiger et al., 2000).
The importance of other glial cells in providing neurotrophic support in the
peripheral nervous system will also need to be examined. Satellite cells, for example,
are still present in the ErbB3 null mutant at early stages of development (although
there may be deficiencies later in development, as suggested by non-neuronal cell
counts in the nodose ganglion) (Britsch et al., 2001). The recently generated Sox 10
null mutant mouse (a transcription factor for, among others, ErbB3), was found to
lack both satellite and Schwann cell precursors. This mutant was found to have more
severe sensory and motor deficits than the ones observed in the ErbB3 knockout
(Britsch et al., 2001). It would thus be of interest to study this null mutant to
determine whether the variations between neuronal populations requiring
intermediate support and those who do not may be even more accentuated, due to




The results presented in this section support the idea that early trigeminal and dorsal
root ganglion neurons are dependent on trophic support from Schwann cells and their
precursors when their axons are growing to their targets whereas nodose neurons are
mostly independent of such support which is consistent with previous in vitro data
suggestive of a prolonged period of neurotrophic independent survival in nodose
neurons when the axons of these neurons are growing to their targets. This difference
in dependence is summarised in Figure 6.20.
The molecular nature of trophic signals from Schwann cell precursors in vivo is
currently unclear. Members of the GDNF family of trophic factors have been
suggested to play a part in the survival effects on motoneurons. GDNF mRNA is
found in Schwann cell precursors and immature Schwann cells, which together with
the loss of motoneurons in GDNF-/- mice by birth suggesting that this is one of the
factors released by Schwann cells and their precursors to promote motoneuron
survival. GDNF is unlikely to promote the survival of DRG neurons, however, since
its receptor Ret is expressed at very low levels at the stages these neurons undergo
cell death in ErbB3-/- embryos. NT-3 is produced by early Schwann cells, and may
thus be a factor important for the survival of sensory neurons during axonal growth,
since both the dorsal root and trigeminal neurons are believed to require this factor
early in development. However, NT-3 secretion by Schwann cell precursors still
remains to be demonstrated (reviewed by Jessen and Mirsky, 1999).
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Figure 6.20: Differences in intermediate trophic dependence on Schwann cells
and their precursors between the trigeminal/dorsal root ganglia
and the nodose ganglion







Figure illustrating the differences in intermediate survival requirements of trigeminal and dorsal root
ganglia neurons (A) and of nodose neurons (B) as they extend axons to their target fields. While
trigeminal and dorsal root neurons require intermediate trophic support from Schwann cells and their
precursors en route to their targets (blue), nodose neurons appear to be less dependent on such





The key findings of the thesis may be summarised as follows:
T, Contrary to previous assumptions, trkA mRNA levels in the trigeminal ganglion
do not appear to be solely regulated by intrinsic mechanisms. The sharp intrinsic
increase in trkA expression taking place between El 1 and E13 (coinciding with the
onset of NGF-dependence) is dampened down by substance(s) released from the
target fields in vitro. This period covers the time between innervation and
programmed cell death in vivo. trkA expression levels then decrease between El4
and El5, with the target fields having no effect on trkA expression in the ganglion at
these later ages.
2. Further to the effect of the target on ganglion trkA expression, there appears to be
a reciprocal interaction controlling target NGF expression in early development. In
vitro results suggest that initial early innervation promotes NGF expression in the
target field. In vivo, a small early decrease in NGF mRNA was detected in target
fields of mice with an early deficiency of neurons.
T The pattern of neuronal death in the trigeminal ganglion of trkA, trkB and
trkA/trkB knockouts suggests that during certain stages in development there are
subsets of neurons, which can survive with either one or the other receptor, whereas
at other stages both receptors are required.
p75 appears to be required for survival in the trigeminal ganglion from E14
onwards, with a truncated receptor isoform promoting survival earlier in
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development than the full-length receptor. This demonstrates a role for p75 in
regulating embryonic sensory neuron survival in vivo.
4. Early trigeminal and dorsal root neurons appear to be dependent on trophic
support from Schwann cell precursors earlier in development, when their axons are
growing to their targets, whereas nodose neurons are more independent of such
support, possibly reflecting the greater distance these neurons axons cover prior to
innervation.
Placing these results in context with each other, they are all concerned with factors
mediating the survival of embryonic sensory neurons. Both aspects of their
regulation (Chapters III and IV) and the effect of their absence (Chapters V and VI)
have been studied. Figure 7.1 attempts to bring these different factors together using
the example of the trigeminal ganglion.
One common aspect to the chapters is that each observation in early development can
be interpreted as a means to optimize survival prior to competition and programmed
cell death (PCD) (Figure 7.1, A and B).
Reduction of trkA expression in early development (Chapter 3) could serve to delay
the onset ofNGF-dependence in some neurons, enabling more to survive before PCD
and thereby maximizing competition, enabling the target field to 'select' the most
appropriately connected neurons. It could be speculated that downregulation by the
target field and an associated trkA-signalling independence is the explanation for
apparent discrepancies between neuronal losses in the trigeminal ganglion of trkA
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knockouts being observed from El3 onwards (Pinon et al., 1996), whereas in in vitro
dissociated cultures (i.e. with no target field present), the onset of trkA-survival
response has been determined as El 1 to E12 (Buchman and Davies, 1993).
The positive effect of innervation on target NGF production (Chapter 4) further helps
optimize selection. Increased expression of NGF would enable neurons that are
dependent on NGF prior to competition to be maintained with sufficient NGF supply.
Further mechanisms to aid survival prior to competition include the early survival-
dependence of trigeminal neurons on BDNF and NT-3, signalling through trkB, and
the subsequent phase where neurons appear to have the potential to survive through
either BDNF and NT-3 or NGF, signalling through trkB or trkA (Chapter 5).
Finally, the early dependence of neuronal populations on Schwann cells and their
precursors (Chapter 6) may be an additional mode of support before neurons are
required to compete for survival factors. In this instance, however, there is no
information on the neuronal support requirement on Schwann cells and their
precursors later in development, during neurotrophin competition and thereafter. It
may thus be that Schwann cells and their precursors support neurons at later stages as
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Figure summarizing the survival factors for mouse trigeminal sensory neurons and their regulation
early in development. (A) Trigeminal ganglion neurons and their target field just before and upon
innervation. After neurotrophin independence, trigeminal neurons become mainly dependent on
BDNF and NT-3 released from intermediate tissue and from their target field (Chapter 5). They are
also dependent on Schwann cell precursors for their survival at this stage (Chapter 6). The arrival of
neurons at the target field appears to promote the expression of NGF (Chapter 4), while trkA
expression on neurons is downregulated in the stages immediately prior to, and after, target field
contact (Chapter 3). (B) Between innervation and programmed cell death (PCD), neurons can be
maintained by either NGF or BDNF (Chapter 5), with inhibition of trkA expression being less
pronounced than at earlier stages (Chapter 3). (C) Time of trophic factor competition, where the
majority of neurons compete for NGF (Chapter 5). (D) After programmed cell death, there appears to
be a diversification of survival-dependency, with some neurons dependent on NGF or BDNF alone
and some neurons dependent on both simultaneously for survival (Chapter 5). Schwann cells and their
precursors may have important functions for neuronal survival at later stages of development and are
hence shown at all ages (adapted from Davies, 2003).
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In addition, it was found that different neuronal populations have different ways to
maximize survival prior to trophic factor competition, with trigeminal ganglion
neurons relying on a variety of factors (Chapters 3,4,5 and 6), whereas nodose
ganglion neurons stay independent of trophic support for a longer period (Davies and
Vogel, 1991, Chapter 6).
The finding that the survival-dependency of neurons diversifies after the period of
neurotrophin competition (Chapter 5) is interesting. Assuming that the most
appropriately connected neurons have been selected, these can now be differentiated
from other neurons by making them dependent on different survival factors or a
combination of them. Although this hypothesis was not directly tested, studies in
other sensory neurons indicate that neurotrophins are involved in the determination
of neuronal phenotype (Lewin, 1996). It could be speculated that the single or joint
trophic factor dependence of different neuronal subpopulations at these late stages of
programmed cell death enables the selection and phenotype determination of neurons
innervating specific targets or specific cells within targets. Neurotrophins may thus
not only be a means to match neuron and target cell populations, but may also serve
to select and differentiate neurons with different functions.
Neurotrophins have also been demonstrated to regulate dendritic growth in the
peripheral nervous system (reviewed in McAllister, 2000). Single or joint trophic
factor dependence may thus also play a role in shaping the dendritic length and
arborisation of different subgroups of neurons, depending on their function.
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More information is needed to fully elucidate the points raised in this thesis. There
are various avenues of research that could be pursued to give more insight about
some of the observations made in chapters III to VI. Firstly, it may be useful to
identify and isolate the substance responsible for the downregulation of trkA mRNA,
in order to determine whether it plays important roles at other stages of development
or in disease, and to identify the mechanism of trkA-downregulation. Secondly, the
extent to which early arriving sensory neurons can regulate NGF mRNA levels in the
maxillary target field will need to be determined using younger ages, adapting the
tissue culture methodology to enable the trigeminal ganglion to stay intact in culture
at these stages. Identifying mouse mutants with reduced or no innervation of the
maxillary target field in vivo may further improve the understanding of events up-
regulating NGF mRNA early in development. The extra- and intracellular
mechanisms mediating this NGF upregulation also require investigation. Thirdly, it
will be interesting to determine the future phenotype of neurons that respond to
different neurotrophins signalling through their trk or p75 receptors at different
stages of development. Such a study could include other trophic factors, such as
cytokines. This may give insights into the way neuronal phenotype is determined by
the individual action or combination of survival factors acting on a neuron during
development. Finally, the study of conditional mutants, with deficits in the survival
of Schwann cells and their precursors but not in the migration of neural crest cells,
should give a better insight on the timing and magnitude of neuronal cell loss in
some sensory ganglia at different stages of development. New tissue culture
methodology, enabling the culture of Schwann cells and their precursors (Lobsiger et
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al., 2000), will be useful in determining the sensitivity of different neuronal
populations to Schwann cell trophic support.
The findings in this thesis do not contradict the neurotrophic hypothesis, but the data
would support a modified theory, at least prior to programmed cell death, in which a
dynamic interplay regulating supply and reception of survival signals, rather than
passive receipt/competition for that signal takes place. There may thus be more
aspects to survival in early embryonic development than previously thought, with
regulatory mechanisms acting in conjunction with other factors in order to maximize
choice during the period of cell death. In summary, it can thus be said that trophic
factors do not only play an important role during the period of naturally occurring
cell death; they are also needed at other stages of development, taking place in the
period before or late in programmed cell death, and can be released from tissues
other than the target fields, such as surrounding intermediate tissues or Schwann cells
and their precursors. Further study of these complex interactions should give more
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This section shows some preliminary findings that have been mentioned in the results section
of chapter 3.
Figure A.l: trkA expression in the Ell trigeminal ganglion after 24 hrs in culture
without or with its peripheral and central targets attached (cultured




















TG-0 TG TGMX TGHB TGMXHB
Expression of trkA in El I trigeminal ganglia after 24hrs in culture without growth factors added to the medium,
TG-0: Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX:
Expression in the ganglion grown with the maxillary process. TGHB: Expression in the ganglion grown with the
hindbrain. TGMXHB: Expression in the ganglion grown with both target fields. As can be seen, trkA expression
still increases, and the target fields still effect a reduction in trkA expression when ganglia are grown without
survival factors. Bars represent the mean ± standard error (n=l-5 per data point).
387
Figure A.2: trkA expression in Ell trigeminal ganglia after 24 hrs in culture with
























TG0 TG-24 TG in MX TG in HB
conditioned medium conditioned medium
Expression of trkA in El I trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3 in maxillary and
hindbrain conditioned medium obtained by growing these target fields in 50f.il of medium for 24hrs. TG-0:
Expression in ganglia before culture. TG: Expression in the ganglion grown alone in control (incubated for 24hrs
without targets) medium TG in MX conditioned medium: Expression in the ganglion grown alone in maxillary
process conditioned medium. TG in FIB conditioned medium: Expression in the ganglion grown alone in
hindbrain conditioned medium Whereas the maxillary process conditioned medium had no effect on trkA
expression, the hindbrain conditioned medium resulted in reduced trkA expression in the trigeminal ganglion.
Flindbrain conditioned medium thus replicates the observations made with hindbrain homogenate. Bars represent
the mean ± standard error (n=4 per data point).
388
Figure A.3: trkB expression in the Ell trigeminal ganglion after 24 hrs in culture





















TG-0 TG TGMX TGHB
Expression of trkB in Ell trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-0:
Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX: Expression in
the ganglion grown with the maxillary process. TGHB: Expression in the ganglion grown with the hindbrain.
TGMXHB: Expression in the ganglion grown with both target fields. As can be seen, trkB expression increases
less than trkA over 24hrs in culture, and the target fields appear to have little effect on trkB expression Bars
represent the mean ± standard error (n=2 per data point).
Figure A.4: trkC expression in the Ell trigeminal ganglion after 24 hrs in culture























TG-0 TG TGMX TGHB
Expression of trkC in Ell trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-0:
Expression in ganglia before culture TG: Expression in the ganglion grown on its own. TGMX: Expression in
the ganglion grown with the maxillary process. TGHB: Expression in the ganglion grown with the hindbrain.
TGMXHB: Expression in the ganglion grown with both target fields. As can be seen, trkC expression increases
less than trkA over 24hrs in culture, and the target fields appear to have little effect on trkC expression. Bars
represent the mean ± standard error (n=2 per data point).
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Figure A.5: p75 expression in the Ell trigeminal ganglion after 24 hrs in culture



















TG-0 TG TGMX TGHB
Expression of p75 in Ell trigeminal ganglia after 24hrs in culture with NGF, BDNF and NT-3. TG-0:
Expression in ganglia before culture. TG: Expression in the ganglion grown on its own. TGMX: Expression in
the ganglion grown with the maxillary process. TGF1B: Expression in the ganglion grown with the hindbrain.
TGMXHB: Expression in the ganglion grown with both target fields. As can be seen, p75 expression increases
strongly over 24hrs in culture, and co-culture with the hindbrain appears to reduce p75 expression in the
ganglion. The maxillary process has little effect on p75 expression in this experiment. Bars represent the mean ±
standard error (n=2 per data point).
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